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ABSTRACT 
 
Molecular Interactions of Salmonella with the Host Epithelium in Presence of 
Commensals 
 
by 
Prerak T. Desai 
Utah State University, 2010 
 
Co-Major Professors: Dr. Bart C. Weimer and Dr. Marie K. Walsh 
Department: Nutrition, Dietetics, and Food Sciences 
 
 
 Food-borne infections are a major source of mortality and morbidity. Salmonella 
causes the highest number of Food-borne bacterial infections in the US. This work 
contributes towards developing strategies to control Salmonella by (a) defining receptors 
used by Salmonella to adhere to and invade the host epithelium; (b) developing a host 
receptor based rapid detection method for the pathogen in food matrix; (C) and defining 
mechanisms of how probiotics can help alleviate Salmonella-induced cell death in the 
host epithelium. 
 We developed a cell-cell crosslinking method to discover host-microbe receptors, 
and discovered three new receptor-ligand interactions. Interaction of Salmonella Ef-Tu 
with Hsp90 from epithelial cells mediated adhesion, while interaction of Salmonella Ef-
Tu with two host proteins that negatively regulate membrane ruffling (myosin 
iv 
 
phosphatase and alpha catenin) mediated adhesion and invasion. We also showed the role 
of host ganglioside GM1 in mediating invasion of epithelial cells by Salmonella. 
 Further we exploited pathogen affinity for immobilized gangliosides to 
concentrate them out of solution and from complex food matrices for detection by qPCR. 
A sensitivity of 4 CFU/ml (3 hours) in samples without competing microflora was 
achieved. Samples with competing microflora had a sensitivity of 40,000 CFU/ml. 
 Next we screened several probiotic strains for pathogen exclusion potential and 
found that Bifidobacterium longum subspp. infantis showed the highest potential for 
Salmonella enterica subspp. enterica ser. Typhimurium exclusion in a caco-2 cell culture 
model. B. infantis shared its binding specificity to ganglioside GM1 with S. ser. 
Typhimurium. Further, B. infantis completely inhibited Salmonella-induced caspase 8 
and caspase 9 activity in intestinal epithelial cells. B. infantis also reduced the basal 
caspase 9 and caspase 3/7 activity in epithelial cells in absence of the pathogen. Western 
blots and gene expression profiling of epithelial cells revealed that the decreased caspase 
activation was concomitant with increased phosphorylation of pro-survival protein kinase 
Akt, increased expression of caspase inhibiting protein cIAP, and decreased expression of 
genes involved in mitochondrion organization, biogenesis and reactive oxygen species 
metabolic processes. Hence, B. infantis exerted its protective effects by repression of 
mitochondrial cell death pathway which was induced in the presence of S. ser. 
Typhimurium. 
(216 Pages) 
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CHAPTER I 
INTRODUCTION 
 
 Enteric bacterial infections cause an estimated 2 million deaths worldwide every 
year (9). In the U.S. infectious food-borne illnesses cause approximately 76 million cases, 
325,000 hospitalizations, and 5,000 deaths annually (8). The total economic burden 
related to hospitalizations is ~$3 billion and the cost due to lost productivity is estimated 
to be between $20 billion and $40 billion annually (8). The economic burden due to 
Salmonella alone in the U.S. is an estimated $2.8 billion (3). Unfortunately, 
implementation of regulations aimed at reduction and prevention has made little impact 
in the overall occurrence of Food-borne diseases (1). This places renewed importance on 
understanding host-microbe interactions to define new methods of control to reduce and 
prevent the ever-increasing number of Food-borne illnesses.  
 In the last 12 years, due to efforts undertaken broadly to reduce the incidence of 
Food-borne illnesses, the relative rates for shiga-toxin producing Escherichia coli 
(H7:O157), Listeria, and Campylobacter infections declined but those due to Salmonella 
remained constant (1). In combination, Salmonella, Shigella and Campylobacter cause 
the vast majority of food associated infectious diseases with these three genera 
accounting for ~90% of Food-borne infections in 2008 (1). In 2008 Salmonella caused 
the highest morbidity for all reported bacterial Food-borne illnesses in the U.S. (1). In 
fact, the health risk related to Salmonella has worsened because of the emergence of 
antibiotic resistant strains in animals and humans (2, 6). Researchers are aggressively 
seeking new strategies that circumvent the problem of drug resistance in bacteria with 
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rejuvenation of programs to discover novel antimicrobials or by using strategies to 
improve the efficacy of the antibiotics in use. Unfortunately, continued emergence of 
drug resistant strains and an alarming increase in multi-drug resistant strains of infectious 
Food-borne disease-causing bacteria warrants increasing effort to search for alternatives 
to antimicrobial chemicals. Examples of this strategy include anti-virulence therapies (5), 
anti-adhesive therapy (7, 10), and the use of probiotic bacteria as dietary supplements (4). 
These approaches result in additional therapeutic options for use of multiple target 
molecules to intervene at key steps of host/microbe association. An emerging concept is 
blocking adhesion or providing alternate surfaces that mimic the host cell as a decoy to 
block disease initiation, thereby blocking disease progression. The success of this 
approach requires understanding the molecular events at the host microbe interface and 
how to modulate the initial interaction between pathogens and the host. Devising 
alternative therapies requires a detailed understanding of the infection process beginning 
with bacterial-gut association (adhesion) to invasion (host signal transduction routes) to 
spread (shedding). This study seeks to discover new adhesin molecules used by 
Salmonella for adherence to human gut epithelial cells to begin development of alternate 
strategies that block disease initiation. 
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CHAPTER II 
 LITERATURE REVIEW 
 
 Salmonella causes food- and water-borne disease around the world. In the U.S. it 
is transmitted by many types of food, including animal and vegetable sources and is the 
highest cause of morbidity and mortality in human due to Food-borne infections (Figure 
2.1). One reason for host diversity is the ability of Salmonella to adapt uniquely to 
specific environments and hosts causing an invasive disease. Additionally, Salmonella 
adapts to a host without causing disease so that an asymptomatic and persistent carrier 
state develops. This effectively creates a mechanism to consistently spread among 
populations. Shedding occurs in chickens, pigs, and humans. Consequently, much of the 
food supply is contaminated with an organism that is quickly transmitted between 
humans and animals, rapidly becomes multi-drug resistant, readily adapts to new 
environments, mutates quickly to form new serotypes, forms an asymptomatic carrier 
state, and is shed after disease symptoms disappear. Therefore, we selected Salmonella to 
determine the effect of specific macromolecules and other bacteria in the food supply that 
can mitigate specific host/microbe and microbe/microbe interactions to reduce infection 
rates. Understanding the molecular interactions during host adherence of Salmonella will 
provide new insights into an important Food-borne disease and provide many target 
molecules for use in prevention and intervention of disease. 
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Salmonella diversity and infection 
 
 
 Salmonella is a pathogen of humans and animals, but the pathogenicity of 
different serotypes with different hosts is not defined well or predictable (Table 2.1). 
Taxonomic classification of Salmonella has evolved continuously over the years. As new 
molecular technologies are used to differentiate microbes they are being applied to 
Salmonella with the goal of developing consistent and correlative predictors of 
host/microbe interactions and infections. Unfortunately, even within the most commonly 
isolated serotypes, many questions remain unanswered that define specific serotype 
diversity and interactions with the host. Using molecular taxonomic methods, Salmonella 
is divided into only two species - Salmonella enterica and Salmonella bongori. Food-
borne illness is almost entirely caused by serotypes within the S. enterica species (1). 
This fact motivates extensive characterization of the large number of food and human 
isolates to define specific serotypes to define predictive associations. It is especially 
important in outbreak investigations, which led to multiple systems of identification 
beyond 16s DNA typing that include bacteriophage typing, serotyping, metabolic 
fingerprints, and genetic fingerprints.  
 Unfortunately, strain differentiation with serotyping is limited in predictive value 
in non-typhoidal serovars. Hence, there is a need to develop a more refined strategy to 
characterize and classify different Salmonella isolates using more specific genomics-
based tools to give predictive information about their host range and physiology for 
disease or persistence. One emerging option is to utilize comparative genomics based on 
the 16 finished genome sequences, 21 draft sequences, and the 42 more genome 
sequences in progress. Comparative genomic hybridizations (CGH) using S. enterica ser. 
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Typhimurium LT2 and another 22 Salmonella members, including all six subspecies of S. 
enterica and S. bongori, found broad concordance with phylogenomic studies using 16S 
DNA (68). This research also noted specific genes that changed during the evolution of 
the groups. With so much sequence information we have the opportunity to harness the 
power of phylogenomics to unequivocally address the question of Salmonella 
phylogenetic diversity, host adaptation, and mechanisms of survival in many different 
environments. This approach promises to link the specific genes or gene clusters to 
specific Salmonella serotypes and host parameters that enable establishment of a 
mutualistic partnership that leads to shedding and disease spread. 
 
Salmonella and antibiotics 
 
 
 In humans, Salmonella-induced gastroenteritis is usually a self-limiting disease, 
but in immunocompromised individuals and infants some of the non-typhoidal serovars 
can cause bacterimia, which requires use of antibiotics. Resistance to antibiotics remains 
a significant problem in many of the Salmonella isolates. This can be attributed to 
persistence of Salmonella under constant antibiotic pressure due to indiscriminate use of 
antibiotics in animal feed coupled to a highly mutable genome (58). According to the 
National Antimicrobial Resistance Monitoring System (NARMS), in 2005, S. ser. 
Typhimurium was the most frequently encountered serotype, accounting for 21.3% of 
Salmonella isolates in the NARMS surveillance program (16). Of all the isolates tested, 
34.8% were resistance to at least one of the antibiotics used for clinical salmonellosis. A 
greater cause of concern though is the prevalence of multidrug resistant isolates; 22.2% 
of the isolates were resistant to five different antibiotics (ampicillin, chloramphenicol, 
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streptomycin, sulfamethoxazole, and tetracycline) (16). This problem demands 
investment in research to define alternative strategies for management of Salmonella and 
the use antibiotics as a last resort. 
 
Salmonella host adaptation 
 
 
 Out of the nearly 2,600 known serovars, ~50 serovars of S. enterica subsp. 
enterica account for >99.5% of all clinical isolates of Salmonella from humans and 
animals (66). In spite of the predominance of S. enterica subsp. enterica serotypes, the 
correlation between serotype, host, and disease is not well established. It is common to 
find that the same serovar causes different disease symptoms in different hosts. Based on 
their host specificity Salmonella serovars can be loosely categorized into two groups 
(44). Members of the first group colonize a narrow range of hosts (commonly known as 
host-adapted serovars) to cause an acute typhoid-like disease (44). Cross-infection of 
these serovars into other non-host adapted species is possible, but the disease is usually 
not as invasive as in its primary host (44). Examples of host-adapted serotypes include S. 
enterica ser. Dublin in cattle, S. enterica ser. Typhi in humans, S. enterica ser. 
Gallinarum in chickens, and S. enterica ser. Choleraesuis in pigs (44). The second group 
is comprised of S. enterica subsp. enterica that infect and persist in a broad range of hosts 
(commonly known as non-host adapted serovars). These cause non-typhoidal 
gastroenteritis. The most common food-associated examples are S. enterica ser. 
Enteritidis and S. enterica ser. Typhimurium, which are found in many food types and 
host species. S. enterica ser. Enteritidis is commonly associated with chickens while S. 
ser. Typhimurium infects humans, cattle, swine, sheep, horses, rodents, chicken, turkeys, 
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ducks, pigeons, and finches. They are commonly transmitted to humans via direct 
interaction with the animal or consumption of the meat. Cross contamination of food 
animal products to water or vegetables is also a source of animal-associated Salmonella. 
 An increasing problem for food safety and public health is the zoonotic 
transmission of non-host adapted serovars between an animal that is an asymptomatic 
carrier to food and subsequently to humans that results in an outbreak of gastroenteritis. 
The carrier state may occur in humans as well as animals. In a Salmonella-infected host, 
after acute salmonellosis is resolved, the organism may persist asymptomatically to be 
shed in the feces for months after the disease symptoms have ceased. In humans ~3% of 
the people infected with typhoid-causing serovars and ~0.1% of people infected with 
gastroenteritis-causing serovars become chronic carriers (51). The existence of carrier 
states in food animals is of particular concern, as Salmonella can directly enter the food 
chain and cause further cross contamination. The exact molecular mechanisms of how 
Salmonella persists in the carrier state are not known for animals or humans, but in some 
animal models fecal shedding is positively correlated with the prophylactic use of 
antibiotics (56). It may be due in part to an altered gut microflora composition caused by 
antibiotic treatment. 
 
Salmonellosis in humans 
 
 
 S. enterica causes two distinct diseases in humans - typhoid-fever (enteric fever) 
and non-typhoidal gastroenteritis (Figure 2.2) 
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Enteric fever 
 
 
The disease in humans is characterized by invasion of Salmonella through the 
small intestine before further spread into the liver, spleen, gall bladder, and bloodstream. 
There are four host-adapted serovars in S. enterica subsp. enterica (Typhi, Paratyphi A, 
Paratyphi B, Paratyphi C) that cause enteric fever in humans. They account for ~2% of 
the total Salmonella isolates from human salmonellosis (17). There are no other known 
hosts, except humans and higher primates, for these four serovars (61).  
 Untreated enteric fever has a mortality rate of 12-30% while antibiotic-treated 
cases have ~1% mortality. The organism is usually transmitted through the fecal/oral 
route and through poor sanitary practices. There are two commercially available vaccines 
for typhoid fever in humans. The first vaccine is a live attenuated strain of serovar Typhi, 
while the other is a preparation of the capsular Vi antigen. Both the vaccines have a 
reported ~55% efficacy (35) at the 3-year interval. Clinical trials of a third, but 
unlicensed vaccine (rEPA-Vi conjugate), have shown a comparative increase in 
efficiency (~89%) and it confers immunity for a longer period (35). Since the only source 
of infection is an infected person, spread of the organism is controlled with antibiotics 
and good hygiene to prevent cross contamination. Enteric fever is not common in 
industrialized regions like the US, but travelers to Asia, Africa, and Latin America are at 
risk. 
 
Non-typhoidal gastroenteritis 
 
 
 Salmonella-associated gastroenteritis is a common food safety concern. It is 
characterized by nausea, cramping abdominal pain followed by diarrhea, fever, and 
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sometimes vomiting. The infection is usually restricted to inflammation of the intestine, 
but complications can arise in at risk populations, such as infants, the elderly and 
immunocompromised patients. The infective dose for gastroenteritis causing serovars 
varies from 104-106 cells (12).Various factors influencing infective dose are serovar, the 
delivery matrix of the organism and various host specific factors (e.g., age and immune 
status) (12). The infective dose of Salmonella in a food matrix containing high fat or 
protein (e.g., cheese, meat) is significantly lower than those containing low of no fat or 
protein (e.g., water, vegetables) (12, 23). Although people from all age groups are 
susceptible to infection with Salmonella, the incidence of salmonellosis in children < 4 
years of age is seven times higher compared to healthy adults (1) (Figure 2.1) 
 The overwhelming majority (roughly 98%) of human clinical isolates of 
Salmonella cause non-typhoidal gastroenteritis. The range of hosts for gastroenteritis-
causing Salmonella varies from warm-blooded (swine, human, cattle, poultry, rodents) to 
cold-blooded (reptiles, amphibians) animals. S. ser. Typhimurium is the most dominant 
serovar causing illness in humans and animals, accounting for approximately 17% of the 
human clinical isolates and 20% of non-human isolates (17). One reason for the high 
prevalence of S. ser. Typhimurium is that it colonizes a broad range of hosts - humans, 
cattle, poultry, sheep, pigs, horses, and wild rodents (7). The second most isolated serovar 
is S. ser. Enteritidis, which accounts for 16% of human clinical isolates and 3% of non-
human isolates (17). No effective vaccine exists for humans against Salmonella-causing 
gastroenteritis.  
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Molecular mechanisms of Salmonella-induced gastroenteritis 
 
 
 Non-typhoidal salmonellosis in humans is characterized by rapid loss of fluid and 
electrolytes, abdominal cramps and in few cases vomiting and fever. The main stages of 
Salmonella infections are adhesion to the host mucosa, invasion of the host mucosa, 
intracellular replication, and dissemination back into the environment via fecal shedding 
(Figure 2.3).  
 The primary symptom of non-typhoidal gastroenteritis is dehydration due to 
passive loss of protein-rich fluid, and a decreased ability to absorb the lost fluids because 
of injury to the mucosal lining caused by acute inflammation (63). In some cases that are 
untreated or in at risk populations death results from dehydration, not the outright 
infection. Since adhesion and invasion of the host mucosa are the required steps for 
progression of the disease, intervention at these stages is an attractive therapeutic 
strategy, especially since antibiotic resistance is increasing. 
 
Adhesion to the host 
 
 
Adhesion of Salmonella, like other microbial pathogens, to a specific stucture on 
the epithelial surface is the first and necessary step of host colonization (78). Several in 
vivo studies have defined the importance of adhesion in the infection process of various 
pathogens. For Salmonella in particular, Sugita-Konishi et al. (80) used a mouse model to 
demonstrate that preventing Salmonella from adhering to the host mucosa significantly 
reduced the amount of Salmonella recovered from the spleen. Clinical studies with 
cranberry juice, an inhibitor of adhesion of uropathogenic E. coli to human epithelial 
cells showed that the juice significantly decreased the rate of urinary tract infections in 
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women (49). These and many other in vivo studies (2, 77, 78) have unequivocally 
established the importance of bacterial adherence in disease progression. A detailed 
understanding of bacterial adhesins and the cognate host receptors will lead to new 
therapies that prevent bacterial adhesion, thereby averting disease. Since a single 
bacterium utilizes many different molecules to bind the host, a thorough characterization 
of all the bacterial adhesins is required to realize the full potential of anti-adhesive 
therapies. 
 Salmonella expresses a variety of adhesins that can be categorized into fimbrial 
and afimbrial adhesins. Five major types of fimbrial adhesins that mediate adhesion to 
epithelial cells are defined: 1) thin aggregative fimbriae, 2) long polar fimbriae, 3) 
plasmid encoded fimbriae, 4) Type I fimbriae, and 5) π-fimbriae. Each fimbrial type uses 
a slightly different host molecule for adherence to the host cell (Table 2.2) 
 Thin aggregative fimbriae are encoded by the csg operon and are essential for 
virulence of Salmonella in the mouse model (81). In vitro, thin aggregative fimbriae of S. 
ser. Enteritidis bind fibronectin, but the in vivo relevance of this interaction is unknown 
(21). In mice, csgA is a pathogen-associated molecular pattern (PAMP) that binds TLR-2 
(82), which subsequently leads to an inflammatory response by the host.  
 Long polar fimbriae in Salmonella are encoded by the lpfABCDE operon and 
mediate attachment of Salmonella to murine Paeyer’s patches, but not to villous 
enterocytes (8). Deletion mutants of lpfC alone had minimal effect on virulence in mice, 
as did single gene deletion mutants of invA (necessary for invasion). However, double 
deletions led to a 150-fold increase in oral LD50 as compared to the wild type strain or the 
single deletion mutants (8, 64).  
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 Another fimbrial operon in Salmonella’s repertoire is the pefBACD operon that is 
contained on the virulence plasmid. This operon mediates adhesion to the mouse small 
intestine and is also important to induce the inflammatory response in the host (6). 
Plasmid-encoded fimbriae specifically bind the Lewis X blood group antigen in vitro 
(18). The in vivo significance of this observation remains to be determined; however, it 
suggests that human hosts are susceptible based on their blood-type, much like found in 
Helicobacter pylori infections (72). Type I fimbriae modulate the adherence of 
Salmonella to human colon carcinoma cells (HT-29) through mannosylated 
oligosaccharides on the cell surface (48), which provides further evidence for the role of 
the host glycan status for Salmonella infection. Type I fimbriae are encoded by the 
fimAICDHF operon with the fimH subunit on the tip of the fimbrial shaft providing 
binding specificity to the host glycan.  
 The π-fimbriae are encoded by the stdABC operon. The stdA gene mediates 
attachment of Salmonella to α-1-2 fucosylated receptor(s) localized in the mucus layer of 
the murine cecum (19). It is speculated that in vivo stdA-mediated binding to the mucus 
layer gives a competitive advantage during colonization of the mouse cecum. Hence, 
Salmonella fimbrial adhesins act like lectins that bind various terminal sugar residues on 
the host cell surface which serves two purposes: 1) to help the organism colonize host’s 
gut and 2) to bring the organism close enough to the host cell surface so that it can invade 
via other proteins on the host and the microbe.  
 Recently a few non-fimbrial adhesins and components of the Type III secretion 
system (T3SS) were implicated to mediate adhesion of Salmonella to the host mucosa 
(Table 2.2). Salmonella contains two T3SS loci; T3SS-1 is associated with invasion of 
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the host mucosa, while T3SS-2 is associated with survival inside host cells. Surprisingly, 
three translocon components of the T3SS-SP1 (sipB, sipC, sipD) mediate intimate 
attachment of the organism to epithelial cells in vitro (55). The cognate host receptors for 
these T3SS molecules are unknown.  
 Two auto transporters (shdA and misL) bind fibronectin. Human intestinal 
epithelial cell expression of both these proteins in vitro correlated with increased 
adhesion and increased invasion of Salmonella (27, 47). Binding to extracellular matrix 
(ECM) components by enteric pathogens is proposed to serve two functions for 
pathogens. One advantage is to colonize damaged host tissue where the ECM 
components are freely accessible. The second function is that binding ECM components, 
like fibronectin, allows the pathogen to modulate the host cytoskeleton via integrins. This 
leads to gap junction disruption that opens direct access to the basement membrane and 
the circulatory system (50, 75). Salmonella uses several receptors to colonize the host via 
different classes of molecules, which again demonstrates the significance of adhesion in 
disease. Table 2.2 summaries the known adhesins that mediate attachment of Salmonella 
to the host mucosal epithelial molecules. The list of molecules implicated as adhesins 
contains Salmonella adhesins that bind sugar moieties on the host cell surface. These are 
all associated with fimbrae. Another series of molecules uses other receptors. Location of 
the sugar moieties it is not entirely clear and no assessment of adhesion with sugars that 
are part of glycans, glycoproteins, or glycolipids is available.  
 While a short list of adhesins is known for Salmonella, in many cases the host 
receptor is unclear. This limits our understanding of the molecular events following 
adhesion. For example, the plasmid-encoded fimbrial protein (PefC) is important for 
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adhesion, but the cognate host receptor is unknown. This lack of information is crucial 
for deciphering the signal transduction events initiated at the host-microbe interface that 
lead to the disease symptoms via membrane protein signaling. One approach is to delete 
the genes needed for invasion. In this light, incubation of human epithelial cells with 
adherent but non-invasive mutants of Salmonella leads to an increase in NFkB activation 
via a signal transduction route initiated from an undescribed receptor (30). Hence, there 
are yet unidentified T3SS-independent mechanisms that lead to modulation of 
inflammatory pathways that are likely therapeutic targets. Additional research to 
characterize the receptors of host Salmonella interactions is definitely warranted and will 
lead to new therapeutic strategies as well as defining new mechanisms of disease 
initiation.  
 
Invasion of the host mucosa 
 
 
The ability of Salmonella to induce its uptake within non-phagocytic epithelial 
cells is central to its pathogenicity (60). The second step in the infection process is the 
invasion of enterocytes. Internalization of Salmonella is rapid, typically occurring within 
15-30 minutes of bacterial contact with the host cell (60). The whole process resembles 
macropinocytosis (34, 60) and progresses with direct injection of bacterially produced 
effector molecules through the T3SS into the host cytosol. This manipulates the 
cytoskeleton via actin filaments causing formation of membrane ruffles among other 
effects (Figure 2.4). The internalized bacteria remain enclosed within a special 
membrane-bound vacuole (Salmonella-containing vacuole (SCV)). Salmonella also 
interferes with the host’s intravessicular trafficking machinery via a different set of T3SS 
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effectors to prevent fusion of SCVs to lysosomal compartments. This bacterially directed 
maturation of SCV leads to the formation of a protected intracellular niche permissive of 
bacterial replication and persistence (28).    T3SS Effectors and modulation of the host actin cytoskeleton. T3SS effectors 
are eukaryotic-like bacterial proteins that interfere with a wide range of cellular 
processes. These effectors are injected directly into the host cytosol by the T3SS that 
resembles a molecular syringe. Table 2.3 lists the characterized T3SS effectors in 
Salmonella involved in invasion and their role in the infection process. Figure 2.5 
(adapted from (60)) shows the interplay of the effectors with the host molecules.  
 Salmonella modulates the host actin cytoskeleton by direct stimulation of actin 
nucleation and polymerization, activation of small GTPases that eventually leads to actin 
polymerization, and via indirect activation of GTPases via phosphoinositide metabolism 
(60). Two of the injected effectors proteins, SipA and SipC, bind actin and directly 
manipulate the host actin cytoskeleton. SipC mimics the actin nucleation activity of the 
endogenous Arp2/3 complex and stimulates actin assembly by bundling and cross-linking 
existing actin filaments (60). SipA promotes actin filament polymerization by reducing 
the monomer concentration necessary for filament assembly, enhancing the filament 
bundling activity of the host protein fimbrin. SipA also binds to the assembled filaments 
and prevents ADF/cofiliin mediated depolymerization. Thus the synergistic activity of 
SipC and SipA promotes the formation of actin filaments in proximity to the attached 
bacteria (60).   
 The protrusive force required to drive the formation of the phagocytic vesicle 
requires formation of highly branched actin filaments. The formation of such a network is 
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mediated by small GTPases of the Rho family, primarily Rac and Cdc42. Two of the 
Salmonella effectors, SopE and SopE2, act as guanine nucleotide exchange factors 
(GEFs) that are specifically targeted towards Rac and Cdc42 to facilitate the exchange of 
GDP to GTP in the GTPases stimulating Rac and Cdc42 activity. Once activated Rac and 
Cdc42 stimulate downstream effectors leading to actin assembly (60).  
 The injected effector protein SopB (also annotated as SopD in some publications) 
indirectly stimulates RhoG activity that leads to hydrolysis of phosphoinositides (28). 
SopB also exerts inositol phosphatase activity on the intermediates in the phosphoinositol 
conversion pathway changing the conversion of PI(3,4)P2, PI(3,4,5)P3, PI(3,5)P2, and 
PI(4,5)P2 (28). The exact mechanism of how RhoG is activated is under investigation, but 
it is proposed that modulation of the phosphoisositide concentration recruits endogenous 
RhoG GEF, SGEF, which leads to activation of RhoG (28). RhoG activates Rac through 
Rac’s GEF which eventually leads to actin polymerization (60).  
 The next step in invasion is phagosome closure. The PI(4,5)P2 hydrolyzing 
activity of SopB leads to reduction of PI(4,5)P2 in the vicinity of the attached bacteria. It 
is hypotized that the local reduction in the PI(4,5)P2 levels leads to dissociation of cortical 
actin from the nascent phagosome resulting in phagosome closure (60).  
 Shortly after bacterial entry the host cytoskeleton is remodeled to its initial state. 
This phenomenon is pronounced in polarized epithelial cells where apical microvilli are 
completely reassembled after invasion. This is achieved by another injected effector SptP 
that acts like an endogenous Rho GAP inactivating the previously activated Rac and 
Cdc42 (by SopE and SopE2) (60).  
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 Once inside the SCV the bactierum prevents fusion of the SCV membrane with 
the lysosomal compartment to avoid intracellular clearance by the host lytic enzymes and 
the immune system. The exact mechanisms of this process are not known, but this 
phenomenon is mediated by T3SS effectors from Salmonella pathogenicity island-2 (SPI-
2) that are secreted in the host cytoplasm across the SCV membrane. 
 Invasion of the host mucosa by Salmonella results in increased expression of 
chemotactic factors by the host. This results in infiltration of neutrophils into the lamina 
propria (74). As the inflammatory reaction progresses, neutrophils migrate through the 
epithelial layer with the accumulation of inflammatory cells. Protein-rich fluid is secreted 
into the intestinal lumen which manifests itself as diarrhea (74). 
 
Novel therapeutic and prophylactic approaches for control of Salmonella 
 
 
Since adhesion of bacteria to the host initiates the infection process, intervening at 
that step represents an ideal strategy for disease prevention. Salmonella is capable of 
binding via multiple adhesins (Table 2.2); hence, it may be difficult to develop a 
universal class of anti-adherence compounds unless common interacting molecules can 
be found. To fully harness the potential of this approach, extensive characterization of 
adhesin/receptor affinity and specificity are needed. Various sugar moieties (mannose, 
fucose, sialic acid, galactose) are important for fimbrial adhesion. Consequently, they are 
immediate targets for discovery and development. The efficacy of anti-adhesive therapy 
is demonstrated in animal models where administration of specific oligosaccharides 
protects the animal from various enteric infections (Table 2.4). The efficacy of various 
sugar moieties for pathogen blocking in animal models is summarized in Table 2.4. 
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Interestingly, human breast milk contains oligosaccharides that are similar to cell surface 
carbohydrates, and some in vitro studies demonstrate their efficacy in disease prevention 
for some populations (52). To fully realize the potential of this approach, a more 
thorough characterization of adhesins is required.  
 The concept of anti-adhesive compounds can be extended to non-carbohydrate 
adhesion-inhibitory agents like antibodies. The efficacy of this approach is demonstrated 
in an E. coli-mouse infection model to block specific receptors (54). The central concept 
is that microbial adhesins make ideal vaccine candidates. Langermann et al. (54) showed 
that immunization of mice with the E. coli FimH adhesin reduced in vivo colonization by 
more than 99%. Furthermore, passive systemic administration of immune sera to FimH 
also resulted in reduced bladder colonization by uropathogenic E. coli (54). Hence, 
characterization of Salmonella adhesins could also provide viable targets for the elusive 
vaccine against gastroenteritis causing serovars. 
The normal gut flora forms the first line of defense against enteric infections (79). 
The composition of this protective flora can be altered by dietary and environmental 
influences making the host susceptible to disease. Disturbance in the normal microflora 
due to pre-treatment of mice with antibiotics makes them more susceptible to Salmonella 
infection (22). The same study also showed that the total number of bacteria in the gut 
was not altered after pre-treatment with antibiotics, but rather the altered composition of 
the gut flora was responsible for the increased susceptibility to Salmonella (22). The use 
of probiotics centers on the idea that probiotic treatments re-establish the natural 
condition which excised in the host before being disrupted by various stresses (36). Many 
studies have linked prophylactic treatment with probiotics to reduced rate of enteric 
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infections. A study in the pig model showed that feeding a five-strain probiotic mixture 
that contained two strains of Lactobacillus murinus, and one strain each of Lactobacillus 
salivarius, Lactobacillus pentosus and Pediococcus pentosaceous reduced pathogen 
shedding and alleviated disease symptoms when animals were infected with S. ser. 
Typhimurium (15). Although the specific mechanism of the pathogen reduction was not 
elucidated, this study suggests that probiotics can inhibit infection and reduce symptoms. 
Broadly, the mechanisms of probiotics to directly influence the pathogen include 
competing for nutrients, production of antimicrobials, and pathogen exclusion at the host 
surface (57).  
 The pathogen exclusion potential of various probiotics is dependent on the 
probiotic as well as the pathogen strain. Jin et al  (45) showed that in vitro L. acidophilus 
inhibited adhesion of S. sv Pullorum, but failed to inhibit adhesion of S. sv Enteritidis and 
S. ser. Typhimurium. A recent study in humans correlated the decreased number of 
Bifidobacterium in the gut to acute salmonellosis (14). A study in the cell culture model 
has also demonstrated the anti-adhesive effect of Bifidobacterium on S. ser. Typhimurium 
(10). The ability of Bifidobacteria to inhibit pathogen attachment is strain dependent and 
independent of Bifidobacteria’ s adhesion properties; an adherent bifidobacterial strain 
does not guarantee pathogen exclusion (11). The mechanisms of adhesion of 
Bifidobacteria to the host are undefined. There is only one study that implicates a solute 
binding lipoprotein (BopA) (41, 42) in adhesion of Bifidobacterium to caco-2 epithelial 
cells in vitro (Table 2.5). The cognate receptor on the host is unknown. The exact 
mechanisms of pathogen exclusion by Bifidobacteria are not yet characterized. 
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 Another well documented mode of probiotic action against enteric pathogens is 
the production of various antimicrobial compounds such as H2O2, lactic acid and 
bacteriocins (57). For example, the strong antimicrobial activity of L. rhamnosus GG 
against S. ser. Typhimurium was due to the accumulation of lactic acid (24). Pridmore et 
al. (70) described an in vitro role of H2O2 in the anti-Salmonella activity of L. johnsonni. 
Lievin et al. showed that two strains of Bifidobacterium isolated from infant gut produced 
a yet unidentified antimicrobial substance that exerted antimicrobial effect against S. ser. 
Typhimurium in vitro, inhibited cell entry, and killed intracellular S. ser. Typhimurium 
using Caco-2 cells (59). 
 At the host mucosa there is a complex multi- way interaction between host, 
pathogen and the resident gut flora that dictates the outcome of the infection. Most 
studies until now have been dedicated to unravel the effect of 
probiotics/commensals/pathogen on the host while the literature on the microbe-microbe 
interaction is sparse at best. Recently there has been a steady increase in reports of 
intraspecies communication that affect the virulence gene expression of pathogens. For 
example, short chain fatty acids like acetate, propionate and butyrate induce the 
expression of hilA (invasion protein transcription activator), which positively regulates 
virulence gene expression in Salmonella (29). Even et al. (33) demonstrated that mixed 
cultures of Lactococcus lactis negatively regulated the virulence genes of Staphylococcus 
aureus. They did not investigate the in vivo relevance of the observation, but the in vitro 
results open a new dimension of looking at the microbe-microbe interactions. 
 Among all age groups the incidence of Salmonella-induced diarrhea is highest in 
infants (17). Bifidobacterium forms the most abundant genera in breast fed infants (53), 
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and since they show anti-infective activity towards Salmonella, the molecular mechanism 
by which they inhibit pathogen adhesion and invasion needs to be investigated. The effect 
of Bifidobacterium on gene expression of Salmonella and how this influences infectivity 
needs to be investigated. 
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Hypothesis and objectives 
 
 
 B. longum subspecies. infantis reduces S. ser. Typhimurium adhesion to gut 
epithelial cells by competing for the same receptors and also improves cell survival by 
modulation of specific pathways in the host. 
These hypotheses will be tested via the following objectives: 
Objective 1. Define the pathogen exclusion potential of selected probiotic bacteria to gut 
epithelium in vitro.  
Objective 2. Define the binding partners of the host-bacteria interaction 
Objective 3. Identify putative signal transduction and metabolic pathways modulated in 
the host and the microbes using caco-2 cells in vitro with adhesion of B. 
infantis and S. ser. Typhimurium.  
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Table 2.1 Number of serovars present in each species of Salmonella (66). 
 
Salmonella species Number of 
serovars 
S. enterica 2,557 
S. enterica subsp. enterica  1,531 
S. enterica subsp. salamae 505 
S. enterica subsp. arizonae  99 
S. enterica subsp. diarizonae  336 
S. enterica subsp. houtenae  73 
S. enterica subsp. indica  13 
S. bongori  22 
Total (genus Salmonella)  2,579 
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Table 2.2 Adhesins used by Salmonella and their cognate partners on the host for 
adherence to the host mucosal epithelium. 
 
Salmonella adhesin molecule Cognate Host receptor Reference 
Fimbrial adhesins   
Plasmid encoded fimbriae (pefC) Unknown (6) 
Plasmid encoded fimbriae (pefA) Galβ1–4(Fucα1–3)GlcNAc (18) 
Fimbrial Adhesin (stdA) Fucα1-2Galβ1-4GlcNAc (19) 
Long Polar fimbriae (lpf operon) Unknown (8) 
Thin aggregative fimbriae (agfA) Unknown (81) 
Type-1 Fimbriae (fimH) Mannose moieties on glyco-
conjugates 
(43) 
Thin curled fimbriae (csgA) Toll-like receptor 2 (TLR2) (82) 
Non-fimbrial adhesins   
Non-fimbrial adhesin (siiE) Unknown (37) 
Auto-transporter like protein 
(shdA)  
Fibronectin (47) 
Autotransporter (misL) Fibronectin (27) 
66-kDA Heat Shock Protein Mucin (32) 
Murien Lipoprotein (lppA, lppB) Unknown (76) 
Outer Membrane Protein (ratB) Unknown (46) 
Intimin-like protein (sinH) Unknown (46) 
Type III secretion system   
Protein Translocase (sipB)  Unknown (55) 
Protein Translocase (sipC) Unknown (55) 
Protein Translocase (sipD) Unknown (55) 
Uncharacterized   
Outer membrane lipoprotein 
(invH) 
Unknown (4) 
Unknown  Mixed Gangliosides  (26) 
Unknown Cystic fibrosis transmembrane 
conductance regulator1 
(67) 
Unknown Galb(1-3)GalNAc (38) 
Unknown Integrins CR3, CR1 (83) 
1receptor for ser. Typhi, but not for ser. Typhimurium. 
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Table 2.3 Salmonella T3SS effectors that play a role in invasion of non-phagocytic cells. 
  
Effector protein Function Reference 
SipA Enhances actin filament assembly and inhibits actin 
disassembly 
(60) 
SipB  T3SS translocon component, acts like an adhesin (55, 60) 
SipC  T3SS translocon component, acts like an adhesin, 
promotes actin polymerization 
(55, 60) 
SipD  T3SS translocon component, acts like an adhesin (55, 60) 
SopE Guanine nucleotide exchange factor (GEF) for Cdc42 
and Rac ;promotes assembly of branched actin filaments 
(60) 
SopE2 Guanine nucleotide exchange factor (GEF) for Cdc42 (60) 
SopB/SigD Phosphoinositide phosphatase; activates RhoG; Other 
roles suspected but not characterized 
(60) 
SptP Rho GAP, functions in repression of host membrane 
ruffling post entry. 
(60) 
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Table 2.4 Anti-adhesive compounds that prevent bacterial infection in vivo. (GIT-
Gastrointestinal tract, UT-Urinary tract) 
 
Organism 
Site of 
infection 
Anti-adhesive molecule 
Bacterial 
Receptor 
Ref 
C. jejuni Mice GIT HMO Unknown (73) 
E coli Mice UT methyl alpha-D-
mannopyranoside 
Type 1 Fimbriae  (5) 
  Mice UT Globotetraose Type 1 Fimbriae  (31) 
  Mice GIT Mannose P-fimbriae  (39) 
H. pylori Pig GIT Sialyl-3'-LacNAc Unknown  (62) 
  Monkey GIT Sialyl-3'-Lac Unknown  (62) 
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Table 2.5 Known adhesins of selected probiotics 
 
Organism 
Microbe 
Protein 
Host receptor Ref 
Lactobacillus 
acidophilus NCFM Mub Mucus (13) 
  SlpA Unknown (13) 
  Fbp Fibronectin (13) 
  CdpA Unknown (3) 
Lactobacillus brevis 
ATCC 8287 
SlpA Laminin, Collagen, Fibronectin (25) 
Lactobacillus johnsonni 
LA1 
EF-tu Mucus (40) 
  GroEL Mucus (9) 
Lactobacillus 
plantarum WCFS1 
Msa Mucus via mannose binding (69) 
Lactobacillus reuteri 
NCIB 11951 
CnBP Collagen (71) 
Lactobacillus salivarius 
UCC 118 
LspA Collagen, Mucin (20) 
Bifibacterium. bifidum BopA Unknown (42) 
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Figure 2. 1 Reported cases of Food-borne illnesses by age (1) 
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Figure 2. 2 The two types of diseases caused by Salmonella. Both are initiated at the 
intestine but enteric fever is characterized by spread of Salmonella to deeper tissues while 
gastroenteritis is limited to inflammation of the intestine (Adapted from (65)). 
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Figure 2. 3 Infective cycle of gastroenteritis caused by Salmonella. Adapted from 
Navaneethan et al. (63). 
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Figure 2. 4 TEM showing invasion of bovine enterocytes by S. ser. Typhimurium. 
Arrows 1 indicates membrane-bound bacteria after engulfment. Arrow 2 highlights 
engulfment at the apical membrane while it is still open to the lumen (Adapted from 
(74)). 
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Figure 2. 5 Interaction of Salmonella with the host through its T3SS effectors (Adapted 
from (60)). 
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CHAPTER III 
IDENTIFICATION AND CHARACTERIZATION OF HOST MICROBE 
RECEPTORS BY WHOLE CELL CROSSLINKING 
 
Abstract 
 
 
 A cell-cell crosslinking method to discover host-microbe receptors was 
developed. The protocol was first applied to discover extracellular matrix (ECM) binding 
proteins in Lactobacillus acidophilus, E. coli and Salmonella ser. Typhimurium. I found 
new bacterial proteins crosslinked to ECM components, in addition to proteins already 
reported in literature. Further, I applied the protocol to crosslink S. ser. Typhimurium to 
epithelial cells, and discovered three new receptor-ligand interactions. Interaction of 
Salmonella Ef-Tu with Hsp90 from epithelial cells mediated adhesion, while interaction 
of Salmonella Ef-Tu with two host proteins that negatively regulate membrane ruffling 
(myosin phosphatase and alpha catenin), mediated adhesion and invasion. I also showed 
the role of host ganglioside GM1 in mediating invasion of epithelial cells by Salmonella. 
 
Introduction 
 
 
Bacterial association with humans is a complex evolutionary partnership the 
impacts health (34) and disease (51). This co-evolution reflects complex host receptor 
and bacterial adhesin partnerships (30). Unfortunately, relatively few receptor/adhesin 
associations are defined (30) and many more exist than can be associated with host 
response to disease Host-microbe receptor/adhesin pairings are one of the most critical 
determinants that control bacterial host range (38), targets bacteria to specific tissues 
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(17). Adhesion is the first step in infection. It initiates the host response by triggering 
signal transduction routes, and prompts the immune system to mount a response to clear 
the infection. In case of invasive bacteria, such as Listeria monocytogenes (45) and 
Salmonella enterica (23), adhesion is the prelude to host cell invasion to cause 
gastrointestinal infection and tissue migration that leads to systemic disease and 
secondary infections or long term carrier states. Likewise, recognition of host cell surface 
molecules by commensal and probiotic bacteria is also important for the observed health 
benefits of bacterial association with humans (34). Probiotic bacteria initiate a pro-
inflammatory or an anti-inflammatory response by the host based on the type of 
microbial ligands bound by host receptors (58). Hence, identification and characterization 
of host-microbe receptor pairs is one of the most important areas in cellular microbiology 
for the discovery of mechanisms initiated by bacterial ligands during adhesion with host 
cell receptors.  
 Control of bacterial infection is becoming increasingly challenging with rising 
antimicrobial resistance (20). This situation calls for alternative compounds and strategies 
to control infectious disease. Disrupting adhesion is a possible strategy to reduce 
bacterial adhesion and invasion, and hence slow or stop disease progression (47); 
however, to fully harness the potential of this approach discovery and extensive 
characterization of receptor/adhesin specificity is needed. Alternatively, microbial 
adhesins can be used as vaccine candidates that have increased immunogenicity if they 
consistently bind to specific host receptors. Langermann et al. (31) successfully 
demonstrated this approach using an adhesin-based vaccine to reduce in vivo colonization 
of E. coli by more than 99% in a murine cystitis model. Identifying the cognate 
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receptor/adhesin partnerships used by pathogenic bacteria to bind and invade host cells is 
the first step in development of a series of alternative therapies that will reduce pathogen 
infection, systemic disease, and bacterial shedding. 
 Identification of receptor/adhesin pairs is difficult. No protocols or methods are 
established that define the ligand-receptor relationships. Even though reports of bacterial 
adhesin are common, they host receptor is usually unknown, or at best inferred from the 
possible set of host receptors. One approach to define the partnership is to screen libraries 
of tagged mutants for defects in adhesion/ colonization phenotype (42). Unfortunately, 
this approach does not reveal the identity of cognate host receptor. Considering the 
usually high redundancy of adhesin molecules (genes) in microbial genomes, screening 
mutant libraries where only a single loci is disrupted, the expected false negative rate will 
be very high leading to an excruciatingly slow approach to find cognate receptors. While 
the affinity pull down approach will define the cognate partnership membership, such as 
the report by Cabanes et al. (9), identity of one at least one host binding partners must be 
known before beginning this type of experiment. This report describes an a priori high 
through put method to discover cognate receptor/adhesin partners in bacterial 
associations. 
 To characterize host-microbe receptor partners, a whole cell cross-linking method 
was developed using a cell impermeable cross-linking reagent, Sulfo-N-
hydroxysuccinimidyl-2-(6-[biotinamido]-2-(p-azido benzamido)-hexanoamido) ethyl-
1,3'-dithioproprionate (sulfo-SBED) ( Appendix Figure A1) to covalently link cellular 
proteins during host-bacterial association. Sulfo-SBED is a heterobifunctional reagent 
that can be used to cross-link proteins (25). The NHS-ester moiety of sulfo-SBED 
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covalently reacts preferentially, with primary amines of one protein that is followed by 
photoactivation of the aryl azide moiety to nonspecifically bind interacting molecules 
within 9-12 Å, thereby covalently cross-linking two protein molecules that are intimately 
interacting. Additionally, the Sulfo-SBED molecule contains biotin that was used to 
isolate the covalently bound complex and a reducible disulfide linkage to release both 
proteins with individual pieces of Sulfo-SBED that remain on the respective proteins. 
Sulfo-SBED is membrane impermeable cross-linking reagent, hence in intact cells, only 
the cell surface proteins would be labeled (25) and presence of proteins from lysed cells 
was prevented by repeated washing of labeled cells in osmotically balanced buffer. By 
exploiting the molecular properties of Sulfo-SBED to cross-link membrane proteins 
within whole cells during adhesion a new method was designed to identify cognate 
receptor/adhesin partners with two-dimension gels and mass spectrometry.  
 I initially used the method to determine ECM binding protein in L. acidophilus, S. 
ser. Typhimurium and E. coli. Later, I identified several new putative receptor ligand 
interactions between S. ser. Typhimurium and epithelial cells. I functionally showed the 
role of 3 of those partnerships in adhesion and invasion of S. ser. Typhimurium. 
 
Materials and methods 
 
 
Cell culture and bacterial strains 
 
 
Caco-2 cells were obtained from ATCC (HTB-37, Manassas, VA) and cultured as 
per ATCC’s recommendation. All the cells used in the assay were between passage 
numbers 22-30. In brief, cells were plated at a density of 105 / cm2 in either a T25 or a 96 
well plate. Cells were maintained in DMEM/High Modified (Thermo Scientific, 
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Rockford, IL) with 16.6% fetal bovine serum (FBS) (HyClone Laboratories, Logan, UT), 
non-essential amino acids (Thermo Scientific, Rockford, IL), 10mM MOPS (Sigma, St. 
Louis, MO), 10 mM TES (Sigma), 15 mM HEPES (Sigma) and 2 mM NaH2PO4(Sigma). 
Cells were considered to be differentiated 14 days post confluence (49), and used for the 
adhesion and crosslinking assay. Bacterial cells were grown as described in Table 3.1. 
 
Labeling bacterial cells and purified proteins  
with Sulfo-SBED 
 
The bacterial cells were labeled with Sulfo-N-hydroxysuccinimidyl-2-(6-
[biotinamido]-2-(p-azido benzamido)-hexanoamido) ethy-1, 3’-dithioproprionate (Sulfo-
SBED) (Thermo Fisher Scientific, IL, USA). The total cell surface protein content on ~ 
109 bacteria was measured using the BCA protein assay (Thermo Fisher Scientific, IL, 
USA). Assuming an average molecular weight of 60,000 Da for proteins, 10 fold molar 
excess Sulfo-SBED (dissolved in DMSO at 50 µg/µl) of the determined protein 
concentration, was added to 109 bacteria suspended in 1 ml of tyrode’s (140 mM NaCl, 
5mM KCl, 1mM CaCl2, 1mM MgCl2, 10 mM glucose, 10mM sodium pyruvate, 10 mM 
HEPES, pH 7.4) The labeling reaction was continued in dark on ice for 45 minutes with 
intermittent shaking. After 45 minutes the reaction was quenched by adding two fold 
molar excess glycine as compared to sulfo-SBED. The bacteria were washed twice with 
tyrode’s by centrifugation at 6000 X g for 2 minutes and resuspended in 1 ml tyrode’s 
buffer.  
 Fibronectin (Sigma-Aldrich Corp, St. Louis, MO) and fibrinogen Sigma-Aldrich 
Corp, St. Louis, MO) were dissolved in tyrode’s at 1 mg/ml and were labeled with 10 
fold molar excess of sulfo SBED as described earlier. After quenching the labeling 
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reaction, the proteins were desalted against tyrode’s using microcon YM-30 filter 
(Millipore, Billerica, MA) exactly as per manufacturer's instructions and resuspended at a 
concentration of ~1 mg/ml. 
 
Identification of microbial adhesins by label  
transfer from purified proteins 
 
 
About ~109 microbial cells were incubated with 1 ml of sulfo-SBED labeled 
fibronectin (1mg/ml; approximately 1.4 X 105 molecules /bacterial cell) or fibrinogen 
(1mg/ml; approximately 1.8 X 105 molecules/bacterial cell) for 30 minutes at 37° C. At 
the end of 30 minutes the suspension was placed under a 15 watt UV lamp (302 nm) at a 
distance of 5 cm for 10 minutes. The cells were washed twice with 1 ml tyrode’s by 
centrifugation at 6000 X g for 2 minutes and resuspended in 500 µl lysis buffer (0.1% 
triton, 150mM DTT) and 250 µl of glass beads (0.1 mm) (BioSpec Products, Inc., 
Bartlesville, OK). The samples were homogenized in a Mini-Beadbeater (BioSpec 
Products, Inc., Bartlesville, OK) by giving 3 pluses at full speed for 30 s with intermittent 
1 minutes incubation on ice. The free biotin in the sample from the reduced non-
crosslinked proteins was removed by passing the lysate through a YM3 microcon filter 
(Millipore, Billerica, MA) as per manufacturer's instructions. The retentate (volume 
brought up to 800 µl with tyrode’s) from YM3 filter was incubated with ~30, 3 mm 
avidin-coated glass beads (Xenopore Corp., Hawthorne, NJ) for 30 minutes on a shaking 
platform to capture the biotinylated proteins. The glass beads were subsequently washed 
3 times with 5 ml of wash buffer (50mM Tris, 1.5 M NaCl, pH adjusted to 7.2) to remove 
nonspecifically bound proteins. The proteins on the washed beads were digested 
overnight using 300 ng of proteomics grade trypsin (Sigma-Aldrich Corp, St. Louis, MO) 
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in 1 ml of 100mM ammonium bicarbonate buffer. The digested proteins were 
concentrated using a speedvac (Thermo Fisher Scientific, IL, USA ) to final volume of 50 
µl and submitted to the Center for Integrated Biosystems, Utah State University (Logan, 
UT) for protein identification by LC-MS/MS. The whole label transfer protocol was 
repeated using unlabeled ECM components as negative controls. 
 
Identification of microbial adhesins by crosslinking  
with pure proteins 
 
 
Microbial cells were interacted, crosslinked with labeled fibronectin/ fibrinogen 
and lysed exactly as described earlier. Fifty µl of the cell lysate was diluted with 50 µl of 
2X Laemmli sample buffer (52.5 mM Tri-HCL, pH 6.8, 25% glycerol, 2% SDS, 0.02% 
bromophenol blue) with or without the addition of 150 mM DTT and heated at 95°C for 
10 minutes. The lysate was then centrifuged at 12000 x g in a micro centrifuge and the 
proteins (50 µl) in the supernatant were separated by SDS-PAGE using the Mini-
PROTEAN electrophoresis system (Bio-Rad Laboratories, Hercules, CA) exactly as per 
manufacturer’s recommendation at a constant current of 30 mAmp per gel, using 4-20 % 
precast Tris-HCL Gels (Bio-Rad Laboratories, Hercules, CA). The gels were stained 
overnight with Imperial protein stain (Thermo Fisher Scientific, IL, USA) exactly as per 
manufacturer’s recommendations. The gels resolved under reducing and non-reducing 
conditions were imaged using the Kodak Image Station 2000R (Carestream Health, 
Rochester, NY). The images for gels resolved under reducing and non-reducing 
conditions were compared and bands missing in the reduced gels were identified. The gel 
bands were picked, in-gel digested and the proteins identified using LC-MS/MS at the 
Center for Integrated Biosystems, Utah State University (Logan, UT). The protein  
49 
 
 
Identification of host microbe receptors  
by cell-cell crosslinking 
 
 
About 109 sulfo-SBED labeled bacteria were interacted with ~106 Caco-2 cells 
grown in a T25 in a final volume of 3.5 ml tyrode’s buffer for 60 minutes at 37˚C. At the 
end of 60 minutes the bacterial suspension was aspirated from the flask. The flask was 
then placed under a 15 watt UV lamp (302 nm) at a distance of 5 cm for 10 minutes. The 
cross linked Caco-2 cells and bacteria were resuspended in 500 µl of lysis buffer (8 M 
urea, 6.0% ampholytes pH Range (3-10) (Bio-Rad Laboratories, Hercules, CA), 0.4 % 
CHAPS, 0.25 % Triton 100, 0.15 % n-Dodecyl-B-β-D maltoside, 0.002% bromophenol 
blue) and 250 µl of glass beads (0.1 mm, BioSpec Products, Inc., Bartlesville, OK). The 
samples were homogenized in a Mini-Beadbeater (BioSpec Products, Inc., Bartlesville, 
OK) by giving 3 pluses at full speed for 30 s with intermittent 1 minutes incubation on 
ice. The samples were stored at -70° C until further use. 
 The cross linked samples were thawed and centrifuged at 12000 x g in a micro 
centrifuge and the supernatant was used for 2D gel analysis. Isoelectric focusing (IEF) 
was performed using 50 µl of sample in tube gels using the Model 175 tube cell (Bio-Rad 
Laboratories, Hercules, CA) as per the manufacturer’s recommendation. In brief 4% 
polyacrylamide gels were cast in 1 mm diameter tubes to a height of 11 cm. Fifty µl 
samples in the lysis buffer was loaded directly on to the tubes and run at 200 V for 2 
hours, 400 V for 4 hours, and finally at 800 V for 8 hours. After the IEF run, gels were 
extruded from the tubes and equilibrated in transfer buffer (3 % SDS, 0.07 M Tris-HCL) 
with or without 150 mM DTT for 15 minutes. The gels equilibrated in the presence of 
DTT were subsequently alkylated in transfer buffer using 150 mM iodoacetamide for 15 
50 
 
min. The tube gels were then resolved in the second dimension using the Criterion 
electrophoresis system (Bio-Rad Laboratories, Hercules, CA) exactly as per 
manufacturer’s recommendation at a constant current of 45 mAmp per gel using 4-20 % 
precast Tris-HCL Gels (# 345-0104, Bio-Rad Laboratories, Hercules, CA). The gels were 
stained overnight with Imperial protein stain (Thermo Fisher Scientific, IL, USA) exactly 
as per manufacturer’s recommendations. 
 The gels resolved under reducing and non-reducing conditions were imaged using 
the Kodak Image Station 2000R (Carestream Health, Rochester, NY). The images were 
compared and spots missing in the reducing gels but present in the non-reduced gel were 
identified. The gel spots were picked, in-gel digested and the proteins identified using 
LC-MS/MS at the Center for Integrated Biosystems, Utah State University (Logan, UT). 
 
Purification of Ef-Tu from Salmonella ser.  
Typhimurium 
 
 
 Elongation factor Tu (Tuf) was affinity purified from S. ser. Typhimurium lysate 
using a GDP-Sepharose column as described by Jacobson et al . (28) and Meide et al . 
(60) with a few modifications. S. ser. Typhimurium was grown in 2 liters of brain heart 
infusion broth (Thermo Fisher Scientific, IL, USA ) to early stationary phase (OD600= 
~2.0). The cells were washed once with equal volume of saline and resuspended in 100 
ml of TE buffer (10mM Tris, 1 mM EDTA, 0.1mM phenylmethylsulfonyl fluoride, pH 8) 
containing lysozyme (Sigma-Aldrich Corp, St. Louis, MO) at 10 mg/ml. The cell 
suspension was incubated at 37 °C for 30 minutes. At the end of 30 minutes sodium 
deoxycholate was added to the suspension at a final concentration of 1 mg/ml and 
incubated for 15 more minutes with gentle stirring. At the end of incubation period 100 
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units of DNase 1 ( Promega Corp., Madison, WI) and MgCl2 at a final concentration of 
10mM were added and incubated for 30 more minutes. The suspension was then 
centrifuged at 25,000 X g for 30 minutes and the supernatant was used for protein 
fractionation. Proteins precipitated from the 25 000 X g supernatant by (NH4)2 SO4 
between saturations of 37% and 64% were dissolved in binding buffer (50mM Tris-HCl, 
1mM DTT, 10mMMgCl2, 0.1mM phenylmethylsulfonyl fluoride, pH 8) at approximately 
a concentration of 5 mg/ml.  
  Periodate oxidation and coupling of the oxidized GDP to the Sepharose were 
done as follows: 0.1 mmol of GDP was dissolved in 1.3 ml of 0.1 M citrate phosphate 
buffer (pH 5.0) and to this solution was added 0.11 mmol of sodium periodate dissolved 
in 0.2 ml of the same buffer. The reaction mixture was incubated in the dark at room 
temperature for 30 minutes. Excess periodate was eliminated by addition of 10 µl of a 
40% (wt/vol) solution of ethylene glycol and incubation for an additional 10 min. One ml 
of this mixture was added to 3 gm. of EAH Sepharose 4B (#17-0569-01, GE Healthcare, 
Piscataway, NJ) that had been swollen in a total volume of 24 ml of 0.1 M Tricine-NaOH 
(pH 8.2) containing 0.5 M NaCI. This suspension was gently rotated for 2 hour at 4°C 
and was subsequently treated with 1.0 ml of 0.3 M sodium borohydrate, freshly dissolved 
in 0.2 M Tricine-NaOH (pH 8.2). After 1 hour, 0.66 ml of the latter solution (again 
freshly prepared) was added and incubation was continued for another hour. At the end of 
incubation GDP-EAH-Sepharose was washed four times with 40 ml of 4 M NaCl.  
 Previously fractionated S. ser. Typhimurium lysate was adsorbed onto the washed 
GDP-EAH-Sepharose by mixing equal volumes of packed resin and of (NH4)2 SO4 
fractionated cell extract .The mixture was dialyzed (12 hours, 22°C) against the binding 
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buffer using a 3.5K MWCO dialysis tubing (Thermo Fisher Scientific, IL, USA). The 
mixture was then packed into a column (0.75 X 20 cm) and washed with the same buffer 
until the absorbance at 280 nm reached baseline. One column volume of the binding 
buffer containing 100µM GDP was then allowed to flow into the column and elution was 
interrupted for 1 hour. Subsequent elution with GDP-containing buffer yielded Ef-Tu in 
homogenous form. The purity of the eluted protein was confirmed by LC-MS/MS. 
 
Determination of adherent and invasive bacteria 
 
 The role of specific receptors in adhesion and invasion of the host by salmonella 
was assayed by determining the changes in the amount of total host (intestinal epithelial 
cells, Caco-2) associated salmonella due to receptor blocking by specific antibodies. The 
amount of total host associated salmonella was determined by either total viable plate 
count or by qPCR as described below. The amounts of total invasive salmonella in the 
host were determined by the gentamicin protection assay with a few modifications as 
described below (16). 
 Total host associated bacteria were determined as follows. Caco-2 cells were 
cultured as described earlier in a 96-well plate. The bacteria were used after two transfers 
for the adhesion assays. Bacterial cells were collected from 2 ml of media after growth 
for 14 hours, washed twice with an equal volume of PBS, and re-suspended at ~108 
CFU/ml, in DMEM/High modified with 1X non-essential amino acids, 10mM MOPS, 10 
mM TES, 15 mM HEPES and 2 mM NaH2PO4 but without the FBS. Caco-2 cells were 
incubated with antibodies or specific proteins as mentioned in Table 3.2 for 60 minutes in 
a final volume of 50 µl at 37˚C in 5% CO2. At the end of 60 minutes, the Caco-2 cells 
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were infected with 50 µl of bacterial cell suspension (MOI 1:100) and incubated for 60 
minutes at 37˚C in 5% CO2. The bacterial cell suspension was aspirated and the Caco2 
monolayer was washed thrice with 200 µl of tyrode’s to remove non-adhered bacterial 
cells from the monolayer. DNA extraction buffer (AEX Chemunex, France) (50 µl) was 
used to lyse the monolayer and the bacteria associated with the host, and incubated at 
37˚C for 15 minutes followed by 95˚C for 15 min. Resulting cell lysate was used to 
determine the number of bacteria associated with the Caco-2 cells (14). Quantitative 
analysis was done using qPCR with a CFX 96 Real Time System (Bio-Rad, Hercules, 
CA). Reactions were performed in a final volume of 25 μl including 1 μl of cell lysate, 
100 nM of PCR primers and iQ SYBR Green Supermix (Bio-Rad, Hercules CA) as per 
manufacturer’s instructions. The primers used for the amplification are listed in Table 
3.1. The reaction parameters consisted of denaturation step at 95°C for 5 min, followed 
by 40 cycles of denaturation, annealing and extension at 95˚C for 15 s, 56˚C for 30 s, 
72˚C for 30 s, respectively and a final extension at 72°C for 1 min. The product was 
verified using a melt curve analysis from 50˚C to 95˚C with a transition rate of 0.2˚C/s. 
The amount of bacterial cells and Caco-2 cells present in each well were estimated using 
a standard curve of CT vs. Log10 CFU and amount of bacteria per Caco-2 was calculated. 
The data were normalized relative to control wells which were not given any antibody 
treatment. The experiment was done in four replicates. 
 The amount of total invaded and adhered bacteria was determined using the 
gentamicin protection assay as follows. Caco-2 cells were infected exactly as described 
earlier. The infected cells were incubated for 60 minutes at 37°C with 5% CO2. Upon 
incubation, media was aspirated and cells were washed three times with tyrode’s buffer. 
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Invaded bacteria were estimated by incubating the cells with 100 µg/ml gentamicin for 2 
hours at 37°C with 5% CO2 to kill bacteria adhered or outside the Caco-2 cells. To 
determine total host associated bacteria, cells were incubated with cell culture media 
without any antibiotic. Cells were again washed three times with tyrode’s buffer and 
lysed with 0.01% triton. The amount of bacteria in the Caco-2 lysate was determined by 
plating serial dilutions on LB agar. The experiment was performed in four replicates. The 
number of adhered bacteria were enumerated by subtracting mean of invaded bacteria (B) 
from mean of total host associated bacteria (A) and error (ΔZ) was calculated as (ΔZ)2 = 
(ΔA)2 + (ΔB)2 where, ΔA is SEM associated with the A and ΔB is SEM associated with 
B. The data were normalized relative to control wells which were not given any antibody 
treatment. Differences in the mean due to treatment were tested by one way ANOVA. 
Post ANOVA, the means were compared to each other by Tukey-Kramer's method. 
 
NFkB reporter assay 
 
 A reporter cell line, monitoring the activity of NFkB was generated by 
transducing Caco-2 cells with lentiviral particles expressing GFP under the control of a 
minimal CMV promoter and tandem repeats of NFkB transcriptional response element. 
Caco-2 cells were seeded at a density of 5 X 104 / cm2 in a 96 well plate and cultured as 
described before. After 2 days Caco-2 cells were transfected with ready to transduce 
lentiviral particles (# CLS-013G, SABiosciences, Fredreric, MD) exactly as per 
manufacturer's recommendations. In brief, cells in each well were transfected with the 
viral particles at an MOI of 1:10, 0.3 µl of SureFECT transfection reagent 
(SABiosciences, Fredreric, MD) in a final volume of 50 µl. Two days after transfection 
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the supernatant was aspirated and the cells were maintained in the cell culture media with 
12µg/ ml puromycin for 18 more days until the cells differentiated, and then they were 
used for the reporter assays. The cells were serum starved for 24 hours prior to infection 
with bacteria. The transfected cells were infected with different bacteria as mentioned 
earlier but at an MOI of 1:1000. At the end of eight hours the amount of fluorescence in 
each well was measured at an Ex/Em of 485/535 using a DTX 880 Multimode Detector 
(Beckman Coulter, Brea, CA). Blank reading from non-transfected cells were subtracted 
from the reported values. Differences in the mean due to treatment were tested by one 
way ANOVA. Post ANOVA, the means were compared to each other by Tukey-Kramer's 
method. 
 
Western Blots 
 
 The relative abundance of target proteins due to different treatments was 
quantified by densitometric analysis of western blots. Caco-2 cells were cultured as 
mentioned before in a 48 well plate. The cells were serum starved for 24 hours prior to 
infection with bacteria. Bacterial cells were grown as mentioned earlier, except that they 
were grown in cell culture media. Caco-2 cells were incubated with either serum free cell 
culture media or, Ef-Tu (2 µg/ml) dissolved in serum free cell culture media with or 
without the presence of S. ser. Typhimurium LT2 ΔinvA at an MOI of 1:1000. The 
experiment was repeated in 4 replicates. The cells were harvested at the end of 60 
minutes by lysis in 30 µl of 1X SDS sample buffer with protease and phosphatase 
inhibitors (52.5 mM Tri-HCL, pH 6.8, 25% glycerol, 2% SDS, 0.02% bromophenol blue, 
50mM DTT, 50 mM Sodium pyrophosphate, 100 mM sodium fluoride, 10 mM 
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orthovanadate, 1 Roche protease inhibitor cocktail tablet/50ml solvent).The samples were 
heated at 95°C for 10 minutes and centrifuged at 12,000 X g for 10 minutes. 20 µl of the 
sample was resolved on precast 10% Tris-HCl polyacrylimide gels (Bio-Rad 
Laboratories, Hercules, CA) at a constant current of 45 mAmp per gel using the Criterion 
electrophoresis system (Bio-Rad Laboratories, Hercules, CA). The resolved proteins were 
then transferred to a PVDF membrane (Bio-Rad Laboratories, Hercules, CA) using the 
Trans-Blot semi-dry electrophorectic cell (Bio-Rad Laboratories, Hercules, CA) as per 
manufacturer's recommendation. Upon completion of the transfer, the blots were probed 
for the presence of p-Akt 473 (#9271), p-AKT 308 (#9275) and p-myosin 19 (#3671), by 
Pierce® Fast Western Blot Kit (Thermo Fisher Scientific, IL, USA), according to the 
manufactures recommendations. Primary antibodies for all the proteins were purchased 
from Cell Signaling Tech. (Boston, MA). The blots were imaged using the Kodak Image 
Station 2000R (Carestream Health, Rochester, NY). Densitometric analysis of the blot 
was done using Image J (1). Differences in the means due to treatment were tested by one 
way ANOVA. Post ANOVA, the means were compared to each other by Tukey-Kramer's 
method 
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Results 
 
 
Identification of fibronectin binding proteins in  
Lactobacillus acidophilus NCFM 
 
 
L. acidophilus binds many different extracellular matrix components (ECM) (13), 
but the identity of most bacterial proteins that mediate this interaction is not known. I 
used a label transfer strategy to identify bacterial proteins that mediate interactions of L. 
acidophilus NCFM with fibronectin. I also wanted to check the feasibility of ultimately 
using this reagent to be able to crosslink whole cells. Fibronectin was labeled with sulfo-
SBED and interacted with L. acidophilus NCFM, crosslinked and subsequently reduced, 
which transferred the biotin label from fibronectin to any proteins within ~13 A° distance 
of fibronectin. The biotinylated proteins in L. acidophilus NCFM were immobilized onto 
avidin coated beads and identified by LC-MS/MS. The identified proteins are 
summarized in Table 3.3. A negative control in which unlabeled fibronectin was 
interacted with the bacterial cells, identified no proteins as being biotinylated. Of the six 
proteins identified, functional analysis of a cdpA deletion mutant showed ~80% reduction 
in adhesion to Caco-2 cells (3). InterProScan sequence analysis of cdpA predicted the 
presence of two protein domains, IPR004903- bacterial surface layer protein, and 
IPR011490 extracellular matrix-binding protein (41). One of the other identified protein; 
LBA0222 was predicted to contain a signal peptide (41) and a transmembrane domain 
(11) at its N-terminal. Since there were no annotated protein families in LBA0222, I used 
Phylobuilder (21) to build neighbor joining trees based on multiple sequence alignments 
of homologs of LBA0222 (Appendix Figure A2). This analysis revealed that the closest 
homolog of LBA0222 in L. acidophilus NCFM was cdpA (E-Value 3.0e-22). Hence this 
58 
 
method functionally identified two homologous proteins in L. acidophilus as fibronectin 
binding proteins, one of which was bioiformatically predicted to contain a domain that 
binds ECM components. I also identified four ribosomal proteins crosslinked to 
fibronectin. Although typically found intracellularly, they have also been found expressed 
on the surface of Streptococcus (55) and E. coli (54). 
 
 
Identification of fibrinogen binding proteins in  
E. coli and Salmonella ser. Typhimurium by  
crosslinking and SDS-PAGE 
 
The label transfer protocol is useful to identify protein interactions, if the identity 
of the at least one of the interacting proteins (e.g. fibronectin in the previous case) is 
known. In a cell-cell interaction model, where the identity of none of the binding partners 
is known, it is possible to get a list of interacting proteins using the label transfer 
approach, but it is not possible establish binding partnerships. To be able to establish 
binding partnerships, I used a slightly different approach with the same crosslinking 
reagent. I initially verified the feasibility of the approach by crosslinking fibrinogen to S. 
ser. Typhimurium and E. coli to identify the fibrinogen interacting proteins, and later 
used the approach for whole cell crosslinking. After crosslinking the protein to the 
bacterial cell surface I lysed the bacteria and separated the crosslinked complex by SDS-
PAGE under reducing and non-reducing condition. The reducing conditions break the 
disulfide bond in the crosslinker, separating the two proteins. This was visualized on a gel 
due to a shift in the molecular weight of the crosslinked complex between the reducing 
and non -reducing gels. Bands which showed such a shift in molecular weight were cut 
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out from the gel resolved under non-reducing conditions, and the proteins were identified 
using LC-MS/MS.  
  I identified three bands that were present in the gel resolved under non-reducing 
conditions (Fig 3.1), but absent in the gels resolved under reducing conditions. Of the 
three bands, two bands contained only fibrinogen, while the third band contained 
fibrinogen as well as murein lipoprotein (Lpp), for S ser. Typhimurium and universal 
stress protein B (UspB) for E. coli (Table 3.4). Lpp is a murein lipoprotein expressed on 
the cell surface and contributes towards the virulence of the organism in the mice model 
(56). Specifically, Lpp is a murein lipoprotein expressed on the cell surface and is an 
established virulence factor in S. sv Typhimurium that mediates invasion (56) Persson et 
al  (50) reported csgA fimbriae in Salmonella to be a fibrinogen binding protein, but since 
csgA is not usually expressed under normal culture conditions (26) it was not found 
cross-linked to fibrinogen. Fibrinogen binding is reported in E. coli (57), but no known 
fibrinogen binding proteins have been discovered. We found UspB, a membrane protein 
in E. coli that is required for ethanol tolerance cross-linked with fibrinogen. Hence using 
a crosslinking approach I identified a murein lipoprotein that mediates adhesion and 
invasion in S. ser. Typhimurium and a cell membrane attached stress tolerance protein in 
E. coli as a fibrinogen interacting protein. Given the success in the initial phase using 
individual host proteins to find established bacterial adhesins, experiments moved to 
cross-link whole cells. 
 
 Identification of host microbe receptors 
by whole cell crosslinking 
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After verifying that the crosslinking protocol worked with microbes and pure 
ECM components, I used the same protocol to crosslink whole cells. I labeled the 
bacteria with sulfo-SBED, crosslinked it with Caco-2 cells, lysed the cells and resolved 
the samples on 2D gels (instead of SDS-PAGE) under either reducing conditions or non-
reducing conditions. Protein spots that were present in the gel resolved under non-
reducing condition, but absent in gels resolved under reducing conditions were picked 
from the gel, and proteins identified using LC-MS/MS. Figure 3.2 shows a representative 
gel resolved under non-reducing conditions The gels were resolved in two replicates and 
only the spots that showed similar migration patterns in both the replicates were picked. 
Forty four such spots were picked, of which 33 spots yielded protein IDs. Out of the 33 
spots with protein ID, nine spots had protein IDs from the host as well as microbe in the 
same spot. Of those nine spots, five spots had proteins whose sum of the molecular 
weights matched the observed molecular weight of the spot on the gel. Hence those five 
spots had proteins from host as well as microbes, which were crosslinked. The identified 
proteins are listed in Table 3.5. Images of both the replicates resolved under reducing and 
non-reducing conditions are shown in Appendix Figure A3. Based on the protein 
identification results (Table 3.5), it can be concluded unambiguously, that STM2699 was 
crosslinked with SPTAN1 and, STM1956 was crosslinked with HSP90AB1. STM4088 
might have been crosslinked to either HSP90B1 or ACTN4, or both the proteins. Ef-Tu 
from salmonella might have been crosslinked to PPP1R12A, HSP90AB1, CTNNA1, 
PTPRE, PPP1R9B or MATR3. STM3286 from salmonella might have been crosslinked 
with ACTB from the host, or it could have also crosslinked with Ef-Tu from salmonella 
itself. 
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Characterization of the protein-protein interactions  
observed from crosslinking 
 
 
 Adhesion and invasion of the host mucosa is the first step in the pathogenesis of 
salmonella. To verify the functional significance of the crosslinked proteins, I determined 
their role in adhesion and invasion of S .ser. Typhimurium. Out of the five bacterial target 
proteins identified from crosslinking, I investigated the role of one of those proteins and 
found that, Ef-Tu was involved in adhesion as well as invasion. Out of the 11 host 
proteins identified, I looked at the role of five of those proteins in adhesion and invasion. 
I found that two of those proteins were involved in adhesion, one protein was involved in 
invasion, while two proteins had no role in adhesion or invasion. 
 Since Salmonella binding with host gangliosides has been reported in the 
literature (14, 37, 48), I also investigated the role of 2 gangliosides, GM1 and GD3 in 
adhesion and invasion. I narrowed down on these two gangliosides as GM1 has been 
reported to be a receptor for many bacterial toxins (40) and has also been shown as a co- 
receptor important in toll like receptor signaling (44). I investigated GD3 as it is the most 
abundant ganglioside present in differentiated Caco-2 cell membranes (53). Figure 3.3 
shows a dose dependent effect of blocking each receptor with antibodies, on the amount 
of total host associated bacteria. Based on these data, the antibody dilution that showed 
optimum pathogen blocking was subsequently used to dissect the role of individual 
molecules in either adhesion or invasion. As evident from the Figure 3.3, PPP1R12A, 
CTNN1A, HSP90AB1 and ganglioside GM1 were involved in association of S. ser. 
Typhimurium to the epithelial cells, as blocking those molecules with antibodies 
significantly reduced the amount of host associated bacteria. PPP1R9B, PTPRE and 
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ganglioside GD3 on the other hand had no effect. Also blocking Ef-Tu on the bacteria 
significantly reduced the amount of host associated bacteria. I further assessed the 
contributions of PPP1R12A, CTNN1A, HSP90AB1, ganglioside GM1 from the host and 
Ef-Tu from the bacteria on adhesion and invasion of S. ser. Typhimurium. 
 I investigated the role of Ef-Tu in adhesion and invasion of S. ser. Typhimurium 
(Fig 3.4) by either blocking Ef-Tu with an antibody, or by adding excess native purified 
Ef-Tu to compete with cell surface associated Ef-Tu, from the same bacteria. In a wild 
type background (WT), blocking Ef-Tu on the bacteria with an antibody caused a 
significant reduction in adhesion as well as invasion (p<0.05). The fraction of 
intracellular host associated bacteria, dropped from 5.8% in unblocked control to 2.5 % in 
Ef-Tu blocked cells. Adding excess Ef-Tu significantly decreased the amount of adhered 
bacteria, but increased the amount of the invaded bacteria. The fraction of intracellular 
host associated bacteria increased from 5.8% in untreated control to 16.6 % in cells 
spiked with excess Ef-Tu, and this effect was dose dependent. The effect of receptor 
blocking on a non-invasive S. ser. Typhimurium ∆invA strain was also assessed. InvA is 
an inner membrane protein that is necessary for the secretion of T3SS-1 effectors, which 
are required for invasion (19). Adding excess Ef-Tu to ΔinvA cells caused a decrease in 
adhered bacteria, while there was no change in amount of invaded bacteria. Based on 
these results it can be concluded that Ef-Tu was directly involved in adhesion and 
invasion of S. ser. Typhimurium.  
 I also investigated the role of the crosslinked host molecules, in adhesion and 
invasion by blocking specific receptors on the epithelial cells with antibodies. Initial 
screening (Fig 3.3) revealed that of the seven host molecules tested, four had a role in 
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either adhesion or invasion. I further tested the role of those molecules in adhesion and 
invasion. Blocking HSP90AB1, CTNNA1, PPP1R12A and GM1 on the host with 
antibodies significantly reduced (p<0.05) the total number of adhered wild type bacteria 
to 26%, 45%, 31% ,and 56%, respectively, relative to unblocked control. Concurrently 
the amount of invaded bacteria was reduced to 78%, 20%, 10%, and 7 %, respectively, 
relative to control. The fraction of intracellular host associated bacteria changed from 
5.8% for the control to 15.5%, 1.4%, 3.7%, and 0.68 % for HSP90AB1, CTNNA1, 
PPP1R12A, and GM1 blocking respectively,. The effect of host receptor blocking on the 
amount of host associated bacteria was also tested on a non-invasive S. ser. 
Typhimurium. Blocking HSP90AB1, PPP1R12A and GM1 on the host reduced the 
adherence of the noninvasive strain to 38%, 71%, and 49 % respectively, relative to the 
non-blocked control, while blocking CTNNA1 had no effect. Total host associated WT 
bacteria reduced to 22%, 20%, 19%, and 59% relative to non -blocked control after 
blocking HSP90AB1, PPP1R12A, CTNNA1 and GM1 respectively. Hence it can be 
concluded that HSP90AB1 was involved in adhesion of salmonella, while rest of the 
tested molecules were involved in adhesion and invasion. Also based on the differences 
in susceptibility to antibody blocking between WT and ΔinvA strain, the role of 
PPPR12A and CTNNA1 were downstream of the effects induced in the host due to 
injection of T3SS-1 effectors. 
 It has been speculated that, since Ef-Tu is a well conserved protein in all bacteria, 
it is a MAMP (microbe associated molecular pattern) that is recognized by the host cells. 
Agrobacterium Ef-Tu is recognized by EFR, a receptor kinase in Arabidopsis thaliana, 
which leads to induction of genes in Arabidopsis necessary for protection from 
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Agrobacterium mediated DNA transformation (65). It has also been shown that Ef-Tu 
from Lactobacillus johnsonni elicits a proinflammatory response in cultured epithelial 
cells (22). Since NFkB is a central regulator of inflammatory response, to test if Ef-Tu 
from S ser. Typhimurium induced a proinflammatory response in cultured epithelial cells, 
I quantified NFkB mediated transcription in a reporter Caco-2 cell line in response to 
excess Ef-Tu. The results are summarized in Figure 3.6. S. ser. Typhimurium (WT and 
ΔinvA) both induced activity in Caco-2 cells. However there was no effect of adding 
excess Ef-Tu or blocking Ef-Tu with an antibody on the activity of NFkB.  
 Of the seven host receptors I tested for an adhesion/invasion related phenotype, 
three were protein phosphatases (PPP1R12A, PTPRE, and PPP1R9B) and one was a 
chaperone protein (HSP90AB1). Two of the three phosphatases (PPP1R12A, PTPRE) 
and HSP90AB1 have been shown to modulate the phosphorylation status of Akt (2, 64) 
at threonine 308 and serine 473. Hence I hypothesized that Ef-Tu modulates the 
phosphorylation status of Akt in Caco-2 cells. Since sigD, one of the T3SS-1 effector has 
been shown to induce phosphorylation of Akt; I tested the hypothesis by relative 
quantification of P-AKT 473 and P-AKT 308by incubating Caco-2 cells with ΔinvA 
strain of Salmonella ser. Typhimurium in presence or absence of excess Ef-Tu (2 µg/ml). 
Levels of P-Akt3 08 were below detection in all the treatments. Levels of P-AKT 473 due 
to different treatments are summarized in Figure 3.7. Presence of S. ser. Typhimurium 
ΔinvA had no effect on levels of P-AKT 473. Presence of excess Ef-Tu with or without 
the presence of the organisms significantly increased the levels of P-AKT 473. Hence Ef-
Tu from S. ser. Typhimurium induced phosphorylation of Akt in epithelial cells 
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Discussion 
 
 
  I developed a crosslinking method to discover host microbe receptors which 
doesn't require any apriori knowledge of interacting protein targets on the host or the 
microbe. I used the method to discover protein-protein interactions between Salmonella 
and cultured intestinal epithelial cells (Caco-2). I discovered five salmonella protein that 
were crosslinked to 11 proteins from epithelial cells. One of the discovered Salmonella 
proteins was translation elongation factor Tu (Ef-Tu). Ef-Tu is typically found 
intracellularly and is one of the most abundant proteins in bacterial cells (18). It is a 
monomeric G protein, which binds and mediates the entry of aminoacyl tRNA into the 
A site of ribosomes, so as to facilitate the elongation of a protein being translated. 
Correct binding of an aminoacyl tRNA into the A site of ribosomes triggers the GTPase 
activity of Ef-Tu. Ef-Ts acts as a guanine nucleotide exchange factor (GEF) for Ef-Tu , 
and exchanges the hydrolyzed GDP for GTP. Hence for translation, a stoichiometric 
ratio of 1:1:1 of ribosomes: Ef-Tu: Ef-Ts is sufficient (35). Yet, in a dividing cell, 
ribosome, Ef-Tu and Ef-Ts exists at a stoichiometric ratio of ~ 1:10:1 (18). Hence in a 
dividing cell Ef-Tu exists at ~ 10 X concentrations then what is usually required for 
translation, indicating that perhaps Ef-Tu is also required in the cell for functions other 
than its role in protein translation. The role of Ef-Tu as a chaperone has also been 
proposed as it was shown that Ef-Tu promoted functional folding of proteins after urea 
denaturation (10). Based on the fact that Ef-Tu can form filamentous structures in vitro 
(7, 8, 62), it has also been proposed that Ef-Tu may be a cytoskeletal element in 
prokaryotes. Soufo et al . recently showed that in Bacillus subtilis, Ef-Tu co-localizes 
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with MreB, an actin like cytoskeletal element and is a major determinant of cell shape 
(12).  
 I characterized the interaction of Salmonella Ef-Tu with host epithelial cells and 
showed that, it mediates adhesion and invasion of Salmonella. Cell surface associated Ef-
Tu from Salmonella has also been shown to interact with the host tumor necrosis factor 
(TNF-alpha) (52). The implications of this association in the infection process are not 
clearly understood. Cell surface expression of Ef-Tu has also been confirmed in 
phylogentically diverse group of bacteria including Lactobacillus johnsonii (22), 
Agrobacterium tumefaciens (65), Mycobacterium tuberculosis (63), Mycobacterium 
leprae (43), Francisella tularensis (6), Helicobacter pylori (39), Mycoplasma 
pneumoniae (4), Mycoplasma genetelium (5), Streptococcus pyogenes (55), 
Streptococcus gordonii (29), and Streptococcus oralis (61). Table 3.5 lists the interacting 
partners of Ef-Tu known in different bacterial species and Figure 3.8 shows a neighbor 
joining tree made by aligning Ef-Tu sequences from bacteria whose Ef-Tu is known to 
interact with specific host proteins. Figure 3.8 demonstrates that there is casual 
correlation between taxonomic distance of the Ef-Tu and similarity of binding partners 
i.e. Ef-Tu from both the Mycoplasma tends to bind fibronectin, while Ef-Tu from both 
the Lactobacillales tend to bind mucins. Data from more organisms is needed to have 
more significant correlations between the phylogenetic distance and similarity of binding 
partners. One to three Ef-Tu gene copies are present in the bacterial genome depending 
upon the species (33), but there was no correlation between number of Ef-Tu copies 
present and surface localization of Ef-Tu. I did not find any correlations between bacteria 
expressing Ef-Tu on the surface and its phylogenetic position either.  
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 One of the host proteins found crosslinked to Ef-Tu was Hsp90. Hsp90 is a highly 
conserved molecular chaperone that has a variety of roles in signal transduction, protein 
folding and protein degradation. A homolog of Hsp90 is also expressed on the cell 
surface and act as microbial receptors for Listeria monocytogenes (9) and Clostridium 
difficile Toxin A (46). Here I show that Hsp90 can specifically mediate adherence of 
Salmonella with epithelial cells. 
 Surprisingly two of host receptors that I found crosslinked to Salmonella, which 
had a role in invasion (PPP1R12A, CTNNA1), interact with the actin cytoskeleton. 
PPP1R12A is a cell surface expressed (27, 36) myosin light chain phosphatase that 
regulates the interaction of actin and myosin downstream of small G protein Rho. 
Increased phosphatase activity of PPP1R12A, negatively regulates formation of 
membrane ruffles (59). Since binding of Ef-Tu with PPP1R12A enhanced invasion of 
Salmonella, it can be speculated that Ef-Tu by a yet unknown mechanism decreased the 
phosphatase activity of PPP1R12A, leading to lesser negative regulation of membrane 
ruffling, which is a downstream effect of T3SS effectors (24).  
 Alpha catenin (CTNNA1) has recently been shown to be a molecular switch, that 
either binds E-cadherin/beta catenin complex as a monomer or, it binds F-actin as a 
homodimer (15). When bound to F-actin, alpha catenin negatively regulates actin 
filament branching by suppressing Arp2/3 mediated actin polymerization, possibly by 
competing with Arp2/3 for actin binding (15). Two of the T3SS effectors (SopE, SopB) 
stimulate Arp2/3 mediated actin polymerization, which is necessary for the formation of 
membrane ruffles and invasion (24). Since interaction of Ef-Tu with CTNNA1 promoted 
invasion only in Salmonella that possess T3SS, it can be speculated that binding of Ef-Tu 
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with alpha catenin decreased its binding with actin by an unknown mechanism, leading to 
increased Arp 2/3 mediated polymerization and hence increased invasion. Hence 
interaction of Ef-Tu from Salmonella with host PPP1R12A and CTNNA1most likely 
promoted invasion by inhibiting the negative regulation of membrane ruffling. This 
mechanism probably acted in concert with membrane ruffling induced by the T3SS 
effectors. 
 The role of gangliosides as receptors for bacteria, viruses and toxins is well 
studied (14). For Salmonella it has been reported that gangliosides act as co receptors 
with TLR5 for flagellar protein FliC, which leads to induction of NfKB activity in 
epithelial cells (48). Here I have reported that ganglioside GM1 is involved in the 
invasion of epithelial cells by Salmonella. Blocking host GM1 with antibody reduced 
adherence ~2-fold, but reduced invasion ~15-fold, hence GM1 probably interacts with a 
Salmonella factor which is very important for mediating invasion. Since a T3SS-1 
deletion mutant and GM1 blocking showed similar phenotypes, it can be speculated that 
GM1 interacts with components of the T3SS. Tejero et al . (32) recently showed that 
three translocon components of the T3SS-1 (SipB, SipC, SipD) mediate intimate 
attachment of Salmonella with epithelial cells before injection of the effectors (SopE, 
SopB) that cause membrane ruffling, and this interaction is important for the successful 
delivery of the SopE and SopB. The identity of the host interacting partners for SipB, 
SipC and SipD is not known. It can be speculated that since GM1 plays such a crucial 
role in invasion, perhaps it is the binding partner for the translocon components for the 
T3SS. 
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 In conclusion, we developed a cell-cell crosslinking method to discover host and 
microbe receptors that mediate interaction between bacterial and mammalian cells. We 
initially verified the method by crosslinking pathogens and commensals with pure ECM 
components and went on to use the method to crosslink Salmonella with epithelial cells. 
New protein-protein interactions were discovered. We showed that interaction of Ef-Tu 
on the Salmonella cell surface with Hsp90 on Caco-2 cells mediates adhesion while 
interaction of Ef-Tu with PPP1R12A and CTNNA1mediates adhesion as well invasion. 
We also showed that host ganglioside GM1 mediates adhesion and invasion. 
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Table 3. 1. Bacteria growth conditions and primers for their quantitation by qPCR. 
 
Bacteria Growth condition qPCR primers Standard curve equation 
Salmonella enterica ser. 
Typhimurium LT2  
(ATCC 700720) Gene: 
16s rDNA 
 
37°C / 220 rpm in 
LB (BD Difco, 
France)  
 
Forward: TGT TGT GGT TAA TAA CCG CA 
Reverse: CAC AAA TCC ATC TCT GGA 
 
Log10 CFU = Ct-46.52/-
5.034 
R2 = 0.99 
Caco2 (ATCC HTB-37) 
Gene: G3PDH 
See cell culture for 
growth description 
Forward: ACC ACA GTC CAT GCC ATC 
AC Reverse: TCC ACC ACC CTG TTG CTG 
TA 
Log10 CFU = Ct-33.69/-4.13 
R2 = 0.99 
 
  
 Table 3. 2 Antibodies used to block host and bacterial receptors 
 
Receptor Protein Description 
Host 
Species 
Dilutions Used Vendor 
HSP90AB1 Heat shock protein 90kDa alpha (cytosolic), 
class B member 1 
Rabbit 
Polyclonal 
1:500, 1:1000, 
1:2000, 1:4000 
#NB110-96885, Novus 
Biologicals 
PPP1R12A Protein phosphatase 1, regulatory (inhibitor) 
subunit 12A 
Rabbit 
Polyclonal 
1:50, 1:100, 
1:200, 1:400 
#NB110-38890, Novus 
Biologicals 
PPP1R9A Protein phosphatase 1, regulatory (inhibitor) 
subunit 9A 
Rabbit 
Polyclonal 
1:250, 1:500, 
1:1000, 1:2000 
#NB120-3483, 
Novus Biologicals 
CTNN1A Catenin (cadherin-associated protein), alpha 
1 
Rabbit 
Polyclonal 
1:50, 1:100, 1:200, 
1:400 
#NB120-2364, 
Novus Biologicals 
PTPRE Protein tyrosine phosphatase receptor type 
E (PTPRE) 
Mouse 
Polyclonal 
1:100, 1:200, 
1:400, 1:800 
#H00005791-A01, 
Novus Biologicals 
Ganglioside 
GD-3 
Ganglioside GD-3 Mouse 
Monoclonal 
1:50, 1:100, 1:200, 
1:400 
#NB120-6217, 
Novus Biologicals 
Ganglioside 
GM-1 
Ganglioside GM-1/ Asialo GM1 Rabbit 
Polyclonal 
1:250, 1:500, 
1:1000, 1:2000 
#AB31119, Abcam 
Ef-Tu Elongation factor Tu Mouse 
Monoclonal 
1:50, 1:250, 1:500, 
1:1000 
#05-235, Millipore 
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Table 3. 3 Fibronectin binding proteins identified in L. acidophilus using a label transfer 
approach. 
 
 
 
 
 
 
 
  
Locus Tag Protein 
Unique 
Peptides 
MASCOT 
Score 
LBA0222  Hypothetical Protein  3 141 
LBA0324  30S ribosomal protein S9  3 126 
LBA0223  Cell separation protein, CdpA  2 141 
LBA0315  30S ribosomal protein S13  2 146 
LBA0291  50S ribosomal protein L3  2 137 
LBA0786  30S ribosomal protein S4  2 104 
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Table 3. 4 Fibrinogen binding protein identified in S. ser. Typhimurium using a 
crosslinking approach. 
 
Band Locus Tag Organism Protein 
Unique 
Peptides 
Mw 
PLGS 
Score 
K1  B3494  E. coli K12  Universal stress 
protein B  
2 13018 103 
FGA  H. sapiens  Fibrinogen alpha 
chain  
22 69713 424 
FGB  H. sapiens  Fibrinogen beta 
chain  
22 55892 320 
FGG  H. sapiens  Fibrinogen gamma 
chain  
20 49464 170 
S1  STM1377  S. 
Typhimurium  
Murien lipoprotein 
lpp 
3 8386 320 
FGA  H. sapiens  Fibrinogen alpha 
chain  
27 69713 2408 
FGB  H. sapiens  Fibrinogen beta 
chain  
18 55892 1596 
FGG  H. sapiens  Fibrinogen gamma 
chain  
15 49464 1239 
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Table 3. 5 Host Microbe proteins identified as binding partners by whole cell crosslinking. 
 
Mw of 
Spot on 
Gel (Da)  
S. Typhimurium Protein Peptides  PLGS 
Score  
Bacteria
l protein 
Mw 
(Da) 
Caco-2 Protein Pepti
des  
PLGS 
Score  
Host 
Protein 
Mw(Da)  
276000 Putative Phage Tail like 
protein (STM2699)  
3 98.2 10804  Spectrin, alpha, non-
erythrocytic 1 (SPTAN1)  
7 446.5 284105 
103000 Flagellar biosynthesis 
factor FliA (STM1956)  
3 87.4 27456 Heat shock 90kDa protein 
1 beta (HSP90AB1)  
13 651.7 83212 
94000 Putative cytoplasmic 
protein (STM4088)  
2 80.1 9306 Tumor rejection antigen 
gp96 (HSP90B1)  
9 394.6 92411 
Actinin alpha 4 (ACTN4)  5 133 104788 
131000 Elongation Factor Ef-Tu 
(STM4146, STM3445) 
5 368 43256 Protein phosphatase 1 
regulatory subunit 12A 
(PPP1R12A) 
14 842.1 115210 
Heat shock 90kDa protein 
1 beta (HSP90AB1) 
4 160.5 83212 
Catenin alpha 1 
(CTNNA1) 
3 100.6 100008 
Protein tyrosine 
phosphatase receptor type 
E (PTPRE) 
2 124.8 80590 
120000 Translation initiation factor 
IF 2 (STM3286) 
8 415.8 97342 Protein phosphatase 1 
regulatory subunit 9B 
(PPP1R9B) 
8 611.6 89396 
Elongation Factor Ef-Tu 
(STM4146, STM3445) 
4 220.8 43256 Matrin 3 (MATR3) 5 195.5 94564 
      Beta actin (ACTB) 4 177.7 41709 
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Table 3. 6 Known interacting host partners of Ef-Tu from other published studies 
 
Order Species Host Binding 
Partner 
Reference 
Actinomycetales Mycobacterium tuberculosis Plasminogen  (63) 
Alphaproteobacteria Agrobacterium tumefaciens  Receptor kinase- 
EFR 
 (65) 
Gamma 
Proteobacteria 
Francisella tularensis  Nucleolin (6) 
Gamma 
Proteobacteria 
Salmonella ser. Typhimurium TNF-Alpha  (52) 
Bacilli Lactobacillus johnsonii Mucins  (22) 
Bacilli Streptococcus gordonii  Mucins  (29) 
Mollicutes Mycoplasma genitelium Fibronectin  (5) 
Mollicutes Mycoplasma pneumoniae  Fibronectin  (4) 
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Figure 3. 1 Fibrinogen binding proteins identified from E. coli and S. ser. Typhimurium 
LT2 by crosslinking labeled fibrinogen with the microbes and then separating the 
proteins under reducing (A4, B3) and non-reducing conditions (A2, A3, B1, B2). Proteins 
identified from bands S1 and K1 are shown in Table 3.4. Bands K2, K3, S2 and S3 
contained fibrinogen subunits (FGA, FGB and FGG) but no bacterial proteins  
 Figure 3.2 
 
Figure 3. 2 Crosslinked proteins resolved by 2D gel electrophoresis under non reducing conditions. The circled spots were 
picked and identified using LC-MS/MS 
 
 
 
Figure 3.3  
 
 
Figure 3. 3 Effect of blocking host and microbe receptors on total host associated bacteria as determined by qPCR. Treatments 
which were significantly different from cells that were given no antibody treatment (Control) (p<0.05) are marked with "*". 
The actual antibody dilutions of each antibody used are in Table 3.2. Error bars indicate standard error from four replicates. 
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Figure 3.4 
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Figure 3. 4 Effect of blocking Ef-Tu with an antibody, and adding excess Ef-Tu, on 
adhesion and invasion of S. ser. Typhimurium in a wildtype (WT) background and non -
invasive (ΔinvA) background. Treatments that do not share a letter are significantly 
different (p<0.05). The % numbers of the x axis represents the fraction of total host 
associated bacteria that were intracellular (invaded). Error bars indicate standard error 
from four replicates. 
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Figure 3.5 
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Figure 3. 5 (A). Effect of blocking specific host proteins with antibodies on adhesion and 
invasion of S. ser. Typhimurium. (B) Effect of blocking specific host molecules with 
antibodies on total host associated S ser. Typhimurium in a wild type (WT) and a non-
invasive (ΔinvA) background. . Treatments that do not share a letter are significantly 
different (p<0.05). The % numbers of the x axis represents the fraction of total host 
associated bacteria that were intracellular (invaded). Error bars indicate standard error 
from four replicates. 
 
 
Figure 3.6  
 
Figure 3. 6 (A) Effect of adding excess Ef-Tu from S. ser. Typhimurium and anti-Ef-Tu on NFkB activity of Caco-2 cells (B) 
Effect of adding excess Ef-Tu from S. ser. Typhimurium and anti-Ef-Tu on NFkB activity of Caco-2 cells in presence of S. ser. 
Typhimurium (WT) or S. ser. Typhimurium ΔinvA. Treatments that do not share a letter are significantly different (p<0.05). 
Cell free lysate from S. ser. Typhimurium was used as a positive control for induction of NFkB mediated transcription. Error 
bars indicate standard error from four replicates. 
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Figure 3.7  
 
Figure 3. 7 Relative densitometric quantification of p-Akt 473 by western blots. 
Treatments not sharing a letter are significantly different (p<0.05). Error bars indicate 
standard error from four replicates. 
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Figure 3. 8 Neighbor joining tree based on alignment of amino acid sequences of Ef-Tu 
from bacteria that have known Ef-Tu binding partners in host cells. The Ef-Tu interacting 
proteins for each organism are mentioned after the species name. 
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CHAPTER IV 
SOLID-PHASE CAPTURE OF PATHOGENIC BACTERIA BY USING 
GANGLIOSIDES AND DETECTION WITH REAL-TIME PCR 
 
Abstract 
 
 
We developed a method for concentrating pathogens from samples without 
enrichment. Immobilized gangliosides concentrated bacteria for detection with real-time 
PCR. A sensitivity of 4 CFU/ml (3 h) in samples without competing microflora was 
achieved. Samples with competing microflora had a sensitivity of 40,000 CFU/ml. The 
variance was less than one cycle. 
 
Introduction 
 
 
 The Centers for Disease Control and Prevention (CDC) estimates that food-borne 
diseases cause approximately 76 million illnesses, 325,000 hospitalizations, and 5,000 
deaths in the United States each year, which in 2000 led to an estimated $6.9 billion 
burden to the U.S. economy for just the top five food-borne pathogens 
(http://www.ers.usda.gov/briefing/FoodSafety/). This avoidable burden can be reduced if 
the disease-causing organism is detected and remedial action taken quickly to control the 
spread of the disease. As such, many efforts to create rapid-detection tests (i.e., <24 h) 
have been undertaken in the last 10 years. The limitation in most methods is the need for 
a pre-enrichment step before detection to increase the population of interest with semi-
selective or selective media. Methods that eliminate the need for enrichment are needed 
to break this time barrier so that results are provided earlier in the disease process. This 
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challenge can be addressed by creating assays that concentrate bacteria or by using 
detection methods that are very sensitive. More recently, use of genetic detection methods 
is widely available due to the large number of microbial genome sequences that 
are available. 
 The AOAC-approved rapid-detection technologies rely on either antibody-based 
tests or nucleic acid-based tests that claim detection limits as low as one organism, but 
these assays still require 24 to 48 h to provide a result. This time is somewhat shortened 
by affinity capture of the infectious agent by antibodies onto a solid matrix and then 
subsequent detection by PCR or real-time PCR (RT-PCR), but these tests still require 
enrichment, are still based on antibody reactions that can have false-positive results, and 
require extensive development time to ensure antibody quality. The approach presented in 
this work avoids the two most time-limiting steps in antibody-based assays, 
development and pre-enrichment. 
 An alternative approach to antibodies is the use of host receptors to capture the 
pathogen, which changes the paradigm of detection to finding those organisms that can 
bind host cells. Gangliosides are a large class of glycolipids that are common 
components of eukaryotic cells. Often, the specific classes are expressed in specific 
tissues that can be exploited to find organisms that will bind cells from specific tissues. In 
addition, the binding of bacteria and toxins to gangliosides has been documented in the 
literature (7, 13, 16, 22). To exploit this paradigm, we used host receptors (isolated mixed 
gangliosides) to mimic pathogen attachment onto the host cell to capture and 
concentrate pathogens from various samples onto a solid surface. With these molecules, a 
variety of pathogens can be captured onto a solid phase and subsequently be detected in a 
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variety of different formats, depending on the amount of information needed during the 
testing regime. Here, we demonstrated that most common food-borne pathogens bind 
immobilized gangliosides onto 3-mm glass beads that are easily removed from the 
sample with physical separation. We determined the lower detection limit of the assay by 
using Escherichia coli O157:H7 as the model organism. After 5 minutes of binding, we 
detected up to 10 cells by RT-PCR within 3 h of sample collection. Spiked E. 
coli O157:H7 was detected in frozen spinach, pasteurized apple juice, and bottled water 
with a detection limit of 4 CFU/g of sample. 
 
Materials and methods 
 
 
Ganglioside immobilization 
 
 
Gangliosides were purified from bovine buttermilk as described by Walsh and 
Nam (26). Briefly, the purification of gangliosides included ultrafiltration of fresh 
buttermilk (Gosners, Logan, UT) with a 1-kDa membrane to remove the lactose, followed 
by an organic extraction with chloroform-methanol-water (40:80:30). The purified 
gangliosides (6 µg) were used for immobilization with 100 g of 3-mm solid glass beads 
(catalog no. 11-312A; Fisher Scientific, St. Louis, MO), which produced bioactive beads 
(gangliobeads) with a mixture of gangliosides on the surface. 
 
 
 
 
 
Screening of bacteria for ganglioside 
binding 
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In brief, all the organisms were grown to exponential phase in media and under 
conditions specific for the organism (Table 4. 1). The organisms were washed twice in 
saline and diluted to an optical density at 600 nm of 0.2 in saline. This suspension (2 ml) 
was exposed to 10 gangliobeads for 10 minutes at 25°C with agitation and washed thrice 
with 50 mM Tris-Cl (pH 7.2) for 5 minutes each time. The presence or absence of the 
particular organism on the beads was confirmed either with specific antibody detection 
via a tagged tertiary antibody or by RT-PCR using universal bacterial 16S primers (IDT, 
Coralville, IA). Rabbit anti-Salmonella antibody (OEM Concepts, Toms River, NJ), 
goat anti-E. coli antibody (BioDesign International, Saco, ME), rabbit anti-Listeria 
monocytogenes antibody (BioDesign International), rabbit anti-Erwinia antibody (Abcam, 
Cambridge, MA), goat anti-Bacillus globigii spores (Dugway Proving Grounds, Dugway, 
UT), rabbit anti-Lactococcus antibody (Center for Integrated BioSystems, Utah State 
University, Logan, UT), and rabbit anti-Lactobacillus antibody (Biotechnology Center, 
Utah State University, Logan, UT) were all immunoglobulin G-type polyclonal 
antibodies. They were diluted as recommended by the manufacturer for an enzyme-
linked immunosorbent assay or to a micromolar concentration if they were custom 
products. Tertiary anti-rabbit and anti-goat conjugated to alkaline phosphatase (Sigma, 
Saint Louis, MO) were diluted as recommended by the supplier. The substrate, p-
nitrophenyl phosphate (Sigma, St. Louis, MO) in 0.1 M glycine buffer, 1 mM MgCl2, 1 
mM ZnCl2, pH 10.4 (1 mg/ml), was added to each sample,
 and the plates were incubated 
for 20 minutes at 37°C. Color development was measured using a BioAssay 7000 plate 
reader (Perkin-Elmer, Norwalk, CT) at 405 nm. Each plate contained controls consisting 
of aliquots of each concentration of the specific antibody, with the appropriate tertiary 
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antibody without bacteria (negative control), the tertiary antibodies alone, and the 
substrate alone. The signal-to-noise value was calculated by dividing the absorbance 
readings from each sample by the negative-control value. The entire experiment was done 
with three biological replicates. 
 Detection with RT-PCR used washed gangliobeads that were added to 100 µl 
distilled water and boiled for 10 minutes to release the DNA. An aliquot of the boiled 
sample (12.5 µl) was used for RT-PCR with universal bacterial 16S primers (IDT, 
Coralville, IA), using a DyNAmo HS Sybr green quantitative PCR kit (MJ 
Research, Waltham, MA) per the manufacturer's recommendations and a DNA Engine 
Opticon 2 thermal cycler (MJ Research). The thermal cycler was run for 50 cycles of 15 s 
at 95°C (melting), 30 s at 60°C (annealing), and 45 s at 72°C (extension and 
plate reading). The threshold cycle (CT) number was reported using Opticon Monitor 
analysis software (version 2.02; MJ Research). Appropriate negative controls for probing 
for nonspecific binding (using 3-mm glass beads instead of gangliobeads) and sterility in 
the beads and buffers (using gangliobeads with saline instead of bacterial suspension) 
were also used along with the test samples. The experiment was done with three 
biological replicates, using duplicate RT-PCRs. 
  Capture and detection of E. coli 0157:H7 from buffers and food. To check the 
lower detection limit of this approach, we exposed 2-ml 10-fold serial dilutions of log-
phase E. coli O157:H7 cells (108 to 100 CFU/ml; cell population was determined using 
plate counts with nutrient agar) to 10 gangliobeads. The beads were either unwashed or 
washed before testing with RT-PCR. The organisms on the beads were detected using the 
commercially available Genevision rapid pathogen detection system for E. 
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coli O157:H7 (Warnex Diagnostics, Quebec, Canada) per the manufacturer's instructions. 
Pasteurized apple juice, commercial bottled water, sterile ultrahigh-temperature milk, 
salami, hamburger patties, and frozen spinach were purchased from the local grocery 
store, plated on nutrient agar (as described in the Bacteriological Analytical Manual (17)), 
and spiked with log-phase E. coli O157:H7 cells at the levels of 106, 104, 102, 101, 100, 
and 0 CFU/25-g sample after the pure-culture population was determined by plating on 
nutrient agar. Spinach, hamburger patties, and salami were diluted 1:1 (weight to volume) 
with saline in a filtered stomacher bag and stomached at high speed using the Seward 
stomacher laboratory system (Lab3; Bristol, England) for 15 min, and the sample 
rinse was spiked with the above-mentioned E. coli O157:H7 population. Food samples 
(25 g) were exposed to 30 gangliobeads on a rocking platform for 30 min. After 30 min, 
the beads were removed by decanting the liquid from the sample and added to 400 µl of 
lysis buffer supplied with the Genevision rapid pathogen detection kit, and PCR was 
performed per the manufacturer’s instructions. The aerobic plate counts of all the foods 
were estimated prior to spiking with E. coli O157:H7 by using nutrient agar at 32°C as 
described in the Bacteriological Analytical Manual (17). The average of three replicate 
plate counts was reported. The experiment was done with three biological 
replicates, using RT-PCR in duplicate. 
 
 
 
Results and Discussion 
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 We screened 20 different bacterial strains for their abilities to specifically bind 
immobilized gangliosides (Table 4. 1). Ten strains of Salmonella, two strains 
of Escherichia coli, Lactococcus lactis, and Bacillus globigii spores bound to the beads. 
However, Lactobacillus acidophilus, Lactobacillus gasseri, Lactobacillus helveticus, 
Listeria monocytogenes, and Erwinia herbicola did not bind to the immobilized 
ganglioside mixture. All of the tested enterobacteriaceae bound the gangliobeads in this 
study. While variability among Salmonella strains with respect to binding gangliosides is 
known, we focused on Salmonella enterica serovar Enteritidis, where all the strains tested 
bound. Of the firmicutes tested, only L. lactis IL-1403 bound the beads, indicating 
that organisms used routinely in fermented foods will not interfere with this assay. None 
of the Listeria strains tested bound the beads. 
 Subsequently, we focused on testing the detection limit by using E. coli O157:H7 
with RT-PCR (Genevision) as a proof of concept for this system (Figure 4. 1). The lower 
detection limit of the Genevision assay (i.e., without addition of gangliobeads for 
concentration) using direct extraction was 1,000 CFU/ml. This detection limit was 
improved with addition of the gangliobead capture step to 10 CFU/ml. Washing beads 
prior to detection via RT-PCR caused a loss in detection for E. coli populations with 
104 CFU/ml, but at lower populations, no significant difference (P > 0.05) was observed. 
Washing the beads led to loss of organisms that were not tightly bound to the bead 
surface, just as described by Blake and Weimer (3), who used a solid-phase enzyme-
linked immunosorbent assay for Bacillus spores from water. To further increase the 
binding capacity, more beads may be added to increase the number bacteria that will be 
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bound (3). Hence, gangliobeads efficiently concentrated E. coli O157:H7 from solution, 
even when the organisms were present at 10 CFU/ml. 
 The inability of the Genevision system alone (without the use of a solid-phase 
concentration) to detect organisms at <1,000 CFU/ml is due to the need for at least 1 
CFU/10 µl (the volume of cell lysate used in each PCR), which equates to 1,000 CFU/ml. 
This limitation was overcome by the addition of gangliobeads to the sample to 
concentrate low cell numbers from a large volume. This resulted in a volume reduction 
that is more compatible with sample processing requirements for PCR (i.e., microliter 
volumes rather than milliliter volumes). 
 After ascertaining the ability of gangliobeads to concentrate E. coli O157:H7 from 
solution, we tested the ability of this approach to detect spiked organisms directly from 
food (Table 4. 2). We detected spiked E. coli O157:H7 in bottled water, apple juice, and 
frozen spinach with a lower detection limit of 4 CFU/g. The lower detection limit for 
hamburger was 400 CFU/g, while for salami and milk the limit was 40,000 CFU/g. 
Except with milk, a significant correlation (r2 = 1; P < 0.0001) between the level of 
background microflora and the minimum detection limit for each food was observed 
(Table 4. 2). Hence, it is likely that the background microorganisms out-competed the 
spiked E. coli O157:H7 for binding to gangliosides, which explains the higher detection 
limits for hamburger and salami. The higher detection limit for milk with no competing 
flora is likely due to the presence of milk fat globule membranes that contain 
gangliosides and lactoferrin, which binds gangliosides. In either case, this would lead to 
competitive binding with E. coli O157:H7 for the gangliosides (26). Weimer et al. (27) 
did not observe competition for solid-phase capture when using antibodies immobilized 
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onto glass beads. In light of these data, the efficiency of binding with gangliobeads is 
affected by the levels of background microflora and other molecules in the foods that 
bind gangliosides. Hence, ganglioside-immobilized beads would be suitable for food 
systems containing low initial microbial populations and foods of non-animal origin (e.g., 
bread, fruit juices, ready-to-eat salad, water, fruits, and vegetables). 
 The variability of the assay was measured for each approach with buffer and 
foods. The standard errors of the means (SEMs) for the decreasing concentrations of E. 
coli ranged from 0.03 to 0.81 cycles in unwashed samples, while washed samples had a 
range of 0.36 to 0.92 cycles (Figure 4.1, error bars). This translated into coefficients of 
variation (CVs) of between 1.9 and 3.9% over the concentrations in the wash treatments. 
For the food samples, the variance and % CV differed by sample, but all SEMs were less 
than 1.32 and all CVs less than 6.8%. The average CV for concentrations in all foods was 
3.1%. 
 The specificity and sensitivity of PCR-based rapid-detection systems have driven 
their increased popularity in the last 2 decades (6). There are several PCR-based pathogen 
detection systems available commercially, such as BAX (DuPont Qualicon, Wilmington, 
DE), Probelia (Sanofi Diagnostic Pasteur, Marnes La Coquette, France), and Genevision 
(Warnex Diagnostics, Quebec, Canada), but all are hindered by a detection limit ranging 
from 103 to 106 CFU/ml tied to the presence of PCR inhibitors in the sample, sample 
dilution prior to cell lysis, or large sample volumes that do not allow a representative 
sample for PCR. To overcome these limitations, the sample is pre-enriched in laboratory 
media for 6 to 48 h prior to detection in at least 2 liters of media. The enrichment 
procedures are labor-intensive and do not allow quantitative or high-throughput 
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automated screening procedures. In addition, all the commercially available PCR-based 
systems require at least 24 to 48 h to report a result. To lower the detection times, various 
researchers have used antibody-coated immunomagnetic beads (4, 8-10, 15, 20, 25, 28) to 
capture a variety of pathogens, such as Salmonella, E. coli, Campylobacter, Listeria, 
Yersinia, and Clostridia, for subsequent detection of them with PCR or RT-PCR. These 
studies achieved sensitivities of 5 to 1,000 CFU/ml within 3 to 10 h in food systems. The 
advantage of using gangliosides over using antibody-coated beads is that one can capture 
a broad repertoire of pathogens by using a single reagent. The specificity of detection can 
be adjusted by using PCR for each pathogen of interest with various primer designs and 
combinations. Simultaneous detection of various pathogens in one PCR is also possible 
by employing multiplex PCR (19). Additionally, coupling gangliobead capture with RT-
PCR without pre-enrichment for detection makes the assay quantitative even at a low 
population of 4 CFU/g. Furthermore, the specificities of ganglioside binding to 
polyomavirus, simian virus 40 (12), Newcastle disease virus (11), human 
immunodeficiency virus (21), adenovirus (2), and human influenza virus (23) suggest 
that this technology has potential use for viral detection when coupled with real-time 
reverse transcriptase PCR (14). Ganglioside-immobilized beads could also be used for 
capturing specific toxins, such as botulinum toxin (1, 24), cholera toxin (5), and E. coli 
heat-labile enterotoxin (18), with subsequent detection via a solid-phase immunoassay, 
such as that reported by Weimer et al. (27). Mason et al. (16) successfully used liposomes 
with encapsulated DNA reporters and ganglioside receptors embedded in the bilayer to 
detect botulinum toxin with a lower detection limit of 0.02 fg/ml. Coupling of 
ganglioside-immobilized beads with the ImmunoFlow system (27), which uses a 
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fluidized bead bed for capture, may increase the sensitivity to as low as 1 CFU 
independent of the sample size, as demonstrated for E coli O157:H7 and Bacillus globigii 
spores by using antibody-coated beads. 
 In conclusion, we demonstrated the ability of gangliosides immobilized on 3-mm 
glass beads to concentrate pathogenic organisms and Bacillus spores directly from 
samples without pre-enrichment. Use of gangliobeads prior to a commercial RT-PCR kit 
for food pathogen detection improved the sensitivity 100-fold in samples that did not 
contain competing bacteria or molecules that bind gangliosides. However, with 
competing microflora and biomolecules the detection limit was 40,000 CFU/g. This 
approach concentrated E. coli O157:H7 directly from foods containing low initial 
bacterial counts and foods of non-animal origin with a detection limit of 4 CFU/g in 3 h. 
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Table 4. 1 Growth conditions and ganglioside binding specificity of selected bacteria. 
(NB = Nutrient broth, NA = not done, MRS = MRS broth, BHI = BHI broth, 1 = 
organism detected via specific antibody, 2 = organism detected by RT-PCR). The 
Bacillus spores were provided as a powder and no growth was needed. 
 
Organisms Strain Medium 
Temp. 
(˚C) 
Growth 
Condition 
Ganglioside 
Binding 
Detection 
Method 
E. coli K12 NB 37 Shaking + 1, 2 
E. coli O157:H7 NB 37 Shaking + 1, 2 
Salmonella enteritidis 8326 NB 37 Shaking + 1 
Salmonella enteritidis 13076 NB 37 Shaking + 1 
Salmonella enteritidis 13314 NB 37 Shaking + 1 
Salmonella enteritidis 31194 NB 37 Shaking + 1 
Salmonella enteritidis 49214 NB 37 Shaking + 1 
Salmonella enteritidis 49215 NB 37 Shaking + 1 
Salmonella enteritidis 49217 NB 37 Shaking + 1 
Salmonella enteritidis 49218 NB 37 Shaking + 1 
Salmonella enteritidis 49220 NB 37 Shaking + 1 
Salmonella typhimurium  700720 NB 37 Shaking + 1 
Bacillus globigii spores  NA NA NA + 1 
Lactococcus lactis IL1403 MRS 37 Static + 1, 2 
Lactobacillus acidophilus 4355 MRS 37 Static - 1 
Lactobacillus acidophilus NCFM MRS 37 Static - 2 
Lactobacillus gasseri 33323 MRS 37 Shaking - 2 
Lactobacillus helveticus 10386 MRS 37 Shaking - 1 
Listeria monocytogenes 43251 BHI 37 Shaking - 1 
Listeria monocytogenes EGDe BHI 37 Shaking - 2 
Erwinia herbicola 33243 NB 37 Shaking - 1 
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Table 4. 2 Minimum detection limit of spiked E. coli O157:H7 in the food types used in 
this study and the levels of food associated background microflora. 
 
Food Type 
Aerobic Plate Count before 
E. coli O157:H7 spike 
(CFU/gm.) 
Lower 
Detection Limit 
(CFU/gm.) 
Water 0 4 
Apple juice 8 4 
Spinach 577 4 
Hamburger 24856 400 
Salami 9350000 40000 
Milk 0 40000 
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Figure 4. 1 Threshold cycle numbers (CT) when gangliobeads were exposed to different 
cell populations of E. coli O157:H7 with or without washing the beads. The error bar 
represents the SEM of CT values from six observations. A CT of >45 was considered no 
detection. Shorter CT is equal to a faster detection time, which indicates a higher 
population. 
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CHAPTER V 
 SYSTEMS LEVEL ANALYSIS OF CROSS TALK BETWEEN THE HOST 
COMMENSAL AND PATHOGEN 
 
Abstract 
 
 
 Bifidobacterium longum subspp. infantis showed the highest potential for 
Salmonella enterica subspp. enterica ser. Typhimurium exclusion in a Caco-2 cell culture 
model among the five screened probiotic strains. B. infantis and S. ser. Typhimurium 
shared binding specificity to host ganglioside GM1 among the tested receptors. Further, 
B. infantis completely inhibited, Salmonella-induced caspase 8 and caspase 9 activity in 
intestinal epithelial cells. B. infantis also reduced the basal caspase 9 and caspase 3/7 
activity in the epithelial cells in absence of pathogen. Western blots and gene expression 
profiling of epithelial cells revealed that the decreased caspase activation was 
concomitant with increased phosphorylation of the pro-survival protein kinase Akt, 
increased expression of caspase inhibiting protein cIAP and decreased expression of 
genes involved in mitochondrion organization and biogenesis and reactive oxygen 
species metabolic processes. Hence B. infantis exerted it’s protective effect by repression 
of mitochondrial cell death pathway which was induced in presence of S. ser. 
Typhimurium. Gene expression analysis of epithelial cells also revealed that B. infantis 
strongly induced expression of genes downstream of cAMP signaling, MAPK signaling 
and NFkB signaling. Using both gene expression and small metabolite profiling of 
bacterial and epithelial cells, I observed a three way crosstalk between the epithelial cells, 
Salmonella and Bifidobacteria. In these interactions, B. infantis prevented catabolism of 
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arginine (a substrate for nitric oxide (NO) production) by S. ser. Typhimurium, making it 
available for increased NO production by the host. This was evidenced by the induction 
of genes necessary for nitrate and nitrite respiration in the pathogen (nitrate and nitrite are 
breakdown products of NO). Using a comparative and functional genomics approach I 
also discovered a cluster of 50 proteins that have been acquired in the B. infantis genome 
through lateral gene transfer, are found only in subspp. infantis (and absent in subspp. 
longum) and are induced only in the presence of the host. Therefore these genes likely 
have been maintained in the genome through selective pressure from the host. 
 
Introduction 
 
 
 The normal gut flora forms the first line of defense against enteric infections (77). 
The composition of this protective flora can be altered by dietary and environmental 
influences making the host susceptible to disease. The use of probiotics centers on the 
idea that probiotic treatments re-establishes the natural condition that exists in the host 
which is disrupted by various stresses (31). Recently, there has been a renewal of interest 
in the use of probiotics, due to the rise in number of multidrug resistant pathogens; and 
the increased knowledge of the roles played by human microbioata in health and disease. 
Renewed interest in probiotics is also reflected by the rapid increase in the numbers of 
“probiotic” products being marketed.  
 Efficacy of probiotics in the prevention of gastrointestinal diseases has been 
observed in several in vivo and in vitro models. A study in the pig model showed that 
feeding a five-strain probiotic mixture (that contained two strains of Lactobacillus 
murinus, and one strain each of Lactobacillus salivarius, Lactobacillus pentosus and 
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Pediococcus pentosaceous) reduced pathogen shedding and alleviated disease symptoms 
when infected with S. ser. Typhimurium (11). Although the specific mechanism of 
pathogen reduction was not elucidated, this suggests that probiotics can inhibit infection 
and reduce symptoms. The pathogen exclusion potential of various probiotics is 
dependent on the probiotic as well as the pathogen strain. Jin et al. (38) showed that in 
vitro L. acidophilus inhibited adhesion of S . sv Pullorum, but failed to inhibit adhesion of 
S. sv Enteritidis and S. sv Typhimurium. A cell culture study has also demonstrated the 
anti-adhesive effect of Bifidobacterium on S. ser. Typhimurium. The ability of 
Bifidobacteria to inhibit pathogen attachment is strain-dependent and independent of 
strain specific adhesion properties (6). 
  Le Blanc et al  (17) recently showed the preventative and therapeutic efficacy of 
L. casei in a mouse model of S. ser. Typhimurium infection. Administration of L. casei 
not only decreased neutrophil infiltration and inflammation, but also increased the release 
of Salmonella specific IgA in the intestinal lumen. Hence the protective effect of 
probiotics goes beyond the commonly reported modes of action that include competing 
for nutrients, production of antimicrobials, and pathogen exclusion at the host surface 
(48). 
 Silva et al. reported the protective effect of B. longum in a mouse model of 
salmonellosis, where mice fed B. longum and infected with S. ser. Typhimurium showed 
higher survival than those infected without the probiotic intervention (76). Surprisingly, 
pathogen levels in the animal feces were similar with or without B. longum even though 
survival rate was higher in the animals supplemented with B. longum. Hence additional 
mechanisms other than competitive exclusion accounted for higher survival of 
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Salmonella infected animals. Among all age groups the incidence of Salmonella-induced 
diarrhea is highest in the infant population (13). Bifidobacteria are one of the most 
numerically abundant and among the first colonizers of the human gut (3). It is estimated 
that in breast fed infants ~10% of the gut microbioata is composed of Bifidobacteria (43). 
Since Bifidobacteria show anti-infective activity towards Salmonella, the molecular 
mechanism by which they inhibit pathogen adhesion and protect the host needs to be 
investigated. 
 At the host mucosa there is a complex multi- way interaction between host, 
pathogen and the resident gut flora that dictates the outcome of the infection. Most 
studies have been dedicated to unraveling the effect of probiotics/ commensals/ pathogen 
on the host while the literature on the microbe-microbe interaction is sparse at best. 
Recently there is a steady increase in literature that reports interspecies communication 
that would affect the virulence gene expression of pathogens. For example, short chain 
fatty acids like acetate, propionate and butyrate induce the expression of hilA (invasion 
protein transcription activator), which positively regulates the virulence gene expression 
in Salmonella (21). Communication between Salmonella and Yersinia through acyl 
homoserine lactones (AHLs) has also been reported, which enhances Salmonella 
colonization in the murine intestine (22). Hence interspecies crosstalk can lead to 
different outcome of the disease  
 I hypothesize that B. longum spp. infantis reduces S sv. Typhimurium adhesion to 
gut epithelial cells by competing for the same receptors and also improves cell survival 
by modulation of specific pathways in the host as well as the pathogen. Modulation in 
cellular networks was probed by determining gene-expression profile and small 
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metabolite profiles of the epithelial cells, B. infantis, and S. ser. Typhimurium during co-
infection. 
 
Materials and method  
 
 
Cell culture and bacterial strains 
 
 
 Caco-2 cells were obtained from ATCC (HTB-37, Manassas, VA) and cultured 
as per ATCC’s recommendation. All the cells used in the assay were between passage 
numbers 22-30. In brief, cells were plated at a density of 105 / cm2 in either a T75 or a 96 
well plate. Cells were maintained in DMEM/High Modified (Thermo Scientific, 
Rockford, IL) with 16.6% fetal bovine serum (FBS) (HyClone Laboratories, Logan, UT), 
non-essential amino acids (Thermo Scientific, Rockford, IL), 10mM MOPS (Sigma, St. 
Louis, MO), 10 mM TES (Sigma), 15 mM HEPES (Sigma) and 2 mM NaH2PO4(Sigma). 
Cells were considered to be differentiated 14 days post confluence (65), and used for the 
adhesion assays, caspase assays and gene expression. Bacterial cells were grown as 
described in Table 5.9. 
 
Determination of adhered and invaded 
bacteria 
 
 
The ability of specific bacteria to block Salmonella binding to epithelial cells was 
tested by determining the changes in the amount of total host (intestinal epithelial cells, 
Caco-2) associated salmonella in presence of specific bacteria. The amount of total host 
associated salmonella was determined by qPCR as described below. The amounts of 
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intracellular salmonella in the host were determined by the gentamicin protection assay 
with a few modifications as described below (24). 
 Total host associated bacteria were determined as follows. Caco-2 cells were 
cultured as described earlier in a 96-well plate. The bacteria were used after two transfers 
for the adhesion assays. Bacterial cells were collected from 2 ml of media after growth 
for 14 hours, washed twice with an equal volume of PBS, and resuspended at ~108 
CFU/ml, in DMEM/High modified with 1X non-essential amino acids, 10mM MOPS, 10 
mM TES, 15 mM HEPES and 2 mM NaH2PO4 but without the FBS. Caco-2 cells were 
infected with either Salmonella alone or Salmonella in conjunction with other bacteria 
(Fig 5.1) in a final volume of 50 µl at an MOI (multiplicity of infection) of 1: 1000. The 
ratio of Salmonella with other bacteria was 1:1. Caco-2 cells were incubated with bacteria 
for 60 minutes. The bacterial cell suspension was aspirated and the Caco-2 monolayer 
was washed thrice with 200 µl of tyrode’s (140 mM NaCl, 5mM KCl, 1mM CaCl2, 1mM 
MgCl2, 10 mM glucose, 10mM sodium pyruvate, 10 mM HEPES, pH 7.4) to remove 
non-adhered bacterial cells from the monolayer. DNA extraction buffer (AEX 
Chemunex, France) (50 µl) was used to lyse the monolayer and the bacteria associated 
with the host, and incubated at 37˚C for 15 minutes followed by 95˚C for 15 min. 
Resulting cell lysate was used to determine the number of bacteria associated with the 
Caco-2 cells (19). Quantitative analysis was done using qPCR with a CFX 96 Real Time 
System (Bio-Rad, Hercules, CA). Reactions were performed in a final volume of 25 μl 
including 1 μl of cell lysate, 100 nM of PCR primers and iQ SYBR Green Supermix 
(Bio-Rad, Hercules CA) as per manufacturer’s instructions. The primers used for the 
amplification are listed in Table 5.9. The reaction parameters consisted of denaturation 
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step at 95°C for 5 min, followed by 40 cycles of denaturation, annealing and extension at 
95˚C for 15 s, 56˚C for 30 s, 72˚C for 30 s respectively and a final extension at 72°C for 
1 min. The product was verified using a melt curve analysis from 50˚C to 95˚C with a 
transition rate of 0.2˚C/s. The amount of bacterial cells and Caco-2 cells present in each 
well were estimated using a standard curve of CT vs. Log10 CFU and amount of bacteria 
per Caco-2 was calculated. The data were normalized relative to control wells which 
were incubated with Salmonella alone. The experiment was done in four replicates. 
Differences in the mean due to treatment were tested by one way ANOVA. Post 
ANOVA, the means were compared to control using Dennett’s multiple comparison test 
 The amount of intracellular and adhered bacteria was determined using the 
gentamicin protection assay as follows. Caco-2 cells were infected exactly as described 
earlier. The infected cells were incubated for 60 minutes at 37°C with 5% CO2. Upon 
incubation, media was aspirated and cells were washed three times with tyrode’s buffer. 
Invaded bacteria were estimated by incubating the cells with 100 µg/ml gentamicin for 
two hours at 37°C with 5% CO2 to kill bacteria adhered or outside the Caco-2 cells. To 
determine total host associated bacteria, cells were incubated with cell culture media 
without any antibiotic. Cells were again washed three times with tyrode’s buffer and 
lysed with 0.01% triton. The amounts of bacteria in the Caco-2 lysate were determined by 
plating serial dilutions on LB agar. The experiment was performed in four replicates. The 
number of adhered bacteria were enumerated by subtracting mean of invaded bacteria (B) 
from mean of total host associated bacteria (A) and error (ΔZ) was calculated as (ΔZ)2 = 
(ΔA)2 + (ΔB)2 where, ΔA is SEM associated with the A and ΔB is SEM associated with 
B. The data were reported as log10 colony forming units (CFU) /well. Differences in the 
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mean due to treatment were tested by one-way ANOVA. Post ANOVA, the means were 
compared to each other by Tukey-Kramer's method. 
 
Caspase assays 
 
 
 Caco-2 cells were cultured in a 96 well plate as mentioned earlier and were 
washed with phosphate buffered saline (PBS) before infection with bacteria. Caco-2 cells 
were infected with either Bifidobacterium longum subspp. infantis ATCC 15697, 
Salmonella ser. Typhimurium LT2 ATCC 700720, or both the organisms simultaneously. 
Upon adding bacterial treatments (MOI of 1:1000) in a volume of 50 µl, cells were 
incubated at 37°C with 5% CO2. After 8 hours, caspase 8, 9 and 3/7 activities was 
measured using Caspase-Glo assay kits (Promega, Madison, WI) exactly as per 
manufacturer’s instructions. Bioluminescence due to caspase activity was measured using 
the DTX 880 Multimode Detector (Beckman Coulter, Brea, CA). Differences in the mean 
due to treatments were tested by one way ANOVA. Post ANOVA, the means were 
compared to each other by Tukey-Kramer's method. 
 
Infection of epithelial cells for gene expression 
 
 
Caco-2 cells were cultured in T75 as mentioned earlier, and were serum starved 
for 24 hours prior to infection with bacteria. Caco-2 cells were infected with either 
Bifidobacterium longum subspp. infantis ATCC 15697, Salmonella ser. Typhimurium 
LT2 ATCC 700720, or both the organisms simultaneously at an MOI of 1:1000 in a final 
volume of 10 ml. All the three bacterial treatments were also incubated in absence of the 
Caco-2 cells in the exact same conditions. All the infected cells were incubated at 37°C 
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with 5% CO2. At 30, 60, and 120 minutes after infection, media with non-adherent 
bacteria was aspirated and 10 ml TRIzol LS reagent (Invitrogen, Carlsbad, CA) was 
added to the cells. This was gently mixed with pipette followed by centrifugation at 7200 
× g for 5 minutes to pellet the bacteria. TRIzol LS supernatant was stored in a clean tube 
and further processed for RNA extraction from Caco-2 cells. The bacterial pellet was re-
suspended in 2 ml of fresh TRIzol LS, gently mixed and further processed for RNA 
extraction from host associated bacteria 
Bacterial RNA extraction and gene 
expression 
 
 
The TRIzol LS suspension containing host associated bacteria was centrifuged at 
7200 × g for 5 minutes. The TRIzol LS supernatant was stored in a clean tube for later 
use. 1 ml of lysis enzyme cocktail containing 50 mg/ml of lysozyme (Sigma) and 200 
U/ml mutanolysin (Sigma) in TE buffer (10mM Tris and 1mM EDTA, pH 8) was added 
to bacterial pellet obtained by centrifugation. The solution was mixed gently and 
incubated at 37°C for 1 hour followed by centrifugation at 7200 × g for 5 minutes. The 
supernatant was discarded and pellet was re-suspended in 250 μl of proteinase K buffer 
(100 mM Tris-HCl, 5 mM EDTA, 200 mM NaCl, and 0.2 % SDS, pH 8) containing 8 
U/ml of proteinase K (Fermentas, Glen Burnie, MD). This was incubated at 55°C for 1 
hour with intermittent mixing. To this, previously stored TRIzol LS was added and gently 
mixed. RNA was isolated from TRIzol LS exactly as per manufacturer's 
recommendations. RNA concentration, A260/280 and A260/230 were measured on 
NanoDrop (Thermo scientific, Waltham, MA) and samples were processed further only if 
the RNA concentration was at least 0.5 µg/µl and ratios were ≥ 1.8. The RNA samples 
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were analyzed for integrity on 2100 Bioanalyzer (Agilent Technologies, Santa Clara, 
CA).  
 Total RNA (10 µg in 20 μl) was reverse transcribed into cDNA with random 
hexamers and Superscriptase II (Invitrogen, Carlsbad, CA) exactly as per manufacturer’s 
recommendations by using 400 U of Superscriptase II/ 10 µg RNA. Upon cDNA 
synthesis, the enzyme was heat inactivated and the RNA templates were degraded with 
80 U of RNaseH (Epicentre, Madison, WI) at 37°C for 20 minutes. The reaction mixture 
was cleaned using the Qiaquick-PCR purification kit (Qiagen, Valencia, CA) exactly as 
per manufacturer’s instructions. Purified cDNA was eluted from the column twice with a 
total of 100 μl of nuclease free water (Ambion, Austin, TX).  
 cDNA was fragmented using DNaseI (Promega, Madison, WI) according to 
manufacturer's recommendations by using 0.6 U of DNaseI/ µg cDNA at 37 °C for 20 
minutes. The fragmented cDNA was labeled using GeneChip DNA Labeling reagent 
(Affymetrix, Santa Clara, CA) and Terminal Transferase enzyme (TdT) (New England 
Biolabs, Ipswich, MA) as per manufacturers' recommendation by using 2µl GeneChip 
labeling reagent and 3µl TdT / µg cDNA at 37 °C for 60 minutes. The samples were 
denatured prior to hybridization, at 98°C for 10 minutes followed by snap cooling at 4°C 
for 5 minutes. 
 Labeled cDNA was hybridized onto two different custom made Affymetrix 
GeneChip designed against all the annotated coding sequences of Bifidobacterium 
longum subspp. infantis ATCC 15697 (50) and Salmonella enterica subsp. enterica 
ser.Typhimurium LT2 ATCC 700720. Briefly the Salmonella array contained 9852 probe 
sets, of which 4735 probe sets were designed against S. ser. Typhimurium. Each probe 
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set contained 11 probes, each 25 nucleotides long. The Bifidobacteria chip has been 
described by Locascio et al (50). 500 ng of labeled cDNA for samples extracted from 
pure culture of B. infantis and S. ser. Typhimurium; 1000 ng labeled cDNA for samples 
extracted from co culture of B. infantis and S. ser Typhimurium; 2000 ng of labeled 
cDNA for samples extracted from co-culture of B. infantis/ S. ser. Typhimurium and 
Caco-2; and 2500 ng of labeled cDNA for samples extracted from co-culture of B. 
infantis , S. ser. Typhimurium and Caco-2 was hybridized onto the respective chips. In 
total, 24 chips Salmonella chips were processed (2 replicates X 3 Time points (30 
minutes, 60 minutes, 120 minutes) X 4 Treatments ) and 8 Bifidobacteria chips were 
processed (2 reps X 1 Time point (120 mins) X 4 Treatments). 
Microarray data normalization and 
statistical analysis of microbial chips 
 
 
Raw data (.cel files) was back ground corrected, quantile normalized and 
summarized using RMA-MS (78).The resultant normalized log2 transformed intensity 
matrix was used for further statistical analysis. To detect differentially regulated genes, 
the Salmonella chip data was analyzed as unpaired time course analysis with “signed 
area” as the time summary method, while for Bifidobacteria chips the data was analyzed 
as two class unpaired data, with T statistic, using Significance Analysis of Microarrays 
(SAM) (84). All the genes were ranked based on the score(d) from SAM output. This pre 
ordered ranked gene list was then used in Gene Set Enrichment Analysis software 
(GSEA) (60, 79) to detect the coordinate changes in the expression of groups of 
functionally related genes, upon respective treatments. Gene sets for Bifidobacteria were 
defined based on annotations from KEGG (41), Cluster of Orthologous Groups of 
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proteins (COGs) (81), Carbohydrate Active Enzyme Database CAZY (66) and genes 
identified from Locasio et al (50). Putative horizontally transferred genes in B. infantis 
were identified using Integrated microbial genomes system (IMG) (55). Genes sets based 
on protein localization were created based on annotations from CoBaltDB (34). Gene sets 
for Salmonella were defined based the annotations from Comprehensive Microbial 
Resource (CMR) (68), Cluster of Orthologous Groups of proteins (COGs) (81), 
Virulence Factors of pathogenic bacteria Database (VFDB) (14, 89), Carbohydrate 
Active Enzyme Database (CAZY) (66), and Biocyc (12). Gene sets based on putative 
horizontally transferred genes in Salmonella were defined using predictions from the 
Horizontal Gene Transfer Database (HGT-DB) (32). Genes sets based on protein 
localization were created using predictions from CoBaltDB (34). 
Caco-2 RNA extraction and gene expression 
 
 
The TRIzol LS supernatant obtained after pelleting the bacteria was freeze thawed 
twice in liquid nitrogen. Two hundred fifty μl water was added to 750 μl of TRIzol LS 
sample. This was further processed for RNA extraction exactly as per manufacturer’s 
instructions. RNA concentration, A260/280 and A260/230 were measured on NanoDrop 
(Thermo scientific, Waltham, MA) and samples were processed further only if the RNA 
concentration was at least 0.5 µg/µl and ratios were ≥ 1.8. The RNA samples were 
analyzed for integrity on 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). 
Synthesis of cDNA, biotin labeled cRNA, fragmentation and purification of cRNA were 
carried out using one-cycle cDNA synthesis kit (Affymetrix, Santa Clara, CA) exactly as 
per manufacturer's instructions. 10 µg of labeled and fragmented cRNA was hybridized 
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onto the Affymetrix HGU133Plus2 GeneChips as per manufacturer's recommendations at 
the Center for Integrated BioSystems (Utah State University, Logan, UT). 
Microarray data normalization and 
statistical analysis of the HGU133 Plus2 
chips 
 
 
Raw data (.cel files) was back ground corrected, quantile normalized and 
summarized using RMA (37). RMA normalized data was then filtered through the PANP 
algorithm (86) to make presence-absence calls for each probe set. Probe sets that were 
called present in at least one of the samples were included in further statistical analysis 
while rests were excluded. The resultant normalized, filtered, log2 transformed intensity 
matrix was analyzed as two class unpaired time course data with “signed-area” as the 
time summary method, using Significance Analysis of Microarrays (SAM) (84). All the 
genes were ranked based on the score(d) obtained from SAM. This pre ordered ranked 
gene list was used as an input for Gene Set Enrichment Analysis software (GSEA) (79) to 
detect the coordinate changes in the expression of groups of functionally related genes, 
upon respective treatments. The gene sets were based on Gene Ontology annotations, 
KEGG annotations, Biocarta annotations and TRANSFAC annotations and were 
downloaded from the molecular signatures database (79) . Ingenuity pathway analysis 
(IPA) was used to map expression data onto pathways. Hierarchical clustering with 
multiscale bootstrapping (1000 times) of all the samples based on normalized data was 
performed using PVCLUST (80). 
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Western Blots 
 
 
Relative abundance of target proteins due to different treatments was quantified 
by densitometric analysis of western blots. Caco-2 cells were cultured and infected 
exactly as those infected for the gene expression. The cells from the T75 were removed 
from the flask by scraping; suspended in 1 ml protease/phosphatase inhibitor cocktail (30 
mM HEPES, 1 mM EDTA, 50 mM Sodium pyrophosphate, 100 mM sodium fluoride, 10 
mM orthovanadate, 1 Roche protease inhibitor cocktail tablet/50ml solvent) and lysed 
using a bead beater at full speed with three pulses of 30 s each with intermittent 
incubation on ice for 1 min. The cell lysates were stored at -70˚C for further analysis. 
50µg protein was diluted in 1X SDS sample buffer and the samples were heated at 95°C 
for 10 minutes and centrifuged at 12,000 X g for 10 minutes. The sample was resolved on 
precast 10% Tris-HCl polyacrylimide gels (Bio-Rad Laboratories, Hercules, CA) at a 
constant current of 45 mAmp per gel using the Criterion electrophoresis system (Bio-Rad 
Laboratories, Hercules, CA). The resolved proteins were then transferred to a PVDF 
membrane (Bio-Rad Laboratories, Hercules, CA) using the Trans-Blot semi-dry 
electrophorectic cell (Bio-Rad Laboratories, Hercules, CA) as per manufacturer's 
recommendation. Upon completion of the transfer, the blots were probed for the presence 
of p-Akt 473 (#9271) and p-AKT 308 (#9275) by Pierce® Fast Western Blot Kit 
(Thermo Fisher Scientific, IL, USA ), according to the manufactures recommendations. 
Primary antibodies for all the proteins were purchased from Cell Signaling Tech. 
(Boston, MA). The blots were imaged using the Kodak Image Station 2000R (Carestream 
Health, Rochester, NY). Densitometric analysis of the blot was done using Image J (2). 
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Differences in the means due to treatment were tested by two way ANOVA with repeated 
measures. 
Small metabolite profiling 
 
 
 Fifty µl of extracellular supernatant and intracellular cell lysate collected from 
the infection experiments were extracted with equal volume of ice cold methanol and 
incubated at -20°C for 60 minutes. The resultant precipitates were separated from the 
sample by centrifugation at 20,000 X g for 10 minutes. The supernatant was evaporated 
to dryness using a speed-vac at room temperature. Metabolite profiles for all the samples 
were determined using GC-MS at the Genome Center, UC Davis (Davis, CA) exactly as 
described by Fiehn et al (28). In brief, the dried sample was derivatized using N-methyl-
N-(trimethylsilyl)-trifluoroacetamide (Sigma, St. Louis, MO) and spiked with retention 
index markers (RI) exactly as described by Fiehn et al (28). The samples were analyzed 
on Agilent 6890 gas chromatograph controlled using Leco ChromaTOF software version 
2.32. as described by Fiehn et al (28). GC/MS peaks were annotated based on the mass 
spectra and retention index using the BinBase database (27). Peak areas were normalized 
by calculating the sum area of all identified compounds for each and subsequently 
dividing all data associated with a sample by the corresponding metabolite sum. The 
resulting data were multiplied by a constant factor in order to obtain values without 
decimal places and, the peak intensities were log2 transformed to remove the 
heteroscedasticity (28). Hierarchical clustering with multiscale bootstrapping (1000 
times) of all the samples based on normalized data was performed using PVCLUST (80) 
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Results  
 
 
 The pathogen exclusion potential of different probiotics is strain dependent. Since 
intestinal epithelial cells are the primary host target during the initial phase of Salmonella 
infection, I screened five different probiotic strains for their ability to block host 
association of Salmonella sv. Typhimurium (Figure 5.1) in cultured gut epithelial cells 
(Caco-2). Of the 5 strains tested B. infantis showed the highest potential for Salmonella 
exclusion. Hence I further characterized the effect of B. infantis on adhesion and invasion 
of S. ser. Typhimurium of intestinal epithelial cells. 
Effect of B. infantis on adhesion and 
invasion of S. ser. Typhimurium 
 
 
 I first tested if B. infantis could displace already adhered S. sv. Typhimurium 
from the epithelial cells, by incubating Caco-2 cells with Salmonella for 30 minutes prior 
to adding B. infantis into the co-culture. As evident from Figure 5.2, adding B. infantis 
had no effect on adhesion and invasion of S. ser. Typhimurium, if the pathogen was 
allowed to interact with the epithelial cells first. However if B. infantis was added to the 
Caco-2 cells 30 minutes prior to Salmonella, it significantly reduced adhesion and 
invasion of Salmonella. A similar effect was observed when both the organisms were 
added together. The degree of reduction of adhered and invaded Salmonella was similar 
to when the Caco-2 cells were incubated with B. infantis first. Interestingly, incubation of 
Salmonella with B. infantis for 120 minutes prior to infection of Caco-2 cells 
significantly caused more adhesion and invasion as compared to when Caco-2 cells were 
infected without the interaction (Figure 5.2). However it should be noted that when 
compared to the control (i.e. adhesion of S. ser. Typhimurium alone) there was still 
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significantly less adhesion and invasion. Hence pre-incubation of S. ser. Typhimurium 
with B. infantis primed Salmonella to be more invasive, and this effect was most likely 
due to gene regulation in Salmonella. To the test the hypothesis, gene expression of S. 
ser. Typhimurium in co-culture with B. infantis (30, 60, and 120 minutes) was 
determined and compared to gene expression profile of S. ser. Typhimurium cultured 
alone. 
 Differentially expressed genes between the two treatments were determined using 
SAM as an unpaired time course analysis using “signed area” as the time summary 
method (84). All the genes were ranked based on the (d) score obtained from SAM (84), 
and the pre-ranked gene list was analyzed using GSEA (79) to make inferences about 
regulation of pre-defined functionally related gene-sets. Table B1 (Appendix B) lists all 
the enriched gene sets in Salmonella when they were incubated with B. infantis for up to 
120 minutes. Genes coding for both the type 3 secretion systems (SPI1 T3SS (q≤0) and 
SPI2 T3SS (q≤0.04) as well the effectors for both the T3SS (q<0.05) were significantly 
induced (Figure 5.3). Hence the increased adhesion and invasion of S. ser. Typhimurium 
due to incubation with B. infantis was concomitant with increased expression of genes 
coding for the T3SS structural proteins and effectors required for adhesion (47) and 
invasion (52).  
 Next I tested if B. infantis excluded the pathogen from the epithelial cells by 
competing for similar receptors. I blocked the same receptors which I had previously 
shown to be important for Salmonella adhesion and invasion, and looked at the effect of 
receptor blocking on adhesion of B. infantis to the host. Blocking HSP90, PPP1R12A, 
CTNN1A and ganglioside GD3 on the host and blocking Ef-Tu on the bacteria had no 
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effect on B. infantis binding (Appendix Figure B1). Blocking ganglioside GM1 on the 
host reduced the adhesion of B. infantis to 75% as compared to unblocked control 
(p=0.054). Hence Salmonella shared its binding specificity for GM1 with B. infantis. 
Effect of B. infantis on caspase activation 
and AKT phosphorylation in epithelial cells 
 
 
 Since Salmonella mediated cell death of host cells is important for disease 
progression (15) , I probed the potential of B. infantis to block Salmonella mediated cell 
death by measuring the activity of caspase 8, caspase 9 and caspase 3/7. Hence I 
measured the activity of the effector caspases (caspase 3/7), and I measured the activity 
of the initiator caspases of the extrinsic cell death pathways (caspase 8) and the intrinsic 
cell death pathway (caspase9). Figure 5.4 shows the level of caspase activity after 8 hours 
in epithelial cells alone or in presence of different bacteria. Epithelial cells incubated with 
B. infantis showed a significant reduction in activity of caspase 9 and caspase 3/7 
(p<0.05), but not caspase 8 as compared to control. Epithelial cells incubated with S. ser. 
Typhimurium showed a significant increase in activity of caspase 8 and caspase 9 
(p<0.05) but not caspase 3/7. Epithelial cells incubated with S. ser. typhimurium and B. 
infantis both showed a caspase activity profile similar to that of cells incubated with B. 
infantis alone, where activity of caspase 9 and caspase 3/7 was significantly lower than 
that of control cells (p<0.05) while there was no effect on the activity of caspase 8. Hence 
B. infantis not only blocked the increase in Salmonella mediated caspase activity, but also 
lowered the basal caspase activity in epithelial cells.  
 Since B. infantis lowered the basal caspase activity, I probed the activation 
(phosphorylation) status of pro survival kinase Akt in epithelial cells. Akt is protein 
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kinase which regulates cell survival through two separate pathways. Akt inhibits 
apoptosis by phosphorylating the Bcl-2 family member Bad, which then interacts with 
14-3-3 and dissociates from Bcl-xL, which prevents downstream activation of caspase 9 
and caspase 3/7 (16). Alternatively, Akt activates IKKα that ultimately leads to NFkB 
activation. This leads to transcription and translation of proteins that directly inhibit 
caspase 9 and caspase 3/7 activity (25). Figure 5.5 shows the phosphorylation status of 
Akt at ser-473 and thr-308 at 30, 60, and 120 minutes after infection with different 
microbes. Incubation of B. infantis with the epithelial cells increased the phosphorylation 
of Akt at ser-473 and thr-308 in a time dependent manner (Figure 5.5) as compared to the 
control, while incubation with Salmonella decreased the phosphorylation at ser 473 and 
thr-308 as compared to the control. Phosphorylation levels of Akt at ser-473 and thr-308 
when both the microbes were present together was similar to those of cells treated with B. 
infantis at 30 and 60 minutes. However by 120 minutes, Akt ser-473 and thr-308 
phosphorylation levels were similar to cells infected with S. ser. Typhimurium. Hence, 
the decrease in caspase activity in epithelial cells due to B. infantis was concomitant with 
increased Akt phosphorylation at ser-473 and thr-308. To further characterize the 
interaction of B. infantis with epithelial cells I determined gene expression profile of 
Caco-2 cells alone, Caco-2 cells with B. infantis, Caco-2 cells with S. ser. Typhimurium 
and Caco-2 cells with both the bacteria after 30, 60, and 120 minutes. 
Gene expression profile and small 
metabolite profile of Caco-2 
 
 
 I determined the global gene expression profiles and small metabolite profiles 
(intracellular and extracellular) of Caco-2 cells alone, and in presence of different 
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bacteria (B. infantis alone, S. ser. Typhimurium alone and B. infantis and S. ser. 
Typhimurium together) at 30, 60, and 120 minutes in two biological replicates. Figure 5.6 
shows the dendogram based on hierarchical clustering of averaged global gene 
expression profile for each treatment at different time points. Hierarchical clustering of 
all samples indicated that the global transcriptome of epithelial cells infected with S. ser. 
Typhimurium and B. infantis simultaneously was more similar to that of epithelial cells 
infected with B. infantis than to the transcriptome of epithelial cells infected with S. ser. 
Typhimurium alone (p<0.01). Figure 5.7 shows the dendogram based on hierarchical 
clustering of intracellular and extracellular small metabolite profiles under different 
infection conditions. Metabolite profiling using GC/MS identified 294 compound peaks 
using the BinBase database (27), out of which 110 GC/MS peaks could be assigned 
positive identification. Hierarchical clustering based on log2 peak areas of all compound 
peaks, revealed that the small metabolite profile formed two big clusters, i.e. a cluster of 
samples with extracellular metabolites and the other with intracellular metabolites 
(p<0.01) (Figure 5.7). Within the extracellular metabolite cluster, Caco-2 cells co-
infected with Salmonella and Bifidobacteria together clustered with Caco-2 cells treated 
with Bifidobacteria alone (p<0.12), while Caco-2 cells infected with Salmonella (60 
minute and 120 minute samples) formed their own cluster (p<0.01). Hence the gene 
expression profile as well as the extracellular metabolite profile of cells co-infected with 
Salmonella and Bifidobacteria together was more similar to those of cells infected with 
Bifidobacteria alone. 
 To gain insight into the functional changes in the epithelial cells due to presence 
of the microbes, I compared the gene expression profile of epithelial cells when they 
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were incubated alone (control) to when they were incubated with either B. infantis 
(treatment) or B. infantis and S. ser. Typhimurium co-culture (treatment). Gene 
expression profile of epithelial cells with microbes was compared to gene expression 
profile of cells without any microbes using SAM (84) as an unpaired time course analysis 
using “signed area” as the time summary method. All the genes were ranked based on the 
(d) score obtained from SAM, and this pre-ranked gene list was analyzed using GSEA 
(79) to make inferences about pre-defined functionally related gene-sets. The gene sets 
consisted of genes annotated by the same Gene Ontology (GO) terms, KEGG pathways, 
Biocarta Pathways and genes that share same transcription factor binding sites defined in 
the TRANSFAC and were downloaded from the molecular signatures database (79).  
 Table 5.1 and Table 5.2 show enriched gene sets (based on GO annotations) that 
were differentially regulated in epithelial cells when incubated with either B. infantis 
alone or with B. infantis and S. ser. Typhimurium co-culture, as compared to epithelial 
cells without any microbial treatment. At an FDR≤0.21; 82 gene sets were enriched in 
epithelial cells treated with B. infantis (12 were induced while 70 were repressed) alone 
(Table 5.1) while 61 gene sets were enriched (all repressed) in epithelial cells treated with 
B. infantis and S. ser. Typhimurium co-culture. There were 36 gene sets (all repressed) 
that were commonly regulated between both the microbial treatments. 
 Incubation of B. infantis with epithelial cells significantly induced expression of 
proteins localized at cell junctions (q≤0.05), particularly adherens junctions (q≤0.11), cell 
matrix junction (q≤0.13) and intercellular junction (q≤0.11). Although tight junctions as a 
gene set was not induced significantly, two proteins important for maintenance of the 
tight junctions; zona occludens 2 ( TJP2) (q≤0.01) and occludin (OCLN) (q≤0.14) were 
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induced. None of the above mentioned gene sets were differentially regulated in presence 
of both B. infantis and S. ser. Typhimurium. Hence incubation of epithelial cells with B. 
infantis induced expression of proteins important for maintenance of cellular junctions, 
but the effect was negated in presence of the pathogen. 
  Incubation of B. infantis with the epithelial cells significantly repressed genes 
required for the functioning of the proteasome (q≤0.01) and the peroxisome (q≤0.02) and 
they remained repressed even in presence of the pathogen. 
 Incubation of B. infantis with the epithelial cells caused repression of the genes 
involved in biogenesis of the mitochondrial matrix (q≤0), mitochondrial membrane 
(q≤0), mitochondrial respiratory chain (q≤0) as well as mitochondrial ribosomes (q≤0). 
All these gene sets were also repressed (q≤0.01) when the epithelial cells were incubated 
with B. infantis and S. ser. Typhimurium co-culture. Subsequently genes involved in 
aerobic respiration (q≤0.21), electron transport (q≤0.20) and oxygen and reactive oxygen 
species metabolic processes (q<0.18) were also repressed. Hence irrespective of the 
presence of pathogen, B. infantis repressed genes related to the biogenesis of 
mitochondria and genes necessary for respiration and reactive oxygen species metabolic 
processes. 
 Figure 5.8 represents expression of genes related to apoptosis signaling in 
epithelial cells after 120 minutes of exposure to B. infantis. Caspase activity data (Figure 
5.4) and phosphorylation of Akt (Figure 5.5) have also been overlaid on the same 
pathway. Multiple anti-apoptotic pathway signaling leading to BAD phosphorylation was 
induced (q≤0.04) (Table 5.3). Hence it is evident from Figure 5.4, that repression of 
caspase 3/7 and caspase 9 activity in epithelial cells by B. infantis was concomitant with 
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increase in expression of cIAP (cIAP directly represses the activity of the effector 
caspases (71)), as well as increase in phosphorylation of Akt and repression of pro-
apoptotic proteins BAD (20) and BID (51). The expression profile of the pathway was 
similar in presence of the pathogen (Appendix Figure B2). Also, since B. infantis 
repressed the basal caspase 9 and 3/7 activity, but not that of caspase 8, it can be 
concluded that B. infantis down regulated the intrinsic death pathway which is initiated 
by non-receptor-mediated intracellular signals that cause changes in the inner 
mitochondrial membrane.  
 To gain further insights into signaling pathways and transcriptional networks 
regulated in the epithelial cells due to B. infantis, enrichment analysis was performed 
based on gene-sets from pathway databases (KEGG and Biocarta), and gene sets that 
contained genes which share similar transcription factor binding sites as defined in the 
TRANSFAC database (Table 5.3, Table 5.4, Table 5.5). Some of the enriched pathways 
(Oxidative phosphorylation, mitochondrial biogenesis, proteasome, peroxisome, cell 
junctions) were redundant with GO gene sets because of overlapping annotations. 
Presence of B. infantis significantly induced genes necessary for functioning of four 
receptor tyrosine kinase (RTK) mediated signaling pathways (i.e. hepatocyte growth 
factor signaling (q≤0.05), platelet derived growth factor signaling (q≤0.04), epidermal 
growth factor signaling (q≤0.05) and insulin signaling pathway (p≤0.05)). Expression of 
epiregulin (EREG),which is a ligand for epidermal growth factor receptor (44) was also 
strongly induced (q≤0)(~12-fold) after 120 minutes of incubation with B. infantis. 
Presence of B. infantis significantly induced expression of genes in the canonical G-
protein coupled receptor pathway (GPCR) (q≤ 0.04). Expression of four GCPR ligands 
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((CXCL1, CXCL2. CXCL3 and CCL20) was also significantly induced (q≤0). 
Presence/absence calls based on PANP (86) revealed that, of the four induced GPCR 
ligands, receptor for CXCL3 ( CXCR4 (82)) was expressed in the epithelial cells, while 
receptors for the other three ligands were not expressed. Expression of CXCR4 in Caco-2 
cells has also been reported by other groups (30). Subsequently, genes under regulation 
of transcriptional factors, whose activity is modulated downstream of RTK and GPCR 
pathways by phosphorylation through the MAPK pathway i.e. CEBPA, CREB1, NFkB, 
and SRF (Table 5.6) were also significantly induced (q≤0). IL6 along with four other 
chemokines (CXCL1, CXCL2, CXCL3 and CCL20) which are under the transcriptional 
regulation of NFkB (83) were strongly induced (q≤0) (16-32-fold) after 120 minutes in 
presence of B. infantis. Eight more genes associated with IL6 signaling pathway were 
also induced (q≤0.04). Furthermore genes downstream of the IL6 signaling, which are 
under the positive transcriptional control of phosphorylated STAT3 were also induced 
(Table 5.6) (q≤0). Hence B. infantis induced expression of genes downstream of RTK, 
GPCR and JAK-STAT signaling pathways. Also expression of agonists of the three 
signaling pathways (IL6 for JAK-STAT (35), EREG for RTKs (36) and CXCL3 for 
GPCR (88)) were also significantly induced, which likely induced an autocrine signaling 
loop in the epithelial cells. 
 Expression profile of the epithelial cells exposed to B. infantis alone and those 
exposed to B. infantis and S. ser. Typhimurium were directly compared, to look at the 
effect of S. ser. Typhimurium on the epithelial cells in presence of B. infantis. Addition of 
S. ser. Typhimurium blocked B. infantis mediated induction of the IL6 pathway (q≤0.02) 
(Appendix Table B2) in the epithelial cells. Genes annotated under GO category cell 
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junctions induced by B. infantis were also significantly repressed (q≤0.13) in presence of 
the pathogen as compared to when only B. infantis was present. Transcription of genes 
having a cAMP responsive element (CRE) in their promoter which is mediated through 
CREB1 binding was also significantly repressed (q≤0) (Appendix Table B2). CREB1 is 
activated by a variety of stimuli leading to phosphorylation of CREB1 (39). Repression 
of genes under the transcriptional control of CREB1 was concomitant with repression of 
four chemokines (CXCL1, CXCL2, CXCL3 and CCL20)(q≤0.01) which are GPCR 
ligands (88). Induction of epiregulin (EREG), which is a ligand for epidermal growth 
factor receptor (44) was also blocked in presence of the pathogen. Hence presence of the 
pathogen blocked B. infantis induced CREB1 mediated gene expression, which was 
likely a downstream effect of repression of ligands for the GCPR (CXCL3), RTK 
(EREG) and JAK-STAT (IL6) pathways. 
Gene expression profile of S. ser. 
Typhimurium 
 
 
 To gain insights into how S. ser. Typhimurium adapts to the presence of B. 
infantis in the host environment, I determined the gene expression profile of S. ser. 
Typhimurium interacting with Caco-2 cells with or without the presence of B. infantis at 
30 minutes, 60 minutes, and 120 minutes after interaction. Gene expression profile of 
Salmonella between the two treatments was compared using SAM (84) as an unpaired 
time course experiment with “signed area” as the time summary method. All the genes 
were ranked based on the score(d) from SAM output and this pre-ranked gene list was 
used with Gene Set Enrichment Analysis software (GSEA) (79) to detect the coordinate 
changes in the expression of groups of functionally related genes, upon respective 
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treatments. Table 5.6 lists differentially regulated gene sets in Salmonella interacting with 
the host, with or without the presence of B. infantis. Presence of B. infantis induced genes 
down-stream of the Qse two component system in Salmonella (57) irrespective of the 
presence of host (q≤0.09) (Table 5.6 and Appendix Table B1). Hence most likely the 
cross-talk between B. infantis and S. sv. Typhimurium was mediated through soluble 
factors sensed by the Qse two component system. The known ligands that trigger Qse 
two component system are epinephrine/norepinephrine (4) and autoinducer 3 (AI-3) (61). 
Epinephrine /norepinephrine are host stress hormones and have been shown to induce 
increased colonization and systemic spread of Salmonella (58). The exact biochemical 
pathway or the genetic basis for production of AI-3 is not characterized, however AI-3 
production has been shown to occur in variety of Enterobacteriaceae (85) including 
Salmonella, while AI-3 production in Bifidobacteria has not been tested yet. 
 Interestingly addition of B. infantis to the host/ Salmonella co-culture repressed 
genes related to arginine catabolism in Salmonella (Figure 5.9). This was reflected in the 
small metabolite profile, where addition of the B. infantis lead to accumulation of 
arginine and ornithine (the substrates), and depletion of putrescine (product). Catabolism 
of arginine is important from a virulence perspective for two reasons. First, catabolism of 
arginine is important for resistance to acid stress (29) and is required for full virulence. 
Secondly, arginine is a source of production of nitric oxide (NO) via nitric oxide synthase 
(iNOS) which is an important inflammatory mediator and necessary for protection of the 
host cell against the invading pathogen (46). Though the exact source of arginine, for NO 
production is not known, it is clear that in addition to intracellular sources of arginine, 
luminal sources of arginine are also required for optimal production of NO by the host 
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(67). Giardia lamblia uses depletion of arginine as a strategy to prevent NO production in 
the intestinal epithelium as shown by Eckmann et al. (23). I observed a depletion of 
arginine in absence of B. infantis (from Salmonella/Caco-2 co-culture), while arginine 
accumulated in B. infantis presence. Hence in presence of B. infantis there was an 
increased pool of arginine available for NO production. The major pathway for NO 
metabolism is the stepwise oxidation to nitrite (NO2
-)and nitrate (NO3
- ) (91). In presence 
of B. infantis, 9 genes related to nitrate and nitrite reduction were strongly induced (q≤0) 
in Salmonella (Figure 5.9, Anaerobic Metabolism).Genes required for synthesis of 
cofactors necessary for functioning of nitrate and nitrite reductases were also 
significantly induced (q≤0) (Table 5.9, Biosynthesis of cofactors- Prosthetic Groups- and 
Carriers- Molybdopterin). This Bifidobacteria mediated induction of nitrate and nitrite 
reductases in Salmonella did not happen in absence of the epithelial cells. Hence 
induction of nitrate and nitrite reductases in Salmonella was most likely a down-stream 
effect production of NO from the host. Hence our data suggests an elegant cross talk 
between the host, commensal and the pathogen, where the commensal prevented 
catabolism of arginine by the pathogen, which probably lead to increased NO production 
by the host as evidenced by induction of genes necessary form nitrate and nitrite in the 
pathogen. 
 Addition of B. infantis to the host/ Salmonella co-culture also repressed genes in 
Salmonella necessary for the TCA cycle (q≤0.09) and induced genes necessary for 
anaerobic metabolism (q≤0) (Table 5.6, Figure 5.9). Surprisingly genes necessary for 
functioning of the mitochondrial respiratory chain were also repressed in the epithelial 
cells as mentioned earlier by the addition of B. infantis into the co-culture (Table 5.1, 
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Table 5.2). Hence addition of B. infantis repressed genes necessary for respiration in 
Caco-2 as well as Salmonella. This was reflected in the small metabolite profile of the co-
culture where (Figure 5.9), addition of B. infantis in the Caco-2/ Salmonella co-culture 
caused a significant accumulation of glucose, fructose, trehalose and maltose (q<0.05) 
extracellularly as well as intracellularly. Glucose 6P, pyruvate and citrate also 
accumulated significantly while rest of the detected TCA metabolites (α ketoglutarate, 
malate, fumarate and succinate) though not statistically significant, showed a depleting 
trend. Hence based on the gene expression and small metabolite profile it can be 
concluded that addition of B. infantis to the co-culture of the host and pathogen, reduced 
the carbon flux through glycolysis and the TCA cycle, while presence of Salmonella 
alone with the host induced genes related to glycolysis (q≤0.01). Induction of glucose 
metabolism in the host epithelium due to Salmonella infection was also reported in vivo 
by Rodenburg et al .(70). The increased glucose catabolism perhaps leads to increased 
mitochondrial ETC function to regenerate the spent reducing equivalent (NAD+), which 
is the main source of reactive oxygen species (ROS) generation in the cell (33). 
Uncontrolled production of ROS directly activates caspase 9 (42) (intrinsic pathway), and 
indirectly activates caspase 8 (extrinsic pathway) via induction of Fas and Fas ligand 
expression (18), which further amplifies caspase 9 pathway. Hence, Bifidobacteria 
mediated blocking of Salmonella-induced caspase 8 and caspase 9 was concomitant with 
decreased carbohydrate metabolism in the host, as evidenced by gene expression in the 
host as well the small metabolite profile. 
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Gene expression profile of B. infantis 
 
 
To gain insights into how B. infantis responds to the presence of the epithelial 
cells and Salmonella, gene expression profiles of B. infantis were determined in cell 
culture media alone; in presence of Caco-2 cells and in presence of Caco-2 /S. ser. 
Typhimurium co-culture after 120 minutes of exposure. Expression profile of the treated 
B. infantis was compared to those of B. infantis incubated alone using SAM (84) as two 
class unpaired data, with t statistic. All the genes were ranked based on the score (d) from 
SAM output. This pre ordered ranked gene list was used in Gene Set Enrichment 
Analysis software (GSEA) (79) to detect the coordinate changes in the expression of 
groups of functionally related genes, upon respective treatments. Table 5.7 lists 
differentially regulated gene sets (q≤0.15) in B. infantis when they were incubated with 
epithelial cells (treatment) as compared to when they were incubated in the same 
conditions without the epithelial cells (control) for 120 minutes. Table 5.8 lists 
differentially regulated gene sets (q≤0.15) in B. infantis when they were incubated with 
Caco-2 /S. ser. Typhimurium co-culture (treatment) as compared to when they were 
incubated in the same conditions alone (control) for 120 minutes. 
 Presence of epithelial cells significantly induced transcription of genes with %GC 
content greater than 70 (q≤0) and less than 40(q≤0), irrespective of the presence of 
Salmonella. Hence these genes were important for the interaction of B. infantis with the 
host. Also since average %GC content of B. infantis is 60% (74) those genes were 
putative horizontally transferred genes (55). Protein translation as a gene set was induced 
(q≤0.01) when B. infantis was incubated with epithelial cells alone while the same gene 
set was significantly repressed (q≤0) when B. infantis was incubated in presence of 
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epithelial cells and S. ser. Typhimurium. Along with translation, oxidative 
phosphorylation was also significantly repressed (q≤0) in presence of epithelial cells and 
S. ser. Typhimurium. Hence presence of Salmonella along with epithelial cells reduced 
translation and energy metabolism in B. infantis. This effect was not observed when B. 
infantis was in presence of Salmonella alone (Appendix Table B4). Hence interaction of 
the pathogen and epithelial cells reduced the fitness of B. infantis. This was surprising as 
presence of B. infantis and Salmonella did not lead to increased expression of enzymes 
needed for reactive species generation (ROS) or increased expression of defensins in the 
epithelial cells which could reduce the fitness of Bifidobacteria. On the contrary in 
presence of both the bacteria, mitochondrial biogenesis and genes needed for generation 
of ROS were repressed in epithelial cells. Hence the fitness of B. infantis in presence of 
the pathogen and epithelial cells was reduced by a yet uncharacterized mechanism. 
 Recently, a comparative genomic hybridization (CGH) study with 15 different 
Bifidobacteria strains revealed that B. longum spp. has at least two distinct subspecies, 
subsp. infantis, specialized to utilize human milk oligosaccharides, and subsp. longum, 
specialized for plant-derived oligosaccharides (50). I reanalyzed the CGH data using 
GSEA and determined what functionally related gene sets were conserved in the infantis 
lineage but divergent in the longum lineage. The results are summarized in Appendix 
Table B5. As reported by Locascio et al. gene enrichment analysis revealed that the genes 
divergent between infantis and longum strains were enriched in functions related to 
human milk oligosaccharide (HMO) metabolism, urease metabolism and solute binding 
proteins of ABC transporters. Furthermore I also discovered clusters of putative 
horizontally transferred genes that were only present in the infantis lineage and absent or 
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highly divergent in the longum lineage. Surprisingly three of the gene sets related to 
horizontally transferred genes (genes with % GC >70, genes with % GC<40 and 
horizontally transferred genes from Firmicutes) were induced in B.infantis in presence of 
the host and pathogen. Hence these genes were most likely acquired through horizontal 
gene transfer in the infantis lineage and conserved in the genome under selective pressure 
from the host. Of the cluster of 50 genes that were putatively acquired through lateral 
gene transfer and also induced in presence of the host (Appendix Figure B3) 28 were 
hypothetical proteins with no known functions. 
 
Discussion 
 
 
 Many studies have linked prophylactic use of probiotics to reduced rate of enteric 
infections (6, 8, 11, 48). The pathogen exclusion potential of various probiotics is 
dependent on the probiotic as well as the pathogen strain (38). Hence I screened 5 
different probiotic strains and found that B. infantis excluded S. ser. Typhimurium most 
effectively among the tested strains. B. infantis blocked pathogen adhesion and invasion 
only if it was added before or with the pathogen. This indicates that it was not able to 
displace already adhered pathogen from the host cells. Among the tested host receptors B. 
infantis shared its binding specificity for ganglioside GM1 with Salmonella. Further I 
also showed that B. infantis blocked Salmonella mediated caspase 8 and caspase 9 
activation. It also reduced the basal caspase 9 and 3/7 activity in the epithelial cells. The 
reduction in caspase activity was concomitant with increased Akt phosphorylation and 
increased expression of the caspase-inhibiting cIAP protein family. Hence, B. infantis 
prevented the activation of the mitochondria-mediated intrinsic cell death pathway.  
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 Most pathogens have evolved mechanisms to subvert host signal transduction 
cascades to influence host cell death decisions (72). Mitochondria integrates a variety of 
signals and mitochondrial membrane permeabilization is the decisive event between cell 
survival and death (72). A variety of pathogen induce cell death by causing mitochondrial 
dysfunction (10, 53, 62) which is mediated through cytochrome c release in the 
cytoplasm leading to caspase 9 activation. During Salmonella infection the antioxidant 
defense system in the host is impaired due to excessive production of reactive oxygen 
species (ROS) (56).This has been shown to increase caspase 9 and caspase 8 activity and 
also observed in this study. A recent study (Shah et al, unpublished data) correlated the 
induction of genes involved in production of ROS , respiration, and mitochondrial 
biogenesis to increased caspase 9 and caspase 3/7 activation during Salmonella infection. 
Surprisingly, B. infantis repressed the same gene categories irrespective of presence of 
Salmonella and also repressed caspase 9 activity irrespective of the presence of pathogen. 
Hence apart from competitive exclusion, B. infantis also mitigated Salmonella mediated 
mitochondrial dysfunction in epithelial cells. It was recently shown that production of 
ROS in the gut gives Salmonella a selective advantage, as the ROS can react with luminal 
sulfur compounds to form tetrathionate which can be used by Salmonella to respire, 
giving it a competitive edge over fermenting gut microbes (87). Our data suggests that B. 
infantis could possibly block ROS production in the gut by down regulation of genes 
needed for aerobic respiration and functioning of the electron transport chain. This 
mechanism could contribute to the Bifidobacteria mediated resistance to Salmonella as 
observed in vivo in mice (75). 
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 B. infantis also induced NFkB mediated transcription of four cytokines IL6, 
CXCL1, CXCL2, CXCL3, and CCL20. Significantly all these genes were repressed in 
presence of Salmonella. Salmonella interferes with the host signal transduction by 
secreting a vast array of effector molecules directly into the host cytosol. One of the 
secreted effectors AvrA blocks NFkB activation by deubiquitination of IkBα (90) which 
leads to down regulation of target genes in the NFkB pathway s IL6, as observed in this 
study as well as by Ye et al (90). Hence presence of Salmonella blocked B. infantis 
mediated induction of NFkB , most likely through AvrA activity, which was induced in 
presence of B. infantis (q≤0). Immunostimulatory effects of Bifidobacteria have also 
been reported by other groups. Ruiz et al. (73) reported that in a mouse model, B. lactis 
triggers IL6 secretion from intestinal epithelial cells which was concomitant with 
activation of MAPK and NFkB signaling (73). In mouse embryogenic fibroblasts, B. 
lactis mediated induction of IL6 was completely dependent on TLR2 signaling (73). Li et 
al . have also reported the immunostimulatory properties of TLR9 dependent CpG motifs 
in Bifidobacteria DNA in macrophages (49).  
 Patients suffering from inflammatory bowel syndrome (IBS) typically report 
increased gut permeability and increased apoptotic rates of intestinal epithelial cells (40). 
In this study, I observed that B. infantis treated epithelial cells showed increased 
expression of tight junction and adherens junction proteins. This was also observed by 
Ewaschuk et al. where soluble factors in B. infantis conditioned media lead to increased 
transepithelial resistance (TER) in epithelial cells and concomitant increased expression 
of tight junction proteins. Hence B. infantis was functionally shown to improve the 
barrier function of epithelial cells. I also observed a B. infantis mediated decrease in 
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activation of caspase 9 and caspase 3/7 concomitant with increased phosphorylation of 
Akt in colonic epithelial cells. Two recent clinical trials showed that B. infantis 
intervention significantly reduced IBD related symptoms (7). The probiotic mixture 
VSL#3 has also been shown effective in management of IBS symptoms. Incidentally B. 
infantis is one of the eight strains present in the mixture (5). These observations suggest 
that B. infantis may be involved in maintaining the barrier functions of the gut epithelium 
in vivo by increased expression of tight junction proteins and by modulating the cell 
turnover rate. 
  To summarize, B. infantis competitively excluded Salmonella from binding to 
epithelial cells. It prevented Salmonella mediated caspase 8 and caspase 9 activation in 
epithelial cells and in absence of the pathogen B. infantis lowered the basal caspase 
activity of epithelial cells. The lowered caspase activity was concomitant with increased 
Akt phosphorylation, increased expression of caspase inhibiting protein (cIAP) and 
repression of genes involved in mitochondrion organization and biogenesis and reactive 
oxygen species metabolic processes. Using gene expression and small metabolite profile I 
also observed a three way cross talk between the epithelial cells, Salmonella and 
Bifidobacteria; where B. infantis prevented catabolism of arginine (a substrate for nitric 
oxide (NO) production) by S. ser. Typhimurium, making it available for increased NO 
production by the host as evidenced by induction of genes necessary for nitrate and nitrite 
(break down products of NO) respiration in the pathogen. Using comparative and 
functional genomics approach, I also discovered clusters of mostly hypothetical proteins 
which have been acquired in the genome of B. infantis through lateral gene transfer and 
are important for the interaction of B. infantis with epithelial cells. 
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Table 5.1 GO gene sets that were differentially regulated (q≤0.21) in Caco-2 cells when 
exposed to B. infantis. NES= Normalized enrichment score. A positive score indicates 
that the gene set was induced in Caco-2 cells when exposed to B. infantis, while a 
negative score indicates that the gene set was repressed. 
 
Name 
Size of 
Gene Set 
Genes 
Regulated 
NES 
FDR q-
val 
Biological process 
Aerobic respiration 15 9 -1.72 0.21 
Apoptotic mitochondrial changes 10 5 -1.78 0.21 
Base excision repair 13 6 -1.77 0.21 
Cellular component disassembly 22 9 -1.74 0.21 
Cellular protein complex disassembly 10 4 -1.70 0.20 
Coagulation 20 8 -1.72 0.20 
DNA catabolic process 16 10 -1.97 0.13 
Electron transport  34 14 -1.83 0.20 
Embryonic development 34 18 1.99 0.12 
Embryonic morphogenesis 10 8 1.90 0.19 
Mitochondrion organization and biogenesis 43 19 -2.35 0.00 
Negative regulation of cell differentiation 15 9 1.81 0.16 
Oxygen and reactive oxygen species metabolic 
process 
12 8 -1.87 0.18 
Pattern specification process 19 10 1.84 0.18 
Protein amino acid autophosphorylation 22 13 1.83 0.15 
Protein folding 50 26 -1.69 0.20 
Regulation of body fluid levels 26 10 -1.81 0.20 
Response to toxin 7 4 -1.96 0.10 
Ribosome biogenesis and assembly 12 8 -1.67 0.21 
rRNA processing 9 3 -1.77 0.20 
Transcription from RNA polymerase iii promoter 17 7 -1.68 0.20 
Cellular component 
Adherens junction 12 6 1.76 0.13 
Basolateral plasma membrane 22 9 1.78 0.16 
Cell junction 48 19 1.93 0.05 
Cell matrix junction 10 5 1.70 0.13 
Envelope 145 64 -1.92 0.01 
Intercellular junction 39 14 1.75 0.11 
Kinesin complex 11 7 1.64 0.18 
Mediator complex 8 5 -1.71 0.03 
Membrane enclosed lumen 341 133 -1.84 0.01 
Microbody 39 18 -1.78 0.02 
Mitochondrial envelope 85 46 -2.30 0.00 
Mitochondrial inner membrane 60 41 -2.67 0.00 
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Name 
Size of 
Gene Set 
Genes 
Regulated 
NES 
FDR q-
val 
Mitochondrial lumen 44 24 -2.63 0.00 
Mitochondrial matrix 44 24 -2.55 0.00 
Mitochondrial membrane 77 44 -2.33 0.00 
Mitochondrial membrane part 50 25 -2.64 0.00 
Mitochondrial part 128 72 -2.72 0.00 
Mitochondrial respiratory chain 23 16 -2.26 0.00 
Mitochondrial respiratory chain complex i 14 10 -2.34 0.00 
Mitochondrial ribosome 22 19 -2.78 0.00 
Mitochondrial small ribosomal subunit 11 10 -2.17 0.00 
Mitochondrion 283 161 -2.60 0.00 
NADH dehydrogenase complex 14 10 -2.33 0.00 
Nucleolar part 12 9 -2.09 0.00 
Nucleolus 91 31 -1.93 0.01 
Organellar ribosome 22 19 -2.79 0.00 
Organellar small ribosomal subunit 11 10 -2.19 0.00 
Organelle envelope 145 64 -1.96 0.00 
Organelle inner membrane 67 39 -2.67 0.00 
Organelle lumen 341 106 -1.86 0.01 
Organelle membrane 243 75 -1.84 0.01 
Peroxisome 39 18 -1.79 0.02 
Proteasome complex 22 16 -1.83 0.01 
Proton transporting two sector atpase complex 15 8 -1.71 0.04 
Respiratory chain complex i 14 10 -2.35 0.00 
Ribonucleoprotein complex 111 46 -2.41 0.00 
Ribosomal subunit 20 16 -2.70 0.00 
Ribosome 37 22 -2.70 0.00 
Small ribosomal subunit 11 10 -2.15 0.00 
Molecular function 
Aldo keto reductase activity 7 6 -1.68 0.12 
Antioxidant activity 14 12 -1.64 0.15 
Cytochrome c oxidase activity 12 8 -1.71 0.12 
Damaged DNA binding 18 6 -1.74 0.10 
Deoxyribonuclease activity 16 9 -1.69 0.13 
Electron carrier activity 58 28 -1.99 0.01 
Endonuclease activity 20 10 -1.78 0.08 
Endonuclease activity GO 0016893 10 6 -1.82 0.06 
Endoribonuclease activity 11 7 -1.92 0.03 
Exonuclease activity 14 9 -1.82 0.06 
Hormone activity 10 4 -1.71 0.13 
Methyltransferase activity 29 13 -1.67 0.13 
Nuclease activity 37 22 -2.05 0.01 
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Name 
Size of 
Gene Set 
Genes 
Regulated 
NES 
FDR q-
val 
Oxidoreductase activity 189 91 -2.05 0.01 
Oxidoreductase activity acting on NADH or 
NADPH 
21 13 -2.13 0.00 
Ribonuclease activity 17 10 -2.15 0.00 
RNA polymerase activity 13 7 -1.93 0.02 
Serine type endopeptidase activity 22 9 -1.71 0.11 
Serine type endopeptidase inhibitor activity 15 6 -1.68 0.12 
Structural constituent of ribosome 73 41 -2.05 0.01 
Transferase activity transferring alkyl or aryl 
other than methyl groups 
25 16 -1.88 0.03 
RNA polymerase ii transcription factor activity 
enhancer binding 
9 5 1.92 0.14 
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Table 5.2 Differentially regulated GO gene sets (q≤0.21) in Caco-2 cells when exposed to 
B. infantis and S. ser.Typhimurium. NES= Normalized enrichment score. A positive 
score indicates that the gene set was induced in Caco-2 cells when exposed to B. infantis 
and S. ser. Typhimurium, while a negative score indicates that the gene set was repressed. 
 
Name 
Size of 
Gene Set 
Genes 
Regulated 
NES 
FDR 
q-val 
Biological process 
Apoptotic mitochondrial changes 10 7 -2.15 0.02 
Mitochondrion organization and biogenesis 43 20 -2.43 0.00 
Oxygen and reactive oxygen species metabolic 
process 
12 7 -2.05 0.05 
Cellular component 
 
Coated vesicle membrane 13 3 -1.69 0.07 
Contractile fiber 15 8 -1.70 0.07 
Contractile fiber part 15 8 -1.71 0.07 
Envelope 145 57 -1.70 0.07 
Extracellular region 160 70 -1.68 0.07 
Extracellular space 80 33 -1.85 0.02 
Microbody 39 15 -1.67 0.07 
Microbody membrane 12 8 -1.64 0.08 
Microbody part 13 8 -1.68 0.07 
Mitochondrial envelope 85 36 -1.96 0.01 
Mitochondrial inner membrane 60 32 -2.33 0.00 
Mitochondrial lumen 44 27 -2.26 0.00 
Mitochondrial matrix 44 27 -2.17 0.00 
Mitochondrial membrane 77 34 -1.96 0.01 
Mitochondrial membrane part 50 36 -2.21 0.00 
Mitochondrial part 128 59 -2.27 0.00 
Mitochondrial respiratory chain 23 17 -1.90 0.01 
Mitochondrial respiratory chain complex i 14 9 -2.01 0.01 
Mitochondrial ribosome 22 18 -2.34 0.00 
Mitochondrial small ribosomal subunit 11 9 -1.95 0.01 
Mitochondrion 283 133 -2.22 0.00 
Nadh dehydrogenase complex 14 9 -1.98 0.00 
Nucleolar part 12 9 -1.92 0.01 
Nucleolus 91 39 -1.90 0.01 
Organellar ribosome 22 18 -2.36 0.00 
Organellar small ribosomal subunit 11 9 -1.97 0.01 
Organelle envelope 145 57 -1.73 0.06 
Organelle inner membrane 67 36 -2.43 0.00 
Organelle lumen 341 95 -1.57 0.02 
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Name 
Size of 
Gene Set 
Genes 
Regulated 
NES 
FDR 
q-val 
Organelle membrane 243 85 -1.64 0.08 
Peroxisomal membrane 12 8 -1.62 0.09 
Peroxisomal part 13 8 -1.66 0.07 
Peroxisome 39 15 -1.61 0.09 
Proteasome complex 22 16 -1.62 0.09 
Respiratory chain complex i 14 9 -2.02 0.01 
Ribonucleoprotein complex 111 59 -1.92 0.01 
Ribosomal subunit 20 16 -2.18 0.00 
Ribosome 37 25 -2.36 0.00 
Sarcomere 7 5 -1.65 0.08 
Small ribosomal subunit 11 9 -1.95 0.01 
Vesicle coat 13 3 -1.64 0.08 
Molecular function 
Carbohydrate binding 21 9 -1.77 0.09 
Carbon carbon lyase activity 16 8 -1.88 0.05 
Carboxy lyase activity 12 7 -1.97 0.07 
Cytokine activity 26 11 -1.72 0.11 
Glycosaminoglycan binding 12 7 -1.71 0.11 
Gtp binding 33 15 -1.93 0.08 
Gtpase activity 67 15 -1.89 0.05 
Guanyl nucleotide binding 33 15 -1.90 0.07 
Heparin binding 10 7 -1.92 0.07 
Hormone activity 10 5 -1.71 0.10 
Oxidoreductase activity acting on NADH or 
NADPH 
21 9 -1.85 0.06 
Oxygen binding 9 4 -1.84 0.06 
Pattern binding 13 8 -1.77 0.10 
Ribonuclease activity 17 12 -1.78 0.10 
Serine type endopeptidase inhibitor activity 15 8 -1.89 0.06 
Transferase activity transferring alkyl or aryl other 
than methyl groups 
25 11 -1.79 0.10 
  
156 
 
Table 5.3 Differentially regulated pathways (q≤0.05) in Caco-2 cells when exposed to B. 
infantis. NES= Normalized enrichment score. A positive score indicates that the gene set 
was induced in Caco-2 cells when exposed to B. infantis, while a negative score indicates 
that the gene set was repressed. 
 
Gene Set Size of 
Gene Set 
Genes 
Regulated 
NES 
FDR q-
val 
KEGG Pathway 
Parkinsons Disease 92 59 -2.78 0 
Oxidative Phosphorylation 96 63 -2.75 0 
Proteasome 39 27 -2.55 0 
Alzheimers Disease 118 58 -2.3 0 
Glutathione Metabolism 38 25 -2.16 0 
Huntingtons Disease 140 76 -2.14 0 
Spliceosome 104 54 -2.03 0 
Drug Metabolism Other Enzymes 24 11 -1.89 0.02 
Pyrimidine Metabolism 72 26 -1.88 0.02 
Ribosome 75 42 -1.86 0.02 
Peroxisome 60 29 -1.85 0.02 
RNA Polymerase 27 17 -1.82 0.03 
Metabolism Of Xenobiotics By Cytochrome P450 32 20 -1.82 0.03 
DNAReplication 32 18 -1.82 0.03 
Antigen Processing And Presentation 37 20 -1.82 0.03 
Type I Diabetes Mellitus 12 9 -1.77 0.04 
Arachidonic Acid Metabolism 21 14 -1.71 0.05 
Autoimmune Thyroid Disease 11 8 -1.71 0.05 
Notch Signaling Pathway 35 18 1.83 0.05 
Phosphatidylinositol Signaling System 45 22 1.89 0.04 
Hedgehog Signaling Pathway 27 7 1.9 0.04 
Adherens Junction 63 38 1.93 0.04 
Focal Adhesion 126 57 1.94 0.05 
Biocarta Pathway 
Proteasome Complex 18 13 -1.97 0.01 
Intrinsic Prothrombin Activation Pathway 14 9 -1.74 0.04 
Phospholipids as signaling intermediaries 20 8 1.86 0.04 
Multiple antiapoptotic pathways from IGF-1R signaling lead to 
BAD phosphorylation 
19 8 1.89 0.04 
GPCR Pathway 25 10 1.89 0.04 
IL 6 signaling pathway 19 8 1.91 0.04 
PDGF Signaling Pathway 27 10 1.92 0.04 
Thrombopoietin (TPO) Signaling Pathway 18 9 1.93 0.04 
EGF Signaling Pathway 27 10 1.94 0.05 
Insulin Signaling Pathway 18 8 1.96 0.05 
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Table 5.4 Differentially regulated Pathways (q≤0.05) in Caco-2 cells when they were 
exposed to B. infantis and S. ser. Typhimurium. NES= Normalized enrichment score. A 
positive score indicates that the gene set was induced in Caco-2 cells when exposed to B. 
infantis, while a negative score indicates that the gene set was repressed. 
 
Gene Set Size of Gene 
Set 
Genes 
Regulated 
NES 
FDR q-
val 
KEGG Pathway 
Proteasome 39 25 -2.35 0.00 
Parkinson’s Disease 92 50 -2.23 0.00 
Oxidative Phosphorylation 96 56 -2.22 0.00 
Antigen Processing And Presentation 37 24 -1.91 0.03 
Complement And Coagulation Cascades 32 17 -1.86 0.05 
Melanogenesis 64 25 1.92 0.03 
Basal Cell Carcinoma 30 16 2.02 0.01 
Notch Signaling Pathway 35 20 2.04 0.02 
Biocarta Pathway 
Proteasome Complex 18 11 -1.91 0.03 
 
  
 
 
Table 5.5 Top ten differentially regulated (q≤0) transcriptional regulons in Caco-2 cells when exposed to B. infantis. NES= 
Normalized enrichment score. A positive score indicates that the gene set was induced in Caco-2 cells when exposed to B. infantis, 
while a negative score indicates that the gene set was repressed. 
 
Gene Set 
Binding 
Motif 
Transcription Factor Remarks 
Size of 
Gene 
Set 
Genes 
Regul
ated 
NES 
FDR 
q-val 
V$CEBP_Q
2_01 
NTTRCNNA
ANNN  
CEBPA: CCAAT/enhancer 
binding protein (C/EBP), 
alpha 
Positive regulation by activated STAT3 (63), positive 
regulation by activity of Erk 1/2 (69) 
128 59 2.17 0.00 
V$CDPCR1
_01 
NATCGATC
GS  
 CUTL1: cut-like 1, 
CCAAT displacement 
protein (Drosophila) 
Negatively regulates transcription of genes; repression 
is relieved by phosphorylation of CULTL1 by PKA 
(59) and PKC 
53 19 2.04 0.00 
V$CREB_Q
2 
NSTGACGT
AANN  
 CREB1: cAMP responsive 
element binding protein 1 
Activated by a variety of stimuli leading to 
phosphorylation of CREB1 mediated by PKA 
principally through GPCR signaling (39)  
140 69 1.96 0.00 
V$CRX_Q4 
YNNNTAAT
CYCMN  
 CRX: cone-rod homeobox SNPs in CRX are correlated to Crohn's disease (1) 104 50 2.05 0.00 
V$NFKAPP
AB_01 
GGGAMTT
YCC  
 NFKB RELA: v-rel 
reticuloendotheliosis viral 
oncogene homolog A 
 Activated by a diverse group of receptors which 
include cytokine receptors, T cell receptors, growth 
factor receptors and Toll like receptors (54) 
95 46 1.97 0.00 
V$PAX8_01 
NNNTNNNG
NGTGANN  
 PAX8: paired box gene 8 
Activity is negatively regulated by glutathionylation 
of PAX8 (9) 
16 11 1.94 0.00 
V$OCT1_01 
NNNNWTA
TGCAAATN
TNNN  
 POU2F1: POU domain, 
class 2, transcription factor 
1 
 Activity positively regulated by BRCA (26) and 
negatively regulated by Glucocorticoid-GCR complex 
(45) 
 
103 54 2.27 0.00 
V$OCT1_03 
NNNRTAAT
NANNN  
 POU2F1: POU domain, 
class 2, transcription factor 
1 
Activity positively regulated by BRCA (26) and 
negatively regulated by Glucocorticoid-GCR complex 
(45) 
93 40 2.05 0.00 
V$SRF_Q4 
 
SCCAWATA
WGGMNMN
NNN  
 SRF: serum response factor 
(c-fos serum response 
element-binding 
transcription factor) 
This gene is the downstream target of many pathways; 
for example, the mitogen-activated protein kinase 
pathway (MAPK)  
124 45 2.10 0.00 
 
 
V$STAT3_0
2 
 
NNNTTCCN  
 STAT3: signal transducer 
and activator of 
transcription 3 (acute-phase 
response factor) 
This protein is activated through phosphorylation in 
response to various cytokines and growth factors 
including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2 
(64) 
75 25 2.08 0.00 
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Table 5.6 Differentially regulated gene sets (q≤0.09) in S. ser. Typhimurium when 
incubated with epithelial cells as compared to when incubated with epithelial cells and B. 
infantis for 120 minutes. NES= Normalized enrichment score. A positive score indicates 
that the gene set was induced in S. ser. Typhimurium when incubated with Caco-2 cells 
and B. infantis together, while a negative score indicates that the gene set was repressed. 
 
Gene Set Size of 
Gene Set 
Genes 
Regulated 
NES 
FDR q-
val 
Biosynthesis Of Cofactors- Prosthetic Groups- And 
Carriers- Molybdopterin 
9 6 1.60 0.08 
Cog J-Translation 170 107 2.51 0.00 
Cog K-Transcription 246 96 1.76 0.04 
DNA Metabolism- DNA Replication- Recombination- 
And Repair 
119 54 1.61 0.09 
Energy Metabolism- Anaerobic 66 26 2.21 0.00 
Genes Induced By QSE Two Component System 44 29 1.63 0.09 
Glycan Biosynthesis-Lps Biosynthesis 27 13 1.74 0.05 
Membrane Transport-Protein Export 16 11 1.80 0.03 
Protein Fate- Protein Folding And Stabilization 34 11 1.60 0.09 
Protein Fate- Protein Modification And Repair 20 11 1.64 0.09 
Protein Synthesis- Ribosomal Proteins- Synthesis And 
Modification 
61 46 1.94 0.01 
Protein Synthesis- Translation Factors 28 19 1.88 0.01 
Protein Synthesis- tRNA And rRNA Base 
Modification 
28 17 2.27 0.00 
Purines- Pyrimidines- Nucleosides- And Nucleotides- 
2-Deoxyribonucleotide Metabolism 
10 4 1.58 0.09 
SPI-3 9 4 1.60 0.09 
Transcription-RNAProcessing 7 6 1.60 0.08 
Mobile And Extrachromosomal Element Functions- 
Prophage Functions 
143 64 -2.41 0.00 
Mobile And Extrachromosomal Element Functions- 
Plasmid Functions 
28 24 -2.01 0.00 
Membrane Transport-ABC Transporters 174 57 -1.99 0.00 
HGT-High %GC 70 46 -2.60 0.00 
Genes With %GC Greater Than 60 196 100 -2.54 0.00 
Energy Metabolism- TCA Cycle 35 8 -1.65 0.09 
Cellular Processes- DNA Transformation 30 26 -1.99 0.00 
Biosynthesis Of Cofactors- Prosthetic Groups- And 
Carriers- Biotin 
8 4 -1.89 0.01 
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Table 5.7 Differentially regulated gene sets (q≤0.15) in B. infantis when incubated with 
epithelial cells as compared to when incubated in the same conditions without the 
epithelial cells for 120 minutes. NES= Normalized enrichment score. A positive score 
indicates that the gene set was induced in B. infantis when incubated with Caco-2 cells, 
while a negative score indicates that the gene set was repressed. 
 
Gene Set  
Size of 
Gene 
Set 
Genes 
Regulated 
NES 
FDR 
q-val 
Genes with %GC >70 48 26 2.53 0.00 
Genes with %GC< 40 34 17 2.05 0.00 
Translation 57 24 1.93 0.01 
Pyrimidine Metabolism 35 15 1.93 0.01 
Purine Metabolism 43 17 1.60 0.11 
Cog J Translation 137 41 1.89 0.01 
Cog F Nucleotide Transport And Metabolism 61 29 1.82 0.01 
CHO-Binding Module Family (Cazy) 5 2 -1.79 0.13 
Glycosyl Hydrolases (Cazy) 41 14 -1.78 0.07 
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Table 5.8 Differentially regulated gene sets (q≤0.15) in B. infantis when incubated with 
epithelial cells and S. ser. Typhimurium as compared to when incubated alone for 120 
minutes. NES= Normalized enrichment score. A positive score indicates that the gene set 
is induced in B. infantis when incubated with Caco-2 cells, while a negative score 
indicates that the gene set was repressed. 
 
Gene Set  
Size of 
Gene 
Set 
Genes 
Regulated 
NES 
FDR 
q-val 
Genes with %GC >70 48 24 2.44 0.00 
Genes with %GC< 40 34 17 2.02 0.00 
Unclassified 683 232 1.85 0.02 
Genes with %GC Content Between 40 and 50 108 24 1.60 0.14 
HGT from Firmicutes 114 36 1.54 0.15 
Translation 57 30 -2.31 0.00 
Oxidative Phosphorylation 11 8 -2.12 0.00 
Cog C Energy Production and Conversion 42 17 -2.01 0.00 
Cog J Translation 137 40 -1.81 0.02 
 
 
Table 5.9 Bacteria with their growth conditions and primers for their quantitation by qPCR 
Bacteria Growth condition qPCR primers Standard curve equation 
Salmonella enterica 
ser. Typhimurium 
LT2  
(ATCC 700720) 
Gene: 16s rDNA 
37°C / 220 rpm in serum 
free cell culture media. 
Cells were washed and 
suspended in fresh serum 
free cell culture media 
before interaction with 
Caco-2 cells 
Forward: TGT TGT GGT TAA TAA CCG CA 
Reverse: CAC AAA TCC ATC TCT GGA 
Log10 CFU = Ct-46.52/-
5.034 
R2 = 0.99 
Caco2 (ATCC HTB-
37) Gene: G3PDH 
See cell culture for growth 
description 
Forward: ACC ACA GTC CAT GCC ATC 
AC  
Reverse: TCC ACC ACC CTG TTG CTG TA 
Log10 CFU = Ct-33.69/-
4.13 R2 = 0.99 
Bifidobacterium 
longum subspp. 
infantis (ATCC 
15697) 
37°C/ Anaerobic in MRS 
broth + 0.05% Cys. Cells 
were washed and 
suspended in fresh serum 
free cell culture media 
before interaction with 
Caco-2 cells 
Forward: ACT ACC CCT GGC CTG AAC TT 
Reverse: GAC AGA GCG TAA CCC AGC 
TC 
 
Log10 CFU = Ct-36.31/-
2.624 R2 = 0.97 
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Figure 5.1 Efficacy of different strains to block Salmonella host association. Treatments 
with "*" are significantly different (p≤0.5) as compared to control (Caco-2 cells 
incubated with Salmonella alone). Error bars indicate standard error from 4 replicates. 
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Figure 5.2 Effect of presence of B. infantis on the relative adhesion and invasion of S. ser. 
Typhimurium to Caco-2 cells. Control (Caco-2 cells incubated with S. ser. 
Typhimurium); Sal-Pre + Bif(Caco-2 cells pre-incubated for 30 minutes with S. ser. 
Typhimurium and then with B. infantis for 30 more minutes); Bif-Pre+ Sal (Caco-2 cells 
pre-incubated with B. infantis for 30 minutes and then with S. ser. Typhimurium for 60 
more minutes); Sal+Bif (Caco-2 cells incubated with S. ser. Typhimurium and B. infantis 
together for 60 minutes); Sal+Bif Incubated(S. ser. Typhimurium and B. infantis were 
first incubated together for 60 minutes and then incubated with Caco-2 cells for 120 
minutes). Treatments that do not share an alphabet are significantly different (p<0.05). 
The % numbers of the x axis represents the fraction of total host associated bacteria that 
were intracellular (invaded). Error bars indicate standard error from three replicates. 
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Figure 5.3 Log2 ratios of genes involved in biogenesis of T3SS and its effectors in S. ser. Typhimurium grown in co culture 
with B. infantis or grown alone. A positive log2 ratio represent induction of genes in presence of B. infantis while a negative 
log2 ratio represents repression of genes. The q value was obtained from SAM.  
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Figure 5.4 Activity of caspase 8, caspase 9 and caspase 3/7 after 8 hours of incubation 
with either no microbe (control), or with B. infantis alone, or S. ser. Typhimurium alone, 
or B. infantis and S. ser. Typhimurium together. Means significantly different from 
control (p≤0.05) for each caspases are marked with "*". Error bars indicate standard error 
from 3 replicates. 
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Figure 5.5 Relative levels of phosphorylated Akt at ser-473 and thr-308 in epithelial cells 
upon infection with different microbes. Error bars indicate standard error from 2 
replicates. 
 
  
 
 
 
Figure 5.6 Dendogram visualizing similarity between global gene expression profiles of Caco-2 cells. The number at each 
cluster edge represents Approximately Unbiased % p value estimated by multiscale bootstrap resampling 1000 times. 
(Host=Caco-2 cells incubated with no microbes, Host+Bif= Caco-2 cells incubated with B. infantis, Host+Sal= Caco-2 cells 
incubated with S. ser. Typhimurium, Host+Bif+Sal= Caco-2 cells simultaneously incubated with 1:1 ratio of B. infantis and S. 
ser. Typhimurium. The time in minutes represent the time after infection at which the gene expression was determined  
 . 
 
 
Figure 5.7 Dendogram constructed by hierarchical clustering of small metabolite profile of all the host microbe interaction 
samples. The number at each cluster edge represents Approximately Unbiased % p value estimated by multiscale bootstrap 
resampling 1000 times (Host= Caco-2, Bif= B. infantis, Sal= S. ser. Typhimurium. The time in minutes represent the time after 
infection at which the metabolite profile was determined. "E" represents the extracellular metabolite profile from culture 
supernatant, while "I" represent the intracellular metabolite profile of all the cells in co-culture.
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Figure 5.8 Log2 ratios of differentially expressed genes (q≤0.1); caspase 8,9, 3/7 activity 
and phosphorylation status of Akt in epithelial cells when they are exposed to B. infantis. 
Data for Akt and caspase activity are same as Fig 5.2 and 5.3. For gene expression data, 
red represents induction while blue represents repression of genes when epithelial cells 
were exposed to B. infantis.  
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Figure 5.9 Log2 ratios of gene expression intensities of S. ser. Typhimurium and selected 
small metabolite peak areas when Caco-2 cells were treated with either S. ser. 
Typhimurium alone or with a co-culture of S. ser. Typhimurium and B. infantis. 
Induction of genes represent that the gene was induced in Salmonella in presence of B. 
infantis as compared to its absence. 
  
-1.64           0             2.69
-1.61           0             5.84
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CHAPTER VI 
SUMMARY 
 
 Food-borne bacterial infections are a substantial source of morbidity and mortality 
in humans (3). In 2008 Salmonella caused the highest morbidity for all reported bacterial 
Food-borne illnesses in the U.S. (1). The economic burden due to Salmonella alone in the 
U.S. is an estimated $2.8 billion (2). Salmonella is a big problem for food safety and 
public health. Broadly, this is because of zoonotic transmission of non-host adapted 
serovars between an animal, that is an asymptomatic carrier to food and subsequently to 
humans, that results in food related out breaks. While it is not possible to completely get 
rid of Salmonella from the livestock, efforts can be still be undertaken to reduce the load 
of the organism from the food chain. The number of pathogen outbreaks can also be 
reduced if the disease causing organism is detected earlier, so that remedial action can be 
taken quickly to control the spread of the disease. This work focused on developing 
strategies to block Salmonella infection and allow for rapid pathogen detection.  
 I hypothesized that B. longum subspecies. infantis reduces S ser. Typhimurium 
adhesion to gut epithelial cells by competing for the same receptors and also improves 
cell survival by modulation of specific pathways in the host. These hypotheses were 
tested via the following objectives. 
Objective 1. Define the pathogen exclusion potential of selected probiotic bacteria in 
vitro to gut epithelium.  
Objective 2. Define the binding partners of the host-bacteria interaction. 
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Objective 3. Identify signal transduction and metabolic pathways modulated in the host 
(Caco-2 cells) and the microbes in vitro due to adhesion of B. infantis and S. 
ser. Typhimurium over time.  
 Efficacy of probiotics in the prevention of gastrointestinal diseases has been 
observed in several in vivo and in vitro models, but this effect is strain dependent and 
there is limited knowledge about the mode of action of probiotics against enteric 
pathogens. I screened several probiotic strains for pathogen exclusion potential and found 
that Bifidobacterium longum subspp. infantis showed the highest potential for Salmonella 
exclusion in a cell culture model.  
 To identify new protein binding partnerships, I developed a cell-cell cross-linking 
protocol, in which bacterial cells were chemically cross-linked to host epithelial cells 
during infection using a cleavable crosslinker. The crosslinked proteins were identified 
by resolving the cross-linked complexes on 2D-gels. This approach identified several 
new receptor pairs in Salmonella and epithelial cells. Interaction of Salmonella Ef-Tu 
with Hsp90 from epithelial cells mediated adhesion, while interaction of Salmonella Ef-
Tu with myosin phosphatase and alpha catenin; two host proteins that negatively regulate 
membrane ruffling , mediated adhesion and invasion. Ef-Tu from Salmonella also 
induced phosphorylation of pro-survival kinase Akt. Ef-Tu is one of the most abundant 
protein on the cell, and this work proved that a sub population of the protein is membrane 
associated. Also Ef-Tu is a highly conserved protein across all Salmonella serovars, 
hence maybe an ideal vaccine candidate effective against all Salmonella serotypes. 
 I also identified host ganglioside GM1 as a receptor that mediated adhesion and 
invasion of Salmonella. Based on the fact that host glycosphigolipids can mediate 
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pathogen attachment, I screened a variety of enteric pathogens, commensals and 
probiotics for ganglioside binding. All the screened Salmonella, E. coli, Bifidobacteria 
and Bacillus bound a mixed population of gangliosides isolated from bovine buttermilk. 
Armed with this knowledge I developed a method for concentrating pathogens from 
samples without pre-enrichment. Immobilized gangliosides concentrated bacteria for 
detection with real-time PCR. A sensitivity of 4 CFU/ml (3 h) in samples without 
competing microflora was achieved. Samples with competing microflora had a sensitivity 
of 40,000 CFU/ml. In conclusion, I demonstrated the ability of gangliosides 
immobilized on 3-mm glass beads to concentrate pathogenic organisms and 
Bacillus spores directly from samples without pre-enrichment. Use of gangliobeads prior 
to a commercial RT-PCR kit for food pathogen detection improved the sensitivity 100-
fold. 
 Next I tested, if B. infantis blocked Salmonella adhesion and invasion by 
competing for the same epithelial cell receptors. I found that B. infantis shared its binding 
specificity to ganglioside GM1 with S. ser. Typhimurium, while it did not use 90KD heat 
shock protein, alpha catenin or myosin phosphatase for binding to the host. Furthermore, 
B. infantis completely inhibited, Salmonella-induced caspase 8 and caspase 9 activity in 
intestinal epithelial cells. B. infantis also reduced the basal caspase 9 and caspase 3/7 
activity in epithelial cells in absence of the pathogen. Western blots and gene expression 
profiling of epithelial cells revealed that the decreased caspase activation was 
concomitant with increased phosphorylation of the pro-survival protein kinase Akt, 
increased expression of caspase inhibiting protein cIAP and decreased expression of 
genes involved in mitochondrion organization and biogenesis and reactive oxygen 
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species metabolic processes. Hence B.infantis exerted it protective effects by repression 
of mitochondrial cell death pathways which was induced in presence of S. ser. 
Typhimurium. Gene expression analysis also revealed that B. infantis strongly induced 
expression of genes downstream of cAMP signaling, MAPK signaling and NFkB 
signaling. Using gene expression and small metabolite profiles I also observed a three 
way cross talk between the epithelial cells, Salmonella and Bifidobacteria. In these 
interactions B. infantis prevented catabolism of arginine (a substrate for nitric oxide (NO) 
production) by S. sv. Typhimurium, making it available for increased NO production by 
the host (Figure 6. 1). This was evidenced by induction of genes necessary for nitrate and 
nitrite (break down products of NO) respiration in the pathogen. Using a comparative and 
functional genomics approach I also discovered a cluster of 50 proteins that have been 
acquired in the B. infantis genome through lateral gene transfer. These gene clusters are 
highly conserved in only subspp. infantis and are induced only in presence of the host. 
Hence they have likely been conserved in the genome through selective pressure from the 
host. 
 In conclusion this work identified novel receptors in Salmonella that mediate 
adhesion and invasion, and therefore are candidates for vaccine development against 
Salmonella. Further, using immobilized host receptors I developed a method for 
concentrating pathogens from samples without pre-enrichment. Mechanisms for pathogen 
blocking by B. infantis included competition for GM1 binding, and inhibition of 
mitochondrial cell death pathway in the host as well as the catabolism of arginine in 
Salmonella. Therefore, I accept the hypothesis that B. infantis reduces S sv. Typhimurium 
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adhesion to gut epithelial cells by competing for the same receptors and improves cell 
survival by modulation of specific pathways in the host. 
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Figure 6.1Proposed three way interactions between host epithelial cells, S. ser. Typhimurium and B. infantis
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Figure A 1 Molecular structure of Sulfo-SBED as provided by the manufacturer. 
 
 
 
 
 
Figure A 2 Neighbor joining tree made by using Phylobuilder based on multiple sequence alignments of homologs of 
LBA0222. The blue box indicates the homologous proteins in L. acidophilus NCFM. 
 
  
 
 
 
 
Figure A 3 Cross-linked proteins resolved under non reducing conditions (1,2) and under reducing conditions (3,4)
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Table B 1 Two way ANOVA with repeated measures of relative levels of phosphorylated 
AKT at ser-473 and thr-308 in epithelial cells upon infection with different microbes at 
30, 60 and 120 minutes post infection. 
 
Source of 
Variation 
Df 
Sum-
of-
squares 
Mean 
square 
F 
% of 
total 
variation 
P value 
pAKT-473 
Interaction 6 1512 252 24 19.13 0.0001 
Time 2 608 304 29 7.69 0.0002 
Microbe 3 5419 1806 26 68.54 0.0045 
Residual 8 84 10    
pAKT-308 
Interaction 6 1213 202.2 4.514 18.69 0.0272 
Time 2 311 155.5 3.471 4.79 0.0822 
Microbe 3 4244 1415 15.44 65.36 0.0115 
Residual 8 358.4 44.8    
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Table B 2 Differentially regulated pathways (q≤0.05) in S. sv. Typhimurium when 
exposed to B. infantis as compared to normal growth. NES= Normalized enrichment 
score. A positive score indicates that the gene set was induced when exposed to B. 
infantis, while a negative score indicated that the gene set was repressed. 
Gene Set 
Size of 
Gene 
Set 
Genes 
Regulat
ed 
NES 
FDR 
q-val 
Amino Acid Biosynthesis- Glutamate Family 19 8 1.57 0.05 
Amino Acid Biosynthesis- Serine Family 21 5 1.55 0.05 
Biosynthesis Of Cofactors- Prosthetic Groups- And Carriers- 
Glutathione And Analogs 
6 5 1.55 0.05 
Cell Envelope- Biosynthesis And Degradation Of Surface 
Polysaccharides And Lipopolysaccharides 
82 29 1.86 0.00 
Cellular Processes- Chemotaxis And Motility 40 22 1.68 0.02 
Cellular Processes- Detoxification 28 16 1.56 0.05 
Cog F-Nucleotide Transport And Metabolism 80 56 1.87 0.00 
Cog J-Translation 170 94 2.27 0.00 
Cog M-Cell Wall Membrane Biogenesis 237 85 1.70 0.01 
Cog O-Posttranslational Modification Protein Turnover Chaperones 142 70 1.57 0.05 
Energy Metabolism- ATP-Proton Motive Force Interconversion 15 7 1.62 0.03 
Energy Metabolism- Pyruvate Dehydrogenase 8 6 1.73 0.01 
Fatty Acid And Phospholipid Metabolism- Biosynthesis 44 24 1.55 0.05 
Fur Regulon 66 33 1.87 0.00 
Genes Induced By Qse Two Component System 44 15 1.65 0.02 
Genes Regulated By HilA 17 11 1.68 0.02 
Genes Regulated By SsrA-SsrB Two Component System 117 55 1.55 0.05 
Glycan Biosynthesis-Lps Biosynthesis 27 23 1.85 0.00 
Membrane Transport-Pores Ion Channels 35 15 1.86 0.00 
Membrane Transport-Protein Export 16 14 1.64 0.02 
Membrane Transport-Secretion System 43 27 1.66 0.02 
Protein Synthesis- Translation Factors 28 19 1.80 0.00 
Purines- Pyrimidines- Nucleosides- And Nucleotides- 2-
Deoxyribonucleotide Metabolism 
10 6 1.70 0.02 
Purines- Pyrimidines- Nucleosides- And Nucleotides- Purine 
Ribonucleotide Biosynthesis 
18 16 1.77 0.01 
SPI-1 40 25 2.04 0.00 
SPI1-T3SS  30 21 1.79 0.00 
SPI2-T3SS  27 18 1.58 0.04 
T3SS  58 42 1.90 0.00 
T3SS Effectors 22 12 1.56 0.05 
Adherence Factors-Fimbrial 66 29 -2.61 0.00 
Cellular Processes- DNA Transformation 30 29 -3.82 0.00 
Genes With% GC Greater Than 60 196 102 -2.04 0.00 
Membrane Transport-Electron Transfer Carriers 31 20 -2.20 0.00 
Mobile And Extra chromosomal Element Functions- Plasmid 
Functions 
28 26 -3.68 0.00 
SPV Locus 4 3 -1.87 0.02 
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Table B 3 Differentially regulated pathways (q≤0.20) in caco-2 cells when exposed to B. 
infantis and S. sv. Typhimurium as compared to when exposed to only B. infantis. NES= 
Normalized enrichment score. A positive score indicates that the gene set was induced in 
Caco-2 cells when exposed to B. infantis and S. sv. Typhimurium, while a negative score 
indicated that the gene set was repressed. 
 
Gene Set 
Size of 
Gene 
Set 
Genes 
Regulated 
NES 
FDR q-
val 
Kegg Pathway 
Nod Like Receptor Signaling Pathway 33 7 -2.17 0.01 
Steroid Hormone Biosynthesis 23 3 -2.10 0.01 
Biocarta Pathway 
Ataxia Telangiectasia-mutated gene 
Pathway 
18 10 -2.12 0.01 
Il6 Pathway 19 9 -2.00 0.02 
GO Annotations 
Cell Junction 48 22 -2 0.13 
Regulation Of Cell Migration 14 8 -1.97 0.13 
Basolateral Plasma Membrane 22 9 -1.93 0.14 
Chemokine Receptor Binding 10 4 -1.94 0.15 
Chemokine Activity 10 4 -1.95 0.16 
Cell Matrix Junction 10 6 -2.02 0.20 
 
  
 
 
Table B 4 Transcriptional regulons that are differentially regulated (q≤0) in Caco-2 cells when they were exposed to B. infantis 
and S. sv. Typhimurium as compared to when they were exposed to only B. infantis. NES= Normalized enrichment score. A 
positive score indicates that the gene set was induced in Caco-2 cells when exposed to B. infantis and S. sv. Typhimurium, 
while a negative score indicated that the gene set was repressed. 
 
Gene Set 
Binding 
Motif 
Transcription Factor Remarks Size 
Genes 
Regul
ated 
NES 
FDR 
q-val 
V$CREB_
Q2 
NSTGAC
GTAANN 
CREB1: cAMP responsive 
element binding protein 1 
Activated by a variety of stimuli leading to 
phosphorylation of CREB1 mediated by PKA 
principally through GPCR signaling 
140 29 -2.17 0 
V$CREB_
Q4_01 
CNNTGA
CGTMA 
CREB1: cAMP responsive 
element binding protein 1 
129 40 -2.25 0 
V$CREB_
Q4 
NSTGAC
GTMAN
N 
CREB1: cAMP responsive 
element binding protein 1 
109 25 -1.99 0 
V$CREBP
1_Q2 
VGTGAC
GTMAC
N 
ATF2: activating 
transcription factor 2 
This protein binds to the cAMP-responsive 
element (CRE),The protein forms a 
homodimer or heterodimer with c-Jun and 
stimulates CRE-dependent transcription. 
134 31 -1.99 0 
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Table B 5 Differentially regulated genesets in B. infantis after 120 minutes of incubation 
with S. sv. Typhimurium as compared to B. infantis incubated alone. NES= Normalized 
enrichment score. A positive score indicates that the gene set was induced in B. infantis 
when exposed to S. sv. Typhimurium, while a negative score indicated that the gene set 
was repressed 
 
Gene Set  Size of 
Gene Set 
Genes 
Regulated NES 
FDR 
q-val 
Genes with%GC >70 48 24 2.64 0.00 
Cog J Translation 137 66 1.97 0.01 
Sec System 9 7 1.96 0.01 
Translation 57 28 1.78 0.04 
Other Transcription Related Proteins 4 4 1.75 0.05 
Purine Metabolism 43 17 1.66 0.09 
Drug Metabolism 5 4 1.65 0.08 
Histidine Metabolism 9 8 1.62 0.10 
Multi Transmembrane  460 198 -1.91 0.02 
Cog G Carbohydrate Transport and Metabolism 191 84 -1.90 0.01 
Glycosyl Hydrolases  41 17 -1.86 0.02 
Cog P-Inorganic Ion Transport and Metabolism 77 19 -1.78 0.03 
Sec Pi Substrate 574 235 -1.70 0.06 
Cog V Defense Mechanism 69 39 -1.68 0.06 
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Table B 6 Gene sets that are conserved in B. infantis but divergent in B. longum based on 
comparative genomic hybridization of 15 Bifidobacteria strains (q≤0.07). 
 
Gene Set Size of Gene Set 
Divergent 
Genes NES 
FDR q-
val 
ABC Transporters 76 50 -1.93 0.00 
Cog G Carbohydrate Transport And Metabolism 191 82 -1.68 0.01 
Cog V Defense Mechanism 69 35 -1.64 0.01 
Genes%GC Less Than 40 34 32 -1.79 0.00 
Genes with%GC Between 40 And 50 108 81 -1.82 0.00 
HGT from Actinomycetales 109 50 -1.81 0.00 
HGT from Firmicutes 114 81 -1.98 0.00 
Human Milk Oligosaccharide Utilization Cluster 61 50 -2.32 0.00 
Lipid Anchored  61 31 -1.58 0.03 
Multi Transmembrane 460 161 -1.5 0.07 
Protein Folding And Associated Processing 13 4 -1.63 0.01 
Sec PII Substrate 69 34 -1.61 0.02 
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Figure B 1 Effect of blocking selected Salmonella receptors with antibodies in Caco-2 
cells on the adhesion of B. infantis. Control represents the adhesion of B. infantis to 
unblocked caco-2 cells. Error bars represent standard error from 4 replicates. 
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Figure B 2 Log2 ratios of differentially expressed genes (q≤0.1) in epithelial cells when 
exposed to B. infantis and S. sv. Typhimurium. For gene expression data, red represents 
induction while blue represents repression of genes when epithelial cells were exposed to 
B. infantis and S. sv. Typhimurium. 
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Figure B 3 Genes in B. infantis that were putatively acquired by lateral gene transfer; 
were only conserved in the subspp. infantis and divergent in subspp. longum; and were 
induced in presence of epithelial cells and S. sv. Typhimurium (q<0.15). The heat maps 
represent averaged relative expression level of the genes under specific conditions from 
two replicates. 
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